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I declare that this thesis has been composed by me.
The wind doth blow,
And we shall have snow,
And what will poor Robbin do then?
He'll sit in a barn,
To keep himself warm,
And hide his head under his wing.
Anon., 1805.
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CFT complement fixation test.
Ci a unit of radioactivity defined as a
distegration fate of 3.7 x lO^/S.
CMI cell-mediated immunity or cell-mediated immune...
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3
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responded with lesions which evolved through classical
pox stages of papule, vesicle, pustule and scab. In
susceptible sheep they resolved within five weeks whereas
in re-infected sheep there was an accelerated response,
the lesions healing within three weeks.
Experiments were designed to correlate the roles of
humoral and cell-mediated immune responses with clinical
responses. Sera were analysed for changes in the levels
of total proteins, serum fractions, IgM, IgGl, IgG2 and
antibodies. Leucuocytes from infected and re-infected
sheep were also assayed for cell-mediated immune responses.
Changes in the total serum proteins of infected and
re-infected sheep, pre-challenge and post-challenge were
not significant. Contrarily, there were significant in¬
creases in the gammaglobulin levels in re-infected sheep
and slight increases in the levels in infected susceptible
sheep.
IgM levels of infected and re-infected sheep were not
markedly altered. IgGl and IgG2, in contrast, increased
significantly after infection and re-infection. The in¬
creases correlated positively with orf antibody titres.
The rate of antibody production was significantly
slower in infected sheep than in re-infected sheep and the
titres attained were much lower in susceptible sheep than
in re-infected sheep.
2.
Transfer of sensitized lymphocytes from recovering
re-infected sheep to susceptible lambs induced accelerated
clinical reactions when these lambs were challenged with
orf virus,
A preliminary study of the effects of immunosuppression
on the pathogenesis of orf, indicated that corticosteroid
delayed the appearances and prolonged the durations of the
lesions. It also delayed the onset of antibody production
and depressed antibody titres, markedly so in re-infected
sheep. It had no effect on the cell-mediated immune re¬
sponses in infected susceptible sheep.
In conclusion, dynamic relationships were found be¬
tween the lesion development and the humoral and cell-
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and goats, Many terms have been used to describe the
condition but the two most common and appropriate are
contagious pustular dermatitis and contagious ecthyma.
Although 'solid' immunity was believed to develop
after natural infection or vaccination, some antithetical
views have recently been expressed. Firstly, most re¬
covered or vaccinated sheep react to secondary challenge
with an accelerated response; normally in a primary re¬
action, the lesions resolve 28 to 40 days after infection
but in secondary reactions the lesions take only 10 to
14 days to resolve. Secondly, attempts to passively
transfer resistance to susceptible sheep using serum from
hyperimmunized or recovered sheep have always failed.
Furthermore, lambs from immune ewes, though receiving co-
lostral antibodies, succumb to the virus with a severe
primary reaction soon after birth. Moreover, vaccination
has been practised for many years and it seems to have
had very little effect on the endemicity of orf.
Several authors have suggested the involvement of
cell-mediated immune responses in pox viruses infections
and that these responses are mainly responsible for the
accelerated reactions after re-infections. The lesions
associated with re-infections with orf virus, however, are
unlikely to be due to a delayed—type hypersensitivity be¬
cause Osman (1976) detected virus multiplication in the
lesions. He also observed rapid clearance of the virus
and the purpose of this investigation is to establish
the possible explanation of this phenomenon. The pre¬
sent project, was therefore, aimed at ascertaining to
what extent humoral and cell-mediated immune responses








Orf was recognised as a contagious disease of
sheep and goats in Europe as early as the middle of
the eighteenth century (Steed 1787). It is a benign
disease characterised by the development of nodular
lesions at an}/ site where the integument is broken. The
commonest sites, therefore, are the lips particularly the
commissures, muzzle, nostrils, around the eyes, coronets
and the teats. Lesions will also appear at any other
site with a wound. The aetiological agent is a para-
poxvirus (Fenner and White, 1976).
Epidemiology
The disease has a world-wide distribution and occurs
where«*ver sheep and goat husbandry is practised. At
present, according to the FAO-WHO-OIE Animal Health Year¬
book (1977), the disease is of economic importance in
Europe, Australia, New Zealand, South Africa, Nigeria,
Zaire and India.
The natural hosts are sheep and goats of any age.
Orf has also been diagnosed in wild thar (Katerand Hansen
1962), chamois (Grausgruber 1964), alpacas (More 1965)
Musk ox (Kummeneje and Krogsrud 1978) and reindeer
(Kummeneje and Krogsrud 1979). Man is suceptible,
being infected xvhen handling infected animals (Hart,
Hayston and Keast 1949; Nagington and Whittle 1961).
8.
Siiuiiaiiy, uoys which had eaten an infected sheep skin
became infected (Wilkinson, I^ydie and Scarnell 1970),
Walley (1888) described orf as a pox-like infection
but he believed that the causative agent was Fusiformis
necrophorus, an opportune bacterium which was often
isolated from sheep naturally infected with orf. In
&
1923, Aynaud demonstrated a ftitrable virus which survived
in dry scabs and caused a disease with some similarities
to those caused by vaccinia-variola viruses.
Aetiology
The development of electron microscopy enabled
Nisbett (1954) and later Nagington, Newton and Home
(1964) and Peters, Mueller and Buttner (1964) to study
in detail the morphology of orf virus and its relation to
other pox viruses. They described orf virus as a mono-
morphic short rod with rounded ends, approximately 252 nm
by 158 nm in size. A tubular thread of 8 to lOp and
7 to 9 nm diameter was w©weO around the core giving the
whole virus particle a ball of yarn appearance. The
morphology and size of the orf virion closely resembled
that of other pox viruses. The dry weight of the whole
virion was 3.69 x lo"^^ and the molecular weight was
1.71 x 10~ (Ichihashi, Matsumoto and Dales 1971).
Peters and his colleagues (1964) showed that milker's
nodule virus, orf virus and bovine papular virus (BPS)
were morphologically more closely related to each other
9.
than to the vaccinia-variola poxviruses. They there¬
fore, suggested that they comprise a new group for which
they proposed the name, the paravaccinia of the pox-
viridae, Nagington, Tee and Smith (1965) further pro¬
posed that the group be renamed the orf sub-group because
orf virus was the-first in the group to be described in
detail. Earlier, in 1958, Webster had found immuno¬
logical relationships among orf, vaccinia and ectromelia
viruses using complement fixation and double diffusion
tests. Later, Wcodroofe and Fenner (1962) showed that
soluble antigens from pox viruses were sub-group specific
and nucleoprotein antigens were group specific. This was
confirmed by Papadopoulos, Dawson, Huck and Stuart (1968).
Several workers have shown that there is no plurality
of orf virus and that the viruses isolated from different
localities and designated as 'strains'in fact all conform
to a single type (Glover 1933; Manley 1934; Horgan and
Haseeb 1947; and Olah and Elek 1952).
Cultivation
Orf virus was first cultivated successfully in 1957
when Greig established virus obtained from infective scabs
in cell monolayer culture derived from embryonic sheep
skin cells. Subsequently, the virus has been establi¬
shed in other cell culture systems using both primary
cell cultures and cell-lines. Plowright, Witcomb and
Ferris (1959) for example reported that orf virus from in-
fected lambs caused cytopathic effects in cell monolayers
derived from lamb and calf testis and kidney^ and
MacDonald and Bell (1961) managed to grow the virus in
cell cultures from embryonic human liver cells. The
cytopathic changes in the cell cultures infected with orf
virus as reported by Greig (1957), Plowright and his col¬
leagues (1959) and Osman (1976) included discrete re¬
tractile cells, round giant cells, large paranuclear
cytoplasmic inclusions of ill-defined area, and varying
degenerative changes in the nuclei of infected cells.
Nagington (1968) studying the behaviour of para¬
vaccinia viruses in cell culture derived from different
host species, concluded that the main difference in their
behaviour occurred during the initial isolation from in¬
fective material, Orf virus from sheep and goat lesions
grew only in cell cultures from sheep tissues but lost
this specificity after a few passages, whereas, BPS virus
and pseudocowpox virus on first isolation were non-specific.
Pathogenesis
Experimental infections of sheep with orf virus pro¬
gress through the classic stages of a pox infection,
namely, macules, papules, vesicles, pustules and scabs
(Walley 1888; Romero-Mercado 1969; Gsman 1976), The
evolution of the natural disease is less well-defined;
most skin lesions being recognized as encrusted nodules
and oral lesions as strawberry-like proliferations.
Uncomplicated lesions arise when the virus gains
entry to the host through broken skin at the site of a
small wound or an abrasion and penetrates the epidermal
cells. Replication of the virus particles causes bal-
n
looning degeneration, nuclear shrikage, and karyolysis
of the cells of the malpighian layers. Cells in the
basal layer undergo proliferative activity leading to
marked acanthosis and elongation of the retia pegs. In¬
flammation sets in accompanied by hyperaemia, oedema and
accumulation of mononuclear cells, especially in the
dermis (Nisbett 1954; Kluge, Cheville and Peeflry 1972).
Healing usually takes place within 40 days depending on
the site involved and the age of the animal. Secondary
infection caused by bacteria or invasion by parasites
such as screw-worm fly larvae can lead to complications
which adversely affect healing and result in mortality
(Blanc 1922; Howarth 1929; Boughton and Hardy 1934;
Hart et al., 1949).
IMMUNOGENESIS OF ORF
General
Several groups of workers have reported that an
animal which has recovered from a natural infection with
orf virus or which has been vaccinated against orf ac¬
quires a 'solid' immunity but there is a considerable dif¬
ference of opinion as to the nature, duration and degree
of this immunity. Aynaud (1923) said that immunity
(1925) claimed that immunity followed both natural and
experimental disease, but that the immunity was not
always of long duration and might disappear after five
to eight months. Glover (1928) showed that, under
experimental conditions, recovered animals possessed a
high degree of immunity which protected them against re¬
infection for a period of at least eight months. Carre'
(1932) reported that animals recovering from natural in¬
fection remained immune for two and a half years, whereas,
vaccinated animals became susceptible after only one year.
In contrast, Boughton and Hardy (1934), investigating
whether vaccination offered a practical and dependable
means of protecting lambs from orf, found that not all
vaccinated animals were completely immune to challenge
when the virus was rubbed into scarified skin. There
was a reaction to the second exposure but the reaction
was of a milder character and of shorter course. The
finding that most of the recovered animals reacted to
secondary challenge was confirmed by Hart and his co¬
workers (1949), Wheeler and Cawley (1956) Schmidt (1967)
and Osman (1976). The secondary reaction produced the
classical stages of a pox infection but the course and se¬
verity of the lesions were markedly shortened compared to
the primary reactions. In addition, Osman (1976) found
that virus multiplication occurred at the site of re-
infection, Using electron microscopy. Osman (1976)
established that the replication of the virus in primary
and secondary infections was readily divisible into
phases of eclipse, exponential increase, plateau, ex¬
ponential decline and resolution. The growth curves
however, differed dramatically; during the exponential
decline phase in the secondary responses, the virus disa¬
ppeared abruptly whereas, in primary response there was a
gradual disappearance of the virus.
Humoral Immunity
The capacity of orf virus to stimulate the production
of specific antibodies in the host has been demonstrated
by many workers including Glover (1933), Nisbett (1954),
Romero-Mercado (1969) and Lutu (1971). Furthermore,
Romero-Mercado (1969) managed to differentiate between
heat-stable soluble complement-fixing orf antigens and
heat-labile soluble precipitating orf antigens. Hence,
antihodie sin the sera of recovered or vaccinated animals
have been revealed using a number of different serological
tests,
Complement fixation tests : Glover (1933) using the
complement fixation test (CFT) demonstrated the presence
of orf antibodies in hyperimmunized lambs but had dif¬
ficulty in detecting these antibodies in the serum samples
from convalescent animals. Similarly, Manley (1934)
failed to observe any specific fixation of complement
with serum from convalescent sheep but Abdussalam (1958)
demonstrated orf antibodies in sera from both convales¬
cent and hyperimmunized sheep, MacDonald and Bell
(1961) using CFT found that orf antibodies developed
prior to any other antibodies in experimentally infected
sheep, Romero-Mercado (1969) and Lutu (1971) found
that in primary infections of sheep with orf virus anti¬
bodies capable of fixing complement developed towards
the end of the first week after infection and persisted
for up to the twentieth week but, when these sheep were
re-infected, high antibody titres were not detected by
CFT,
Precipitation tests: Orf antibodies detectable by
tube precipitation tests were not demonstrated in the
sera from hyperimmunized lambs or convalescent sheep by
Glover (1933) or Manley (1934), Abdussalam (1958) on
the other hand, using tube precipitation tests found that
sera from convalescent lambs gave weak precipitin reactions
with first supernatant or buffer solution in which orf
virus had been suspended and concluded that because of
the weak reaction shown by the sera from convalescent
animals and none by scab extracts the test was not of dia¬
gnostic value for orf as it was for vaccinia. However,
Romero-Mercado (1969) and Lutu (1971), using gel diffusion
technique, were able to detect antibodies in the sera from
naturally and experimentally infected sheep and convales¬
cent sheep by the precipitation tests. They both found
that the gel diffusion test xvas less sensitive for de-
tectina antibodies in sheep with primary reactions to
orf virus whereas, high orf antibody tit res were readily
detected by gel diffusion in sheep re-infected with orf
virus or re-vaccinated against orf.
Neutralization tests : Aynaud (1923) was unable
to demonstrate any inactivating effect of sera from con¬
valescent sheep on orf virus in a crude scab suspension
whereas, Glover (1933) showed that sera from hyperimmunized
and
lambs/to a lesser extent, sera from convalescent sheep
had a neutralizing effect on orf virus suspensions.
Abdussalam (1958) verified Glover's findings but MacDonald
and Bell (1961) failed to neutralize the effect of the
virus using sera from convalescent sheep and infected
human beings. Trueblood, Chow and Griner (1963) simi¬
larly, failed to inactivate orf virus with serum from
hyperimmunized or recovered animals and this led them to
suggest that there was lack of protective antibodies in
animals infected with orf virus. In addition, Khanduev,
Guesev and Dzhakulov (1969) reported that serum from re¬
covered sheep failed to inhibit the growth of orf virus
in cell cultures although the sheep themselves resisted
re-infection. They, therefore, postulated that pro¬
tective antibodies might be produced at the site of in¬
fection. Poulain, Gourreau and Dautigny (1972) claimed
that orf virus adapted to grow in sheep foetal muscle cell
culture was neutralized by sera from sheep infected with
orf virus, convalescent sheep and sheep vaccinated against
orf. rney also claimefl that the neutralizing etrect
was transmitted through the colostrum and therefore,
advocated the immunization of pregnant ewes in order to
protect their offspring0 Boughton and Hardy, however,
many years previously (1934) had conclusively shown that
colostrum from recently vaccinated ewes did not protect
their lambs0
Agglutination tests : None of the many investigators
studying the immunology of orf were able to detect orf
antibodies in sera from convalescent or hyperimmunized
sheep by agglutination or haemagglutination tests (see
for example, Glover 1933; Manley 1934; Boughton and
Hardy 1934; Abdussalam 1958; Romero-Mercado 1969; Lutu
1971).
Passively Acquired Immunity
Boughton and Hardy (1934) found that the progeny of
ewes which were immune to orf did not acquire immunity
passively by ingesting colostrum. When such lambs were
challenged within 72 hours of birth they developed a
severe form of the disease. This observation was cor¬
roborated by Trueblood and his colleagues (1963), Romero-
Mercado 1969, Lutu 1971 and Kerry and Powell (1971).
Kerry and Powell (1971) in addition, found that neonatal
lambs responded satisfactorily to vaccination.
Khanduev and his comrades (1969) and Gsman (1976)
likewise, were unable to protect susceptible sheep from
orf infection by injecting them with sera from hyper-
immunized sheep or convalescent sheep.
Cellular Immunity
Boulter (1969), reviewing the situation of protection
against poxviruses noted that, although there was general
agreement that humoral factors played an important role
in acquired immunity to pox virus infection, recent evidenc
showed that immunity to these infections were not due
solely to antibodies. He suggested that the integrity
of the cellular mechanisms of immunity, which were mani¬
fested by delayed hypersensitivity, were of vital im¬
portance in the immunity to poxviruses. Blanden (1971)
evaluated the contributions to host responses in the re¬
covery from mousepox infection in susceptible mice in
which some were passive recipients of spleen cells from
immune mice, some were injected with hyperimmune sera and
others received interferon. He found that immune
spleen cells transferred highly efficient anti-viral
activity into susceptible mice whereas, hyperimmune serum
was significantly less virucidal and the interferon was
ineffective. He also showed that the immune spleen
cells released mediators of cell-mediated immunity in
vitro when exposed to mousepox antigens.
Although it was suggested long ago that cell-
mediated immunity contributed to primary vaccinia virus
infections (Portier and Richet 1901; Pirquet 1907) and
that cell-mediated immune responses were responsible
for the accelerated reaction to re-vaccination with
vaccinia virus against smallpox (MacKinnon and Defries
1931; Craigle and Wishet 1933; Broom 1947 ), it is
only recently that these suggestions have been accepted,
A number of clinical conditions have been recognized in
human beings in recent years which exemplifies the im¬
portance of cell-mediated immune responses in vaccinia
virus infections. For example, Glasgow (1970) cited
a case of progressive vaccinia in a patient who had no
demonstrable abnormalities of humoral immune responses.
After immunoglobulin therapy failed to arrest the prog¬
ress of the lesion, transfer of leucocytes from an immune
donor was tried and resulted in improvement and eventual
recovery from the infection.
The possibility that immunity to orf might be due
to factors other than humoral responses was first sug¬
gested by Aynaud (1923) who, having failed to demonstrate
any neutralizing effect in serum from convalescent sheep,
postulated that immunity to orf was mediated by cellular
elements. This hypothesis was not seriously considered
until 1976, when Osman attempted to transfer orf immunity
to susceptible lambs using immune cells from sheep which
had just recovered from orf, He harvested spleen cells
from the recently recovered sheep and transferred them in
to susceptible lambs which he then challenged with orf
virus. The results were not conclusive. Nevertheless
Csman (1976) speculated, that the presence ox anxiDoaies
in the immune sheep played an important part in the ac¬
celerated secondary response of enhancing the multi¬
plication of the virus at the site of re-infection.
Enhanced virus virulence has been attributed to
maternally derived antibodies in infants and calves in¬
fected with respiratory syncys-tial virus (Kapikian jet al.
1969; Kim et al., 1970; Chanock et ad., 1970; Smith
et al., 1975; Macintosh _ejt al., 1978). The develop¬
ment of lymphocytic choriomeningitis disease in mice has
also been attributed to cell-mediated responses directed
against their own virus-infected tissue,and humoral anti¬
bodies are thought to modulate this interaction (Rowe
1954; Hotchin 1971). Rowe (1954) had observed that
the severity of the disease was reduced in thymectomized
neonatal mice but the severity was restored when the thy-
mectomized mice were implanted with thymus cells. How¬
ever, Osman (1976) did not observe accelerated responses
when susceptible sheep were challenged immediately after
receiving hyperimmune serum. In fact, typical primary
reactions resulted.
IMMUNIZATION
After the aetiology of orf was established numerous
workers investigated methods of actively immunizing
animals. Aynaud (1923) treated dried infective scabs
20.
with chloroform and glycerins and claimed to have used
it successfully as a vaccine,, In England, Glover
(1933) likewise, claimed to have used successfully a
vaccine composed of infective scab suspension in glycerine.
Boughton and Hardy (1934) developed a vaccine made out
of dry powdered crusts which was diluted immediately be¬
fore use with distilled water and this was widely used
by farmers in the U.S.A. Hart and his colleagues (1949)
used suspensions of scabs from naturally occurring cases
ground in 50 percent glycerine and saline as a vaccine
in Australia. A major hazard of using live virus
vaccines was the establishment of foci of infection;
vaccination of clean flock therefore was not advised.
(Anon., 1973).
Olah and Elek (1953) were able to protect susceptible
sheep against orf using formalin inactivated virus.
Similarly, Richter and Jansen (1968) found that heat in¬
activated vaccines evoked a reasonable immunity and re¬
commended this vaccine for flocks not yet infected with
orf virus.
Vaccination was recommended just before the risk
periods of the year and if the periods were prolonged a
six-monthly revaccination was advised (Anon., 1973).
Kerry and Powell (1971) advocated the vaccination of a
day-old lamb because there was no evidence of maternally
acquired immunity in the lambs.
t
Several commercial vaccines are at present available
and contain mild live virus levigated in either glycerine
or blue-green base, Wellcome Veterinary Division
supply an orf vaccine which consists of glycerinated sus¬
pension of scab material obtained from sheep infected with
a modified strain of orf virus. Tasman Vaccine Labor¬
atory also supply a mild living orf virus vaccine sus¬
pended in a blue-green base recommended for use in sheep
prior to the time of the year when the disease usually
appears.
Most literature on orf vaccination is open to censure
because details regarding methods of assessing the induced
resistance are seldom given. There is no quantitative
evidence, moreover, that vaccination has altered the






In this chapter, the general materials, equipment
and techniques used throughout the undertaking of the
project are described in detail. The formulation of
buffers, stains and fixatives and commercial suppliers
of reagents are given in Appendix II.
THE VIRUS
The strain of orf virus used was collected from
naturally infected sheep on Easter Bush Farm, Roslin,
Scotland. The scabs were removed from the lesions
using sterile forceps and stored in plastic bijoux at
-20°C for periods between six and 48 months. To pre¬
pare a 20 percent suspension of the virus particles,
the scabs were thawed and then soaked for 15 minutes in
phosphate buffered saline (PBS) at pH 7.3 before being
ground in a mortar. The PBS diluent also contained
50 mg of streptomycin and 100 units of penicillin per ml.
The suspension was centrifuged in glass universal bottles
at 1610 g^ for 30 minutes. The supernatant fluid was
harvested and five ml aliquots were stored in glass
bijoux at -114°C for use as a source of virus for ex¬




Suffolk and Cheviot sheep and their crosses were
1 3,000 rpm in MSE Superminor Centrifuge.
24.
ub tdJ.Il^u frOlu Edi Ltii Bus>li FcLjTm cuid. "tilt; Muiculin Research
Institute, Edinburgh. Most were weaners but maturer
and younger lambs were used in some experiments.
The sheep were designated 'susceptible' or 'previously
infected' sheep. Those designated as susceptible came
from a flock which had been examined clinically every
fortnight for more than 10 years and the animals had no
apparent signs or history of orf. Those designated
as previously infected were animals in which the disease
had run its full course after natural or experimental in¬
fection with orf.
The animals were housed and fed hay supplemented
with a concentrated diet based on oats. During the
course of experimental infection they were held indivi¬
dually in metal crates.
Rabbits
New Zealand White rabbits kept individually in cages
were used for producing antisera to orf virus, whole sheep
serum, sheep IgGl, sheep IgM and sheep IgA. They were
2
fed commercially prepared balanced diets .
Goats
White goats were used for producing antisera to
sheep IgG2. These goats were housed with sheep and fed
hay supplemented with concentrates.
2 Oxoid Ltd.
V-J UXiiC C-i. O
Mature guinea pigs were used for producing peritoneal




The first step in infecting sheep was to scarify
the skin to permit entry of the virus. A multi-cross
pattern was scratched on the inner side of one of the
thighs using four sterile disposable blood lancets1 bound
together with a tape. Inoculation of the orf virus was
then accomplished by dropping 0.1 ml of 20 percent scab
virus suspension onto the scarified skin from a one ml
tuberculin syringe and then rubbing the suspension into
the wound using the shaft of the hypodermic needle. The
animals were examined daily for lesion development using
2
an optical flashlight .
There was no obvious systemic response following the
application of orf virus suspension to the scarified areas.
The local reaction which occurred evolved through the
following stages. There was reddening and slight oedema
along the lines of scarification on the second and third
day after infection. This was followed by development
1 Microlance, Becton, Dickinson and Company.
2 Magnalite, Manning Holoff Company.
26.
of papules then vesicles which contained clear serous
fluid on the fourth and fifth day post-inoculation. On
the sixth day the vesicles were prominent, raised and
confluent . Pustules became manifested on the seventh
day. The infected area was at this stage surrounded
by a zone of congestion. By the tenth day crusts were
evident and had started to dry up along the edges of the
lesion to form a firm and brittle scab. Removal of the
scab at this stage revealed a raised, raw, bleeding sur¬
face. Complete resolution varied; with susceptible
animals it took four to six weeks and with re-infected
sheep it took two to three weeks ..
CELL CULTURE TECHNIQUES
Primary Cell Cultures
Lamb testis (LT) cells and calf testis (CT) cells
were employed for primary cell cultures.- They were pre¬
pared as follows by the method described by Osman (1976)
with minor modifications. Fresh testes, removed
aseptically from the donor, were placed in a sterile
beaker with sterile Hanks' balanced salt solution (HBSS)
containing 50 mg of streptomycin and 10O units of penicillin
per ml. and 10 percent of foetal calf serum"'". The paren¬
chyma of the testis was exposed, detached from the Tunica
albuginea and rinsed several times in HBSS, before
1 Gibco Biocult Ltd.
27.
cutting into email fragments with scissors. The frag¬
ments were washed further in HBSS and placed in a conical
flask to which four volumes of 0.25 percent trypsin were
added to one volume of the fragments. The mixture was
gently agitated with a magnetic stirrer for 30 minutes at
37°C. The supernatant fluid was discarded and fresh
trypsin added to restore the original volume; trypsini-
zation was allowed to proceed at 37°C with agitation as
before. The supernatant fluid was harvested periodi¬
cally and fresh trypsin added until all the fragments were
completely digested. The cells were then sedimented at
4°C, washed twice in HBSS and once in Eagles Growth
Medium (EGM) consisting of 10 percent Eagles medium in
2 1
Earles salts , 10 percent of new born calf serum , 10
percent of tryptose broth, 200mmol of glutamine, 1G0 units
of penicillin, 50 mg of streptomycin and 2.5 ml of 4.4
percent of sodium bicarbonate. The viability of the
cells was checked and viable cells counted using the
Nigrosin dye exclusion method (Appendix II). The cells
4
were then diluted in the EGM to 10 cells/ml and either
seeded in test-tubes or Roux bottles or stored in glass
bijoux at -114°C after the addition of dimethyl sulphoxide
to give a concentration of 7.5 percent.
Established Cell Lines





from African green monkey kidneys, was obtained from a
commercial source^ They were seeded and maintained
2
in Tissue Culture 199 (TC199) growth medium in test
tubes or tissue culture flasks.
Adaptation of Orf Virus to Cell Cultures
The virus was grown in primary monolayer of lamb
testis cells inoculating 0.1 ml of a 10 percent virus
suspension into each tube. On first passage, complete
cell destruction was observed within 48 hours. This was
also observed in the second passage but in the third pas¬
sage, cytopathic changes started appearing on the third
day post-inoculation in the forms of discrete refractile
cells, followed by swelling and rounding up of the infected
cells. On the fifth day after inoculation about 50 per¬
cent of the cells were clumped or detached from the wall
of the culture tubes . ' The titre of virus
3
obtained was 2.15 x 10 TCID^ /ml in the LT cells and it
did not increase despite serial passages.
After at least five passages in LT cells, the virus
was further passaged in CT cells to obtain high yields
of the virus. The viral titre attained was 3.16 x 10^
TCID^/ml.
VERO cell-adapted orf virus was gifted by Dr. Omar
A. H. Osman and this was used as source of antigens for
serological tests after three passages in VERO cells.
1. Gibco Biocult Ltd.
2. Wellcome Reagents Ltd.
The virus was always harvested from infected cells
by immersing the test tubes or culture flasks alternatively
in dry ice and warm water three times. The frozen and
thawed culture fluid was then centrifuged at l,600g for
15 minutes. The supernatant fluid was collected and
stored in glass or plastic universal bottles at - 20°C.
Virus Titrations
Cell monolayers of either testis cells or CT cells
were established on test-tube walls or flying cover-slips
in test-tubes and 0.1 ml of a series of ten-fold dilution
were added to each tube. Four tubes were used for each
dilution. The cultures were then incubated at 37°C for
one hour to allow the virus to be adsorbed and penetrate
the cells. Maintenance medium containing 5 percent of
calf serum was added and the cultures incubated at 37°C.
They were examined microscopically every day over a period
of seven days for evidence of cytopathic changes. The
titres were calculated using the Reed-Muench formula
(Lennette and Schmidt, 1969).
The flying cover-slips were stained with Giemsa"*"
after fixing the monolayers in methanol and were examined
under oil-immersion for intracellular changes.
MICROSCOPIC STUDIES
Light Microscopy
Cell cultures were examined by light microscopy to
1 Giemsa stain.
detect the presence of the virus by the cytopathic changes
in the cells. An inverted light microscope^ was used
for examining the cell cultures for confluent monolayers
in control uninfected cultures and cytopathic effects in
the infected cultures. Stained coverglips of infected
3
cells were examined with a standard light microscope for
evidence of cytoplasmic and nuclear changes .
Electron Microscopy
Electron microscopy was the ultimate tool used for
confirming the presence of orf virus in scabs, in infected
cell cultures and in medium from infected cell cultures.
Direct negative staining was carried out on a copper
grid. A copper grid of 400 mesh and 3 mm diameter,
coated with carbon was laid on the material to be examined
for 30 seconds. The excess fluid on the grid was removed
with filter paper. The virus particles were then stained
using two percent phosphotungstate acid (PTA) or methyl-
amine tungstate (MT). Staining was done by layering
the grid on either PTA or MT for 30 seconds. After
blotting dry, the grid was mounted and examined in the
4 *
electron microscope .
Ultrathin sections of infected cells were prepared
from monolayers of infected cells. Cell monolayers
2 Nikon Model 182813 x 4 objective.
3 Nikon Model 182813 x 100 objective
4 Siemes E.M.
j*^r'.;•Vsti .••• v.T:*. vvi'V ■ TP-"- ••7&. : . 4 * rr,rfrs rfv'V-.! . - \ s ... : , .* ,»
When present typical orf particles resembling a
ball of yarn with strands running diagonally across the
i. i •• ■■■■
.
particle were observed (Plate I) .
infected with orf virus and not yet detached from the
glass wall were washed with phosphate buffer at pH 7.4
then fixed with 3 percent glutaldehyde in phosphate
buffer (PB) for five minutes, washed three times in PB
and then stained with one percent osmium tetroxide for
2.5 minutes. The cells were detached with a glass rod,
put in gelatin vials and dehydrated in 30 percent alcohol
for five minutes then in 50 percent alcohol for five
minutes, 80 percent alcohol for five minutes, 100 percent
alcohol for five minutes and finally in epoxy propane for
five minutes. The cells were embedded in araldite,
sectioned"^" and stained in PTA by placing the sections on
the grids.
STATISTICAL ANALYSES
The sizes of the experimental groups were planned
for ease of statistical analyses by conventional methods.
The commonest techniques used were Student t-tests,
Analyses of Variance, Correlation and Linear Regressions.
The significance of changes in total serum proteins,
specific serum protein levels, immunoglobulin values, and
orf antibody titres was tested by dividing mean differences
1. Huxley microtome.
between the prechallenge and post-challenge values by
the standard error of the difference. The significance
of its calculated value was ascertained from tables of
an4 GocWffcn*.
t-values (SnedecorA1974).
The daily group means of the humoral and cell-
mediated immune study groups were compared by the non-
<"->4 C*(W«nc
paired t-test (Snedecor^l974).
When three or more groups were compared analyses of
variance were used. If the comparison revealed signi¬
ficants differences between the means, the data were
further analysed by a modified Duncan's multiple-range
test to identify the significant subsets (Harter, 1960).
34.








Immune responses to most antigens are characterised
by the appearance of antibodies in the blood or tissues
which combine specifically with the antigens that stimu¬
lated their production,, This an tigen-antibody inter¬
action has a number of consequences; for example, the
antigen molecules or particles may be agglutinated or
precipitated and their effect neutralized or the specific
antibody on combining with the antigen may facilitate its
uptake and subsequent digestion by phagocytes„ In addition,
cellular antigens may combine with antibodies and undergo
cytolysis by the activation of the complement pathway.
When serum proteins are separated electrophoretically,
they separate into alpha^- alpha^-, beta-, and gamma¬
globulins and albumin. Antibody activity is located
mainly in the gamma-globulin fraction and some in the
alpha- and beta-globulins. However, with the recognition
that there is considerable heterogeneity among the mole¬
cules which function as antibodies, they are now generally
described as immunoglobulins . Four major classes of im¬
munoglobulins designated IgG, IgM, IgA and IgE have been
identified in sheep serum and external secretions and have
been characterized by their physiochemical and immuno¬
chemical properties, and their metabolic and function
features (Aalund, Osebold and Murphy, 1965; Hammer,
Kickhofen and Schmidt, 1971; Wells and Eyre 1972; Butler
and Maxwell 1972), The IgG class has been further sub¬
divided into two subclasses, IgGl and IgG2 (Aalund et al.,
1965)o
Following natural infection with viruses or im¬
munization with a variety of viral antigens the three
major classes of immune globulins in the serum partici¬
pate in the immune response in a sequential manner (Uhr
and Finkelstein 1967). The initial antibody response
is characterised by the development of IgM which is sub¬
sequently replaced by IgG and to a small extent by IgA
(Ogra, Karzon, Righthand and Macgillivray 1968). IgG
antibody has been found to be more efficient in viral
neutralization than IgM antibody but less efficient than
IgM in complement fixation and agglutination reactions
(Ogra, Morag and Tiku, 1975). The role of IgA is not
fully understood, but-appears to be one of limiting col¬
onization with a virus at mucosal surfaces since it is
the major class of immunoglobulin found in the secretions
bathing external mucosal surfaces (Duncan, Wilkie, Winter
A.
1972; Smith, Dawson, Wells and Burrells, 1975, 1976).
Although complement-fixing antibodies and precipit¬
ating antibodies are present in sheep which have recovered
from orf or in animals which have been vaccinated against
orf (Glover 1933; Romero-Mercado 1969; Lutu 1971), the
contribution of individual immunoglobulin classes or sub¬
classes has not yet been determined. The purpose of the
following experiments was therefore to attempt to charact¬




A series of challenge experiments was carried out
to follow the development of humoral immunity to orf
virus in normal sheep after primary infection, and in
sheep re-exposed to orf virus0 The animals for the
experiments were divided into the following groups:-
Group 1 consisted of 16 previously infected sheep
that were challenged with orf virus by scarification.
Group 2 consisted of five previously infected sheep
that were not re-infected and were used as uninfected con¬
trol group.
Group 3 consisted of eight susceptible sheep which
were infected with orf virus. This group was set up to
show changes occurring in primary orf infections as opposed
to the changes in re-infected sheep (group 1).
Collection of Serum Samples
Ten ml of blood for serum samples were collected by
jugular venepuncture using "Vacutainers1*^", one day before
challenge, then daily for the first two weeks after chal¬
lenge and thereafter, once every week for a further three
weeks. The blood was allowed to clot at 37°C for one
hour, centrifuged at 716g for 15 minutes to retract the
blood clot. The serum was harvested into glass or
plastic bijoux and stored at -20°C until all the samples
for the 35 days of the experiment were collected.
1 Becton, Dickinson and Company.
Electrophoresis of Serum Proteins
^ ^ ^ ^ -+- -4- ^ ^ ur wvin+«-J ^ 4 v, X-V, ^ ^ ^ XT
^liaxiyco xxi tnc p'cx u LC v_/ j_ w ucxno xii uixc o jl. cx vjx
the experimentally infected sheep were examined by
electrophoresis on "phoroslides" which were strips of
cellulose acetate membranes bonded to mylar"*". Four
"phoroslides" were marked for identification, prebuffered
for 15 minutes in 0.05M barbitone buffer (BB) at pH 8.6
then inserted into a four-cell electrophoretic cell"*" con¬
taining 40 ml of barbitone buffer at pH 8.6. Sera were
applied to the "phoroslides" using sample applicators"*"
which consisted of two welded stainless steel strips moulded
into a plastic handle to form a space which delivered a
sample volume of 0.25 pi. The power module was con¬
stant 100 volts. The "phoroslides" were then removed,
stained with 1.8 percent Ponceau-S dye"*" in distilled water
for ten minutes at room temperature and then destained in
a series of three trays containing five percent acetic
acid in deionized distilled water. The "phoroslides" were
air-dried, dehydrated in ethanol and then cleared in a
solution consisting of glacial acetic acid and ethyl
acetate (70;30). The cleared strips were dried in a
vented oven at 60°Co Densitometric quantitation was per¬
formed on the stained "phoroslides" using a phoroscope"*".
(Plate 2 and 3).
Total Serum Protein Concentrations
The total serum protein concentrations were deter¬
mined using the Biuret method. Test tubes were set up
1. Millipore Corporation.
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Sera from sheep No. 768 taken on Day 0,
1, 13 and 14.
Plate 3 Densitometric tracing of the 'phoroslides'
s.4
Sera from sheep No. 768 collection day 0
and 13.
 
in pairs and the following solutions were added to each
4.9 ml of 3 percent sodium hydroxide prepared in
distilled water,
0,1 ml of the serum sample or seronorm/ a refer¬
ence protein standard containing 7g/lG0ml.
1 ml of Biuret reagent, a copper solution made
up of 17.3g of copper sulphate, 173g trisodium
citrate and lOOg sodium carbonate dissolved in one
litre of warm deionized distilled water.
The contents of the tubes were thoroughly mixed and the
blue concentration allowed to develop for a minimum time
of 30 minutes. The absorbances of the standard serum (As)
and the serum samples (Ax) were read at 545 nm against
2
the reagent blank in a spectrophotometer .
The protein content of the serum samples were then calcul¬
ated using the equation:-
g/lOO ml of serum = x 7
Thereafter the values were translated into g/1.
Immunoglobulin Levels
Levels of various classes of immunoglobulins in the
sera from sheep infected with orf virus were determined
by single radial immunodiffusion. To carry out single
radial immunodiffusion, pure sheep immunoglobulins were
isolated and.purified then antisera to the immunoglobulins
prepared in rabbits and goats as follows:-
1. Nyegaard and Co., Oslo.
2. Unicam, SP 180Q.
Isolation and purification of IgM immunoglobulin:
Pure IgM was prepared by the precipitation of euglobulins
from pooled normal sheep serum and by the fractionation
of the dissolved euglobulins by gel-filtration chromato¬
graphy. A euglobulin fraction assumed to contain most
of the IgM was precipitated by dialyzing 50 ml of serum
in Visking tubing"*" against running tap water at room tem¬
perature for 72 hours. The precipitate was harvested
by centrifugation at 1,600 g for 15 minutes at 4°C. The
3
precipitate was then dissolved in four ml of 0olM Tri s ->
2 "
NAOH buffer at pH 8,0. Sephadex G200 was used for the
gel-filtration chromatography. Twenty g of Sephadex G2CO
was left in 750 ml of Tris-N*0H buffer at pH 8.0 for five
hours in a boiling water bath. The gel slurry formed
was allowed to cool and was then degassed before packing
into column to form a gel bed of 90 cm long and 2.5 cm
3
diameter. The column was connected to the LKB unit , was
checked for homogeneity by running through two ml of 0.2
2
percent Blue Dextran 200O . Two ml of the dissolved
euglobulin sample was applied to the column and fraction¬
ation allowed to proceed at a flow rate of 20 ml per hour.
The first peak, which contained most of the IgM was col¬
lected in test tubes and a further two ml sample was frac¬
tionated. The collected eluent was concentrated by
1. Visking tubing - Medicell International Ltd.
2. Pharmacia. 3. LKB unit consisted of peri-
static pump (Varioperpex 120O0) control unit (Uvicord II
8300) fraction collector (Ultrac 7COO and chromatogram
recorder type 6520.
dialysis against 40 percent polyethylene glycol 60GG^".
Isolation and purification of IgGl, and IgG2: Pure
IgGl and IgG2 were prepared by the precipitation of
globulin fractions of pooled normal sheep serum and then
by fractionation of the dissolved precipitate in ion-
exchange chromatography. The globulin fraction assumed
to contain most of the serum immunoglobulins was precipi¬
tated by adding, dropwise, an equal volume of 41 percent
saturated ammonium sulphate at pH 6.5. The mixture was
stirred continuously at room temperature for 3G minutes
then was allowed to stand at 4°C overnight. The pre-
2
cipitate was harvested after centrifugation at 2,800 g
for 20 minutes, washed once in saturated ammonium sul¬
phate and then dissolved in 0.01M phosphate buffer (PB)
at pH 7.4. The fraction provided the starting material
for preparing pure IgGl and IgG2 by ion-exchange chro-
3
matography. Diethylaminoethyl cellulose was equili¬
brated in 0.01M PB then packed into a column of 40 cm
long and 2.5 cm diameter which was connected to the LKB
unit. The re-dissolved ammonium sulphate-precipitated
globulin fraction was dialyzed against PB for 24 hours
at 4°C and then loaded onto the column. Separations of
the IgGl and IgG2 were carried out by stepwise elution.
IgG2 was eluted first with 0.01M PB and IgGl using 0.G5M
PB. The eluted samples were concentrated by dialysis
against 4G percent polyethylene glycol. The IgGl and
1. Carbowax - BDH.
2. 4,0G0 rpm in Minifuge Hereaves Christ.
3. DE 52, Whatham.
IgG2 elutes were purified further by re-fractionation
once on DE 52 and once on Sephadex G2CG column.
Immunoelectrophoresis: The purity of the isolated
immunoglobulin fractions was checked by immunoelectro-
phoresis. Square glass plates (6x6 cm) were filled
with melted 1.5 percent Special agar"'" in barbital buffer
at pH 8.6 and allowed to solidify at room temperature.
A well—trough pattern was punched out with the help of
a template and the agar plugs were removed from the wells
into which the different isolates were added. The
plates were then placed in a tray of an electrophoretic
2
chamber filled with barbital buffer at pH 8.6. Moist
wicks made out of filter paper were attached to the edges
of the gel into the buffer thus creating electrical con-
tinuity. A current of 100 volts was applied for 60
minutes. The plates were then removed and placed in
a moist chamber. Rabbit anti-whole sheep serum was
placed in the troughs and diffusion was allowed to proceed
at room temperature overnight. The plates were then
washed in saline and the precipitation lines observed
(Plates 4-6).
Protein content of the purified immunoglobulins:
Determination of the protein content of the purified sheep
IgM, IgGl and IgG2 was carried out using Folin and
3
Ciocalteau's reagent . Volumes of 0.2ml of a protein
4
standard or the test samples were mixed thoroughly with
10 ml of alkaline copper solution (5ml of 0.1 percent





LKB. 3. BDH Chemicals.
Difco laboratories, Detroit, U.S.A.
Plate 4 IgM - A - well with whole sheep serum.
B - well with isolated sheep IgM.
Trough - Rabbit anti-whole sheep serum.
Plate 5 IgGx A - well with whole sheep serum.
B - well with isolated sheep IgG^.
Trough - Rabbit anti-whole sheep serum.
Plate 6 IgG2 A
B
Trough
- well with whole sheep serum.
- well with isolated sheep IgG2.
- Rabbit anti-whole sheep serum.
B
tube and allowed to react for 15 minutes,, Concentrated
Folin's and Ciocalteau's reagent was diluted 1/3 in DDW
and one ml of the diluted reagent was added to the test-
tubes. The tubes were left at room temperature for 30
minutes to allow the dark blue colouration to develop.
The absorbance of the blue colour was read at 750 nm in
a spectrophotometer against a reagent blank. The pro¬
tein content was calculated using the following equation:
g/100 ml = Absorbance an test samples ^ ^
Absorbance in the standard protein
Thereafter the results were translated into g/1:-
Immunoglobulin Fractions
Igm IgC2
1.44 g/1 2.2 3.7
Antisera preparation; Antisera to sheep IgM and
IgGl were raised in mature New Zealand white rabbits by
Mr. Ali Shubber. He injected each rabbit intramuscul¬
arly with 2 mg of purified sheep IgM or IgGl thoroughly
mixed with Freund's complete adjuvant"^. He repeated
the injections four times at two weeks intervals. I
administered booster doses to these rabbits and bled them
one week later. I harvested the sera and checked for
antibody titres using the Ouchterlony gel-diffusion test.
If the titre of the antiserum was at least 1/32 more
blood was collected; if not the rabbits were given
1 Difco Laboratories, Detroit U.S.A.
further booster doses of appropriate antigens in complete
Freund's adjuvant. Enough rabbit anti-sheep IgA serum
was kindly donated by Mr. Ali Shubber and this was used
in the preliminary test.
Similarly, the IgG2 antiserum was raised in two
goats which were first immunized by Mr. Ali Shubber who
had injected each with 5 mg/kg body weight of pure sheep
IgG2 mixed thoroughly in complete Freund's adjuvant. I
gave these goats booster doses twice at a two week inter¬
val and bled them one week later to check for antibody
titre. If the titre was 1/32 then more blood was taken
for antiserum. The different antisera were made mono¬
specific by a series of cross-absorptions with appropriate
antigen in order to remove anti-light chain activity.
Antiserum to IgM was absorbed using 2 mg/ml of pure IgGl
and 2 mg/ml of IgG2, antiserum to sheep IgGl was absorbed
using 2 mg/ml of pure sheep IgG2; antiserum IgG2 was ab¬
sorbed by 2 mg/ml of IgGl (Plates 7 and 8).
Ouchterlony double diffusion test ; The titres of
the antibody in the antisera prepared in the rabbits and
goats was determined by double diffusion in agar gel.
Seven ml of melted 2 percent Special agar was pipetted on¬
to petri dishes or slides precoated with Q.3 percent agar
then
on a levelled surface /hllowed to solidify. Seven wells
were punched out using a standard template and the gel
plugs removed from the wells by suction. The wells were
filled carefully with sheep serum in the central well and
Plate 7 Antisera Production to IgM and IgG^
All Wells had whole sheep serum
Troughs 1 and 3 - antisera to sheep 19^2
Troughs 2 and 4 - antisera to sheep IgM.
Plate 8 Antisera Production to IgG^
All wells had whole sheep serum
Troughs 1-4 had antisera to sheep IgG-^.
 
different dilutions of the antiserum in the outside
five wells. The sixth well xvas filled with 0.15 per¬
cent of sodium chloride. The slides or petri dishes
were then placed in moist chamber and incubated at room
temperature for 24 hours. The precipitation lines
were read with the help of an oblique light viewer"*".
The double diffusion test was also used in the prelim¬
inary tests carried out to determine the changes in the
levels of various immunoglobulins in the sera from the
sheep experimentally infected with orf virus.
Single radial immunodiffusion: The levels of various
immunoglobulins in the sera were determined by a single
radial immunodiffusion method first described by Mancini,
Carbonara and Heremans (1965) and later modified by
2
Fahey and McKelvey (1965). Melted 3 percent agarose
in phosphate buffered saline (PBS) at pH 7.3 was mixed
with an equal volume of the appropriate rabbit or goat
antiserum warmed to 56°C and then poured onto glass plates
(10 x 10 cm) on a spirit-levelled stand. The antisera
to IgGl and IgG2 were diluted 1/10 and the antiserum to
IgM and IgA were diluted 1/5 in PBS before heating to
56°C and mixing with the melted agarose. The agarose-
antiserum mixture on the plates was allowed to solidify
then, using a template, 81 wells were cut in the gel and
the agar plugs removed from the wells by suction. Each
well was filled with 2 jul of the test ovine serum diluted
1/4 for the determination of the levels of IgM and IgG2
1. Luckham Ltd.
2. BDH Chemicals.
1/32 for the determination of the levels of IgGl. A
standard reference serum diluted 1/2, 1/4, 1/8 and 1/32
was put in the first four wells in the top left-hand
corner. The plates were then incubated in humid
chamber at room temperature for 24 hours for IgGl, IgG2
and IgA and for 48 hours for IgM. The diameter of the
precipitin rings werq measured using a calibrated magni-
(Plates 9 - 11) .
fied viewer / The results were plotted on a linear
graph as a function of the reference serum concentration.
The concentrations of the test ovine sera were then cal¬
culated from a linear regression derived by the method
of least squares (Snedecor and Cochran, 1974 ).
The standard reference serum was made up of 0.1 ml
of serum from all the animals whose serum samples were to
be quantitated. This pooled serum was first tested
against the known concentrations of the purified IgM,
IgGl and IgG2 and the concentrations of various immuno¬
globulin classes were determined as described above
and were as follows
IgM igG1 IgG2
5 g/1 20 6.5
Passive Haemagglutination Tests
The passive haemagglutination tests were carried out
to detect orf antibodies in the sera from the sheep ex¬
perimentally infected with orf virus.
1o Nikon
Plate 9 Single Radial Immunodiffusion
IgM determination.
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10 Single Radial Immunodiffusion
IgG^ determination.
Plate 11 Single Radial Immunodiffusion
IgG2 determination.
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Preparations of orf antigen: Grf virus passaged
eight times in cultures of lamb testis cells and five
times in the cultures of calf testis cells was concentrated
from 50 ml to 25 ml by dialysis against 40 percent polye¬
thylene glycol. The virus particles in the concentrated
fluid were sedimented by ultracentrifugation at 78,624 g^
for 30 minutes. The supernatant fluid containing the
soluble antigens was dialyzed against phosphate buffer
at pH 7,4 for 24 hours at 4°C. This solution was
clarified by centrifugation at l,6CGg for 30 minutes.
The protein content of this antigen preparation determined
using Folins' phenol reagent was 30,4 mg/IGG ml. The
antigen preparation was then stored in a plastic universal
bottle at - 20°C until required.
Sensitization of the erythrocytes: Sheep erythrocytes
were collected in a 50 ml "Vacutainer" containing 20 ml
of Alsever's solution2 and stored at 4°C for three days.
The cells were washed three times in 0.15 percent sodium
chloride and three times in PB at pH 7.4 before they
were diluted in PB to a final concentration of 2.5 percent.
Twentyfive ml of the erythrocyte suspension was then mixed
with 3 ml of 2.5 percent glutaraldehyde in PB and 15 mg
of the soluble antigen solution was added immediately.
Sensitization was allowed to proceed at 37°C with gentle
magnetic stirring for 60 minutes by which time the cells
had turned chocolate brown from their normal bright red
colour. The coated cells were then washed three times in
1. Reckmann, Model L2-65B.
2. See Appendix II for composition.
PB and suspended in PB containing 0.2 percent bovine
serum albumin"'" as a stabilizer and 0.02 percent sodium
azide as an antibacterial agent. Control cells were
similarly treated with glutaraldehyde but antigen was
not included. The final suspension of the antigen coated
cells and the control cells were stored at 4°C for three
months.
The tests : The test was carried out in V-shaped
2
96-well microtitre plates . The test serum samples were
inactivated by heating in waterbath at 56°C for 30 minutes
after which they were absorbed by adding 0,3 ml of 20 per¬
cent concentration of control cells to 0.1 ml of serum.
A series of two-fold dilutions of each absorbed serum
sample was then made in PB in the microtitre plates and
an equal volume of the coated cells at a concentration of
0.6 percent was added to each well. A sample of serum
from a sheep known not to possess antibodies to orf virus,
a sample of positive serum and erythrocytes not coated
with antigen but treated with glutaraldehyde were included
as controls. Antibody titrations were conducted using
2-fold dilutions steps. The titration end-point was
taken to be the dilution giving 50 percent agglutination
as






Serum Protein Patterns of Sheep Challenged with Orf Virus
Group I : Estimations of the total protein contents
of the sera from 16 sheep previously infected with orf
virus ranged from 54 to 86 g/1 and in the samples taken
after challenge ranged from 52 to 116 g/1 (Appendix
Table I). The mean values of daily samples ranged from
73 - 14 to 83 - 8.3 g/1. The mean differences between
the pre- and post-challenge values were not significant
(Table I).
Electrophoresis of the same serum samples resolved
the serum protein components into five readily discernible
bands conventionally attributed to albumin and alpha-1,
alpha-2, beta- and gamma-globulins. The calculated serum
protein values are shown in Appendix Table's 2-6. The
mean differences between pre-and post-challenge values
of albumin and alpha-1 alpha-2 and beta-globulins were
not significant (Tables 2 - 5 ). In contrast, the
mean differences between the pre- and post-challenge
values of the gamma-globulin fractions were significantly
greater on days 9 to 14 post-challenge (Table 6). A
plot of the daily means of gamma-globulin values reflects
this trend (Figure I): the mean gamma-globulin levels in
the pre-challenge sera was 19.5 - 8.0 g/1. The levels
increased gradually after challenge to reach a peak value
of 24„0 - 9.2 g/1 on the ninth day, then decreased to the
Figure 1
The daily means of gammaglobulin levels of:-
A - Previously infected sheep challenged with
orf virus (Group 1).






















pre-challenge value by day 35, the day the experiment was
terminated.
Group 2: The estimates of the total protein con¬
tents of the sera from five previously infected sheep which
acted as an uninfected control group ranged from 61 to 76
g/1 (Appendix Table 11). The mean values of the daily
samples ranged from 63.6 - 1.34 to 69.2 - 3.77 g/1. The
mean value of the samples taken at the onset of obser¬
vations was not different from the mean value of the pre-
challenge samples of the previously infected sheep in the
group I (t. . = 1.77; P> 0.2). There were significant
( )
changes in the mean differences between the group 2 samples
taken at the onset of observations and the samples taken
on 2, 3, 4, 5, 12, 14 and 21 days later (Table 7).
The densitometric evaluations of the serum protein
fractions in the same samples are given in Appendix Tables
12-16. The mean differences between the values at the
on-set (albumin and alphal-, alpha2-, beta- and gamma¬
globulin) of observations and during the subsequent 35 days
were not significant (Tables 8-12), Comparison of the daily
gammaglobulin values between the challenged and unchallenged
previously infected sheep is shown in Table 13 and Figure I.
Group 3: Estimations of the total protein contents
of the sera from eight susceptible sheep challenged with
orf .virus ranged from 67 to 81 g/1 in the sera taken before
challenge and 63 to 81 g/1 in the sera taken after chal¬
lenge. The mean values of daily samples ranged from
66.2 t 4.7 to 72 i 3.C g/1 (Appendix Table 21). The
mean value of the pre-challenge samples was similar to
the mean value of the previously infected sheep and mean
values of previously infected sheep which were not chal¬
lenged (t(22) = 0,945, P 0.30 and = 0.784, P 0.40).
respectively. The mean differences between pre- and
post-challenge values were not significant (Table 14).
Electrophoresis evaluations of the serum proteins
in the same serum samples are shown in Appendix Tables
22-26. The mean differences between the pre- and post-
challenge values of albumin and alphal-, alpha2-, beta- and
gammaglobulins were not significant (Tables 15-19). Com¬
parison of the daily mean values of gamma-globulins of
the challenged susceptible and previously infected sheep
is shown in Table 20 and Figure 2.
Immunoglobulin Concentrations
A preliminary test was carried out to check the
changes in the different immunoglobulin classes and sub¬
classes in the sera from sheep of the previously infected
group which was challenged with orf virus. There was
a clear indication of changes in the IgM, IgGl and IgG2
levels between the serum samples collected before chal¬
lenge and during the course of the infection, but there
were indetectable changes in the levels of IgA therefore,
changes in this class of immunoglobulin were not studied
in the subsequent experiments.
Group I: Changes observed in IgM, IgGl and IgG2
levels in the serum samples collected from the 16 previously
infected sheep which were challenged with orf virus are
shown in Figure 3 and Appendix Tables 7-9.
60.
Figure 2: The daily means of gammaglobulin levels
in sheep infected and re-infected with orf virus.
A: Re-infected sheep (Group I).













The mean level of IgM in the pre-challenge sera was
3.6 -1.0 g/1 and after challenge the mean level rose
to 4.5 - 1.6 g/1 on the second, third and fourth day
but decreased to pre-challenge levels by the seventh
day after challenge (Table 21 and Figure 3).
The IgGl levels in the same serum samples rose
from pre-challenge mean value of 15.8 ^ 6.9 g/1 to a
peak value of 22.2 i 9.2 g/1 on the 12th day after
challenge, thereafter decreasing gradually. The changes
in the IgGl levels were statistically significant from
days 11 to 35 after challenge (Table 22 and Figure 3).
Similarly, IgG2 levels in the same' serum samples
rose from pre-challenge mean value 5.7 - 2.7 g/1 to 6.6
- 3.1 g/1 on day 11 after challenge and these levels de¬
creased gradually to the levels before challenge by day
35 (Table 23 and Figure 3).
Group 2: No significant changes were found in
the levels of IgM, IgGl and IgG2 in the sera from the
five previously infected sheep that were not challenged
(Tables 24-26 and Figure 3). The IgM levels ranged from
3.28 i 0.63 to 3.76 - 0.88 g/1; IgGl levels ranged from
11.92 t 1.24 to 12.86 - 1.02 g/1 and for IgG2 the levels
ranged from 4.52 - 0.4 to 4.99 ^ 0.55 g/1 (Appendix
Tables 17-19).
Comparison between the daily means of the IgGl of
the challenged and un -challenged previously infected
sheep revealed significant increases in the values in the
challenged sheep particularly after the tenth day of challenge
gure 3 The daily means of the IgM, IgG^ and IgG2
levels in challenged and unchallenged previously in¬
fected sheep.
A - IgG^ levels in challenged sheep (Group I)
3 - IgG2 levels in unchallenged sheep (Group 2)
C - IgG2 levels in challenged sheep (Group 1)
D - IgG2 levels in unchallenged sheep (Group 2)
E - IgM levels in challenged sheep (Group 1)
F - IgM levels in unchallenged sheep (Group 2).
Days Post Challenge
(Table 27 and Figure 3). Comparisons of the IgM and
IgG2 levels between the two groups were not significant
(Tables 28 and 29).
Group 3: Only slight changes which were not
significant were noted in the levels of IgM. The IgM
mean levels ranged from 3.05 g/1 at day O to 3.3 g/1
on the sixth day after challenge arid the IgG2 mean levels
ranged from 4.4-2 g/1 in the pre-challenge sera to 5.2
- 2.2 g/1, highest value recorded on day 14 post-challenge.
The increases in IgG2 levels were significant on days 14,
21 and 35. (Tables 3C and 32, Figure 4 and Appendix
Tables 28 and 29).
The IgGl levels in the same serum samples ranged
from 11.5 - 5.9 g/1 in the sera collected before challenge
to 13.6 - 5.6 g/1 on day ten after challenge. The in¬
crease in the IgGl levels was statistically significant
on day 11 (Table 31 and Figure 4 Appendix Table 2%) .
Comparison between IgGl values of unchallenged sus¬
ceptible and previously infected sheep revealed that there
was a significant difference from da}/ 12 through to day
35 (Table 33). In contrast, the comparison of IgM and
IgG2 levels were not significant (Tables 34-35).
Orf Antibodies
Orf antibody titres varied from group to group, animal
to animal, and from day to day, but, in general, higher
titres occurred in previously infected sheep challenged
with orf virus than in susceptible sheep with a primary
orf infection (Table 36).
The daily means of the IgM, IgG^ and
IgG2 levels in the sheep infected and
re-infected with orf virus.
IgG^ levels in re-infected sheep
(Group 1).
IgG^ levels in infected susceptible
sheep (Group 3).
IgG2 levels in re-infected sheep,
(Group 1).
IgG2 levels in infected susceptible
sheep (Group 3).
IgM levels in re-infected sheep
(Group I).
IgM levels in infected susceptible
sheep (Group 3).
 
Group 1; The rise in orf antibody titres detected
in the 16 previously infected sheep challenged with orf
virus is illustrated in Figure 5 . Eight of the pre¬
viously infected sheep had detectable orf antibodies in
the pre-challenge sera indicating previous infection.
After challenge, the antibody titres rose progressively in
all re-infected sheep reaching the highest mean value of
4.62 i l.l on day 13. Thereafter, the titres gradually
decreased to 3.62 - 0.88 on day 35, the day the experi¬
ment was terminated. The mean increase in the antibody
titres was statistically significant on days 8 to 35 (Table
37 ) .
Comparing the dynamics of the antibody responses of
previously infected sheep which had detectable antibodies
in the pre-challenge sera, with those of the sheep which
had no antibodies or only traces of antibodies revealed
that the slopes were similar but the positions of the lines
were significantly different (Fanuro F ^ = 2.36; P> 0.05).
Similarly, there was no significant difference in the
slopes of the exponential declines (FiF^ = 0.43;
P> 0.05 Figure 6 Appendix Tables 10, 10a, and 10b).
The correlation between mean daily gammaglobulin
levels and mean daily antibody titres was positive and
significant (^-j^ = 0.76; P <0.01) . There was not,
however, a significant correlation between the gammaglob¬
ulin values and antibody titres of the sheep on specific
days . Nevertheless, the correlation between
gammaglobulin values and antibody titres in most individual
67
Figure 5 The daily means of orf antibody titres of:-
A - Previously infected sheep challenged with orf
virus (Group 1 ..
B - Previously infected sheep not challenged (Group
2).
Days Post Challenge
sheep was significant (Table 39).
Likewise, the correlation between the mean IgGl
levels and mean daily antibody titres was positive and
significant (r^^^ = + 0.864; P <0.01). Similarly
there was no significant correlation between the IgGl
levels and antibody titres on specific days although a
significant correlation was noted between the IgGl levels
and antibody titres in most individual sheep (Table 41) .
Group 2: The orf antibody titres of five previously
infected sheep which were not challenged with orf virus
ranged from 1.6 to 2 over the period of the experiment
(Figure 5). Consequently, when the antibody titres of
the daily means of the challenged and non-challenged
previously infected sheep were compared, significant
C\r\d\ JVoW* °^ r4
differences were detected on days 5, 7 &&&■ 8-, and from
t&o—12th day onwardsj (Table 42).
Group 3: None of the pre-infection serum samples
from eight susceptible sheep had measurable orf anti¬
bodies. Changes were minimal during the first week of
infection but, thereafter, the antibody titres rose to
2.7 on day 12 and remained more or less at the same level
up to daj/ 35.
There was a positive and significant correlation
between the daily mean levels of gammaglobulin and the
daily mean antibody titres (r. . = + Q.67 ; P<0.01)
114)
and between the daily mean levels of the IgGl and the
daily mean antibody titres (r(]_4) = + 0.67; P < 0.C1).
There was no significant correlation between the gamma¬
globulin values and antibody titres on specific days
(Tables 43 and 44). Nevertheless, the correlation
between gammaglobulin and antibody titres and between
IgGl values and antibody titres in most sheep were positive
and significant (Tables 43 and 44).
The rate of antibody production in the infected sus¬
ceptible sheep was significantly slower than in the chal-
2
lenged previously infected sheep (Figure 6) (F21 = ^.56',
P <0.G1). The "onset" of orf antibody production in in¬
fected susceptible sheep was 7.6 - 3.6 days after infection
and in the challenged previously infected sheep was 5.3 -
2.6 days after challenge; the difference was not stat¬
istically significant ("^21) = 1*697; P>0„20). The
peak titres of orf antibody were detected earlier in the
challenged previously infected sheep than in the infected
susceptible sheep, namely, on days 10.3 - 2 and 23.1 -
11 respectively. The difference was highly significant
(t(13) = 3.30; P <0.01).
The antibody titres of the previously infected sheep
were significantly higher than the titres of the sus¬
ceptible sheep after challenge (Table 36 and Figure 7).
Figure 6: The rate of orf antibody production in
sheep infected and re-infected with orf virus.
A - Re-infected sheep with detectable antibodies
before challenge.
B - Re-infected sheep without detectable antibodies.
C - Infected susceptible sheep.
I J 1 I
0 10 20 30 40
Days Post-cha 11 enge.
• Significant Change-
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Figure 7: The daily means of orf antibody titres
of: -
A - Previously infected sheep challenged with orf
virus (Group I).
B - Susceptible sheep infected with orf virus
(Group 3).
TABLE I.
MEAN DIFFERENCE OF TOTAL SERUM PROTEIN CONTENTS (DAY 0




Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation.
1 + 0.88 2.23 0.39 >0.80 N.S.
2 - 7.17 3.71 1.93 >0.10 N.S.
3 - 0.83 3.08 0.27 >0.80 N.S.
k + O • V+J co 1.86 0.20 >0.90 N.S.
5 - l+.oo 2.81+ 1.1+1 >0.20 ■ N.S.
6 - 1.50 1.76 0.85 >0.50 N.S.
7 - 0.50 3.07 0.16 >0.90 N.S.
8 - 2.50 2.31 1.08 i>0.30 N.S.
9 - 6.56 3.20 2.05 >0.10 N.S.
10 - 2.50 2.76 0.91 >0.1+0 N.S.
11 - 5.31 3.25 1.63 >0.20 N.S.
12 - 8.25 3.38 2.1+1+ ^0.05 S.
13 - 5.06 2.59 1.95 >0.10
1U - 3.69 2.01+ l.8l >0.10 #.S.
21 - 1.56 2.57 0.61 >0.60 H-s.
28 - 0.81 3.30 0.25 >0.90 H-s.
35 + 0.63 2.6o 0.2k >0.90 H-s.
S. = Significant.
N.S. = Not Significant.
TABLE 2.
MEAN DIFFERENCE OF ALBUMIN LEVELS (LAY 0
INFECTED SHEEP CHALLENGED WITH ORF VIRUS











1 + O.Ol* 1.1*0 0.03 > 0.90 N.S.
2 - 1.03 1.97 0.52 > 0.70 N.S.
3 + 1.33 1.33 1.13 > 0.30 N.S.
1* - 3.08 1.U7 2.10 > 0.10 N.S.
5 - 0.07 1.70 0.01* > 0.90 N.S.
6 - 0.79 1.1*3 0.55 > 0.60 N.S.
7 + 1.62 2.01* 0.79 > 0.50 N.S.
8 - 1.22 1.1*7 0.83 > 0.50 N.S.
9 - 1.63 1.31* 1.05 > 0.1*0 N.S.
10 0.00 1.83 0.00 > 0.90 N.S.
11 - 0.1*9 1.92 0.26 > 0.80 N.S.
12 - 2.36 2.13 1.19 > 0.30 N.S.
13 - 2.38 1.53 1.66 > 0.20 N.S.
11* - 1.03 0.9U 1.10 > 0.1*0 N.S.
21 + 0.09 1.85 0.05 > 0.90 N.S.
28 - 1.72 1.65 1.01* > 0.1*0 N.S.
33 + 0.13 1.36 0.11 *,0.90 N.S.
N.S. = Not Significant.
TABLE 3.
MEAN DIFFERENCE OF ALPHAS-GLOBULIN LEVELS (DAY 0 - DAY X) OF
PREVIOUSLY INFECTED SHEEP CHALLENGED WITH CRF VIRUS - GROUP I.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 + 0.29 0.37 0.79 >0.50 N.S.
2 + 0.18 0.61+ 0.27 >0.80 N.S.
3 + 0.2$ 0.57 0.1+5 >0.70 N.S.
1+ + 0.51+ 0.1+6 1.17 >0.30 N.S.
5 + 0.10 0.51+ 0.18 >0.90 N.S.
6 + 0.81 0.51 1.58 >0.20 N.S.
7 + o.$i+ o.58 0.93 >0.1+0 N.S.
8 + 0.79 0.53 1.1+9 >0.20 N.S.
9 - 0.53 0.1+1+ 1.22 >0.30 N.S.
10 + 0.23 0.1+6 0.50 >0.70 N.S.
11 + 0.16 0.53 0.30 >0.80 N.S.
12 - 0.28 0.61 0.1+6 >0.70 N.S.
13 - 0.01+ 0.1+1+ 0.08 >0.90 N.S.
li+ - 0.31 0.52 0.59 >0.60 N.S.
21 + 0.31 0.1+3 0.71 >0.50 N.S.
28 + 0.11+ 0.52 0.28 +>0.80 N.S.
35 - 0.08 0.1+8 0.17 >0.90 N.S.
N.S. = Not Significant.
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TABLE 4.
MEAN DIFFERENCE OF ALPHA2-GLOBULIN LEVELS (DAY 0 - DAY X)
OF PREVIOUSLY INFECTED SHEEP CHALLENGED WITH ORF VIRUS -
GROUP I.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 — 0.52 0.67 0.77 >0.50 N.S
2 - 1.15 0.65 1.77 >0.10 N.S
3 - 0.05 0.42 0.12 >0.90 N.S
4 + 0.68 0.68 1.00 >0 .40 N.S
5 - 0.96 0.74 1.30 >0.30 N.S
6 - 0.60 0.63 0.95 >0.40 N.S
7 - 1.08 0.61 1.76 >0.10 N.S
8 + 0.03 0.66 0.05 >0.90 N.S
9 - 0.45 0.59 0.76 >0.50 N.S
10 - 0.58 0.67 0.87 >0.40 N.S
11 - 0.89 0.59 1.51 >0.20 N.S
12 - 1.38 0.74 1.86 >0.10 N.S
13 - 0.56 0.70 0.81 >0.50 N.S
14 - 0.46 0.67 0.69 >0.50 N.S
21 - 0.99 0.64 1.55 >0.20 N.S
28 - 0.46 0.73 0.63 >0.60 N.S
35 0.53 0.55 1.00 >0.40 N.S
N.S. = Not Significant.
TABLE 5.
MEAN DIFFERENCE OF BETA-GLOBULIN LEVELS (DAY 0 - DAY X) OF
PREVIOUSLY INFECTED SHEEP CHALLENGED WITH ORF VIRUS - GROUP I.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 - 0.56 0.69 0.81 > O • VXl 0 N.S.
2 - 0.57 0.98 0.58 l> 0.60 N.S.
3 - o.l+i 0.73 0.56 > 0.60 N.S.
b + 0.05 o.U5 o.ll > 0.90 N.S.
5 - 1.59 . 0.88 1.81 > 0.10 N.S.
6 + 0.08 0.71+ 0.10 > Oo\•0 N.S.
7 - 0.03 0.62 0.01+ !> 0.90 N.S.
8 + 0.16 0.72 0.22 > 0.90 N.S.
9 - 0.53 0.61 0.86 > 0•0 N.S.
10 - 0.32 0.61+ 0.50 > 0.60 N.S.
11 - 0.75 0.62 1.21 t> 0.30 N.S.
12 - 0.01 0.56 0.01 > 0.90 N.S.
13 0.25 0.53 0.1+7 > 0 • O N.S.
11; - 0.13 0.61+ 0.21+ > 0.90 N.S.
21 - 0.13 0.56 0.22 i> 0.90 N.S.
28 - 0.11 0.50 0.21 > 0.90 N.S.







MEAN DIFFERENCE OF GAMMAGLOBULIN LEVELS (DAY 0 - DAY X)
OF SHEEP REINFECTED WITH ORF VIRUS - GROUP I.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 + 1.49 0.69 2.14 < 0.05 S.
2 - 0.77 1.54 0.50 > 0.50 N.S
3 - 0.68 0.82 0.82 >0.50 N.S
4 + 1.71 1.30 1.31 > 0.30 N.S
5 - 0.13 1.30 0.64 >0.60 N.S
6 - 0.13 0.86 0.15 >0.90 N.S
7 - 1.53 1.18 1.30 > 0.30 N.S
8 - 2.10 1.06 1.98 >0.10 N.S
9 - 4.43 1.36 3.26 < 0.01 H.S
10 - 3.16 1.23 2.57 < 0.02 S.
11 - 4.00 1.21 3.31 ' < 0.01 H.S
12 - 4.05 1.07 3.74 < 0.01 H.S
13 - 2.99 1.10 2.72 <.0.02 S.
14 - 2.37 0.92 2.58 < 0.02 S.
21 - 0.80 1.09 0.73 >0.50 N.S
28 + 0.51 1.08 0 .47 > 0.70 N.S
35 0.77 1.18 0.65 >0.60 N.S
S = Significant.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE 7
MEM DIFFERENCE OF TOTAL SERUM PROTEIN CONTENTS (DAY 0 - DAY X)
OF UNCHALLENGED PREVIOUSLY INFECTED SHEEP - GROUP 2.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 + 0.80 1.39 0.30 i> 0.70 N.S.
2 + 1+.20 1.07 3.92 < 0.02 s.
3 + 1.1+0 0.21+ 3.80 <+ 0.01 H.S.
1+ + 1+.60 1.29 3.56 <j 0.05 S.
5 + 3.60 1.1+3 3.92 <1 0.02 s.
6 + 0.80 1.65 0.1+8 > 0.70 N.S.
7 + 0.80 .0.97 0.82 > 0.50 N.S.
8 + 2.1+0 1.03 2.33 01—1.0A N.S.
9 + 2.60 1.30 1.73 > 0.20 N.S.
10 + 3.00 2.68 1.12 > 0.1+0 N.S.
11 + 2.80 1.32 2.12 s> 0.10 N.S.
12 + 1+.20 1.1+6 2.87 <J 0.05 S.
13 + 2.b0 2.33 1.03 >0.1+0 N.S.
11+ + 1.60 0.60 2.66 <+ 0.05 S.
21 + 1.20 0.20 6.00 <; 0.01 H.S.
28 + 0.20 0.38 0.31+ > 0.80 N.S.
33 + 1.80 1.11 1.62 0CM.0A N.S.
5 = Significant.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE 8.
MEAN DIFFERENCE OF ALBUMIN LEVELS (DAY 0 - DAY X) OF UN¬
CHALLENGED PREVIOUSLY INFECTED SHEEP - GROUP 2.
Days
Post- Mean Standard. Inter-
Challenge (x) Difference Error t P pretation
1 - 2.30 2.53 0.91 > 0.50 N.S.
2 - 0.60 2.72 0.22 > 0.90 N.S.
3 + 1.02 3.21 0.32 > 0.80 N.S.
1+ + 0.96 3.H 0.31 > 0.80 N.S.
5 + 5.26 3.21+ 1.62 > 0.20 N.S.
6 - 1.1+8 2.62 0.56 > 0.60 N.S.
7 - 2.36 2.58 0.91 > 0.50 N.S.
8 + 0.38 1+.36 0.09 >0.90 N.S.
9 - 0.11+ 2.91 0.05 >0.90 N.S.
10 + 1.18
. 3.67 0.32 > 0.80 N.S.
11 + 1.26 3.25 0.39 > 0.80 N.S.
12 + 0.60 1+.00 0.15 > 0.90 N.S.
13 - 1.35 3.99 o.3l+ > 0.80 N.S.
11+ - 2.50 1+.05 0.62 > 0.60 N.S.
21 - 1.06 3.57 0.30 > 0.80 N.S.
28 - 2.30 3.29 0.70 >. 0.60 N.S.
35 - l+.oo 3.21+ 1.23 > 0.30 N.S.
N.S. = Not Significant.
TABLE 9.
MEAN DIFFERENCE OP ALPHA-j-GLOBULIN LEVELS (DAY 0 - DAY X) OP










1 + 0.36 0.1+1+ 0.82 > 0.50 N.S.
2 + 0.52 0.82 0.63 > 0.60 N.S.
3 + 0.32 0.38 O.8I4 !> 0.50 N.S.
h + 0.08 0.22 0.36 > 0.80 N.S.
5 — 0.86 0.91 0.95 > O.I4O N.S.
6 + o.3b 0.31 O1—1•1—1 > o.Uo N.S.
7 + 0.146 0.1+7 0.98 > 0.1+0 N.S.
8 + 0.0I+ 0.22 0.18 > 0.90 N.S.
9 + 0.36 0.36 1.00 > o.l+o N.S.
10 + 0.36 0.27 1.33 > 0.30 N.S.
11 - 0.03 0.19 0.16 > 0.90 N • 0.
12 - 0.6I4 0.56 1.1J4 > o.i+o N.S.
13 + 0.12 0.65 0.18 > 0.90 N.S.
lb + 0.0I+ O.I4O 0.10 > 0.90 N.S.
21 + 0.32 0.33 0.97 > 0.1+0 N.S.
28 - 0.06 0.61+ 0.09 > 0.90 N.S.
35 + 0.61 0.91 0.67 > 0.60 N.S.
N.S. = Not S ignificant.
TABLE 10
MEM DIFFERENCE OF ALPHj^-GLOBULIN LEVELS (DAY 0 - DAY X) OF UN¬










1 - 2.1k 2.50 0.86 >0.50 N.S.
2 + 0.18 1.18 0.15 >0.90 N.S.
3 + 0.06 0.57 0.11 >0.90 N. S.
k + 0.32 0.60 0.53 >0.70 N.S.
5 - 0.12 0.87 0.11+ >0.90 N.S.
6 - 0.02 1.03 0.02 >0.90 N.S.
7 + O.48 0.55 0.56 >0.60 N.S.
8 + 0.76 1.23 0.62 >0.60 N.S.
9 + 0.76 0.86 0.88 >0.50 N.S.
10 + 0.80 0.93 0.86 >0.50 N.S.
n - 0.10 0.71 0.11+ >0.90 N.S.
12 + 0.01+ 0.90 0.01+ >0.90 N.S.
13 - o.kb 0.81+ 0.52 >0.70 N.S.
lk + 0.7U 1.02 0.73 >0.50 N.S.
21 + 0.28 0.86 0.32 >0.80 N.S.
28 - 0.22 0.30 0.73 >0.50 N.S.
35 + 0.1+6 0.82 0.56 >0.70 •CO
N.3. = Not Significant.
TABLE 11.
MEAN DIFFERENCES OF BETA-GLOBULIN LEVELS (DAY 0 - DAY X) OF








1 0.18 0.33 0.5U >0.70 N.S.
2 - 0.1+2 0.81+ 0.50 >0.70 N.S.
3 + 0.51+ 0.81+ 0.61+ >0.60 N.S.
b - 0.52 . 1.12 0.1+6 >0.70 N.S.
5 - 1.22 0.75 1.62 >0.20 N.S.
6 - 0.02 0.31 0.06 >0.90 N.S.
7 - 0.36 0.1+1+ 0.82 >0.50 N.S.
8 + 0.38 0.33 1.15 >0.1+0 N.b.
9 - 0.16 0.36 0.1+1+ >0.70 N.S.
10 + 0.20 0.75 0.27 >0.80 N.S.
11 - 0.08 0.52 0.15 >0.90 N.S.
12 - 0.52 1.01+ 0.50 >0.70 N.S.
13 + 0.02 1.07 0.02 >0.90 N.S.
lb + 0.1+2 0.60 0.70 >0.60 N.S.
21 - 0.36 0.72 0.50 >0.70 N.S.
28 - 0.88 0.1+1+ 2.00 oCM•oA N.S.
35 — 0.1+6 0.50 0.92 >0.1+0 N.S.
N.S. = Not Significant.
TABLE 12.
MEAN DIFFERENCE OF GAMMA-GLOBULIN LEVELS (DAY 0 - DAY X)










1 - 0.02 0.90 0.02 >0.90 N.S.
2 + 0.80 1.08 0.71+ >0.50 N.S.
3 + 0.1+1+ 0.72 0.61 i> 0.60 N.S.
1+ + 0.61+ 0.63 1.02 >0.1+0 N.S.
5 + 0.00 0.75 0.00 >0.90 N.S.
6 + 0.80 1.16 0.69 > 0.60 N.S.
7 + 1.16 1.18 0.98 > 0.1+0 N.S.
8 - 0.7U 1.01+ 0.71 > 0.60 N.S.
9 + 0.51+ 0.55 0.98 ;> 0.1+0 N.S.
10 - 0.18 0.73 0.25 >0.90 N.S.
11 + 0.66 0.71+ 0.89 >0.50 N.S.
12 + 1.20 2.03 0.59 > 0.60 N.S.
13 + 1.06 2.17 o.i+9 > 0.70 N.S.
11+ + 0.82 0.97 0.81+ ^0.50 N.S.
21 + 1.00 1.58 0.63 > 0.60 N.S.
28 + 1.06 0.96 1.10 > 0.1+0 N.S.
35 + 1.16 1.55 0.75 >0.50 N.S.
N.S. = Not Significant.
TABLE 13.
COMPARISON OP THE DAILY MEANS GAMMAGLOBULIN LEVELS BETWEEN
GROUPS 1 AND 2.
Days
Post- Degrees of Inter-
Challenge Freedom t P pretation
0 21 0.35 > 0.80 N.S
1 21 0.15 > 0.90 N.S
2 17 0.81 > o■LA•O N.S
3 17 0.38 > 0.80 N.S
1+ 12 1.13 > 0.30 N.S
5 17 0.33 i> 0.80 N.S
6 17 0.32 > 0.80 N.S
7 17 0.68 > 0.60 N.S
8 17 0.69 > oir\•o N.S
9 21 1.1+8 > 0.20 N.S
10 21 1.08 > 0.30 N.S
11 21 1.53 > 0.20 N.S
12 17 2.23 < 0.05 S.
13 " 21 2.31 < 0.05 S.
lb 21 2.12 < 0.05 s.
21 21 1.1+6 > 0.20 N.S
28 21 0.75 > 0.50 N.S
35 21 2.01+ > 0.10 N.S
3. = Significant.
N.S. = Not Significant.
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TABLE 1U.
MEAN DIFFERENCE OF TOTAL SERUM PROTEIN CONTENTS (DAY O -
DAY X) OF SUSCEPTIBLE SHEEP INFECTED WITH ORF VIRUS -
GROUP 3.
Days
Post- Mean Standard Inter-
Challenge (X) difference Error t p pretation
1 + 1.87 1.31 1.43 > 0.20 N.S
3 + 4.87 1.45 3.36 0 0.01 H.S
5 + 1.87 1.49 1.26 > 0.30 N.S
7 + 4.38 1.68 2.60 < 0.05 S.
8 + 0.38 2.43 0.15 > 0.90 N.S
9 + 2.38 2. 53 O. 94 > 0.40 N.S
10 + 0.75 2.56 0.29 > 0.80 N.S,
11 + 0.38 1.73 0.22 > 0.90 N.S
12 + 1.50 2 .08 0.72 > 0.50 N.S
13 - 0.86 2.46 0.35 > 0.80 N.S
14 + 2.14 2.43 0.88 >0.50 N.S
21 - 0.71 3.18 0.22 i> 0.90 N.S
28 + 0.86 1.94 O .44 > 0.70 N.S,








MEAN DIFFERENCE OF ALBUMIN LEVELS (DAY O - DAY X) OF
SUSCEPTIBLE SHEEP INFECTED WITH ORF VIRUS - GROUP 3.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t p pretation
1 - 0.95 1.19 0.80 !> 0.50 N.S
3 + 3.19 1.61 1.98 !> O.IO N.S
5 + 2.04 1.74 1.17 S> 0.30 N.S
6 + 3.05 0.92 3.31 <! 0.02 s.
7 + 3.38 1.10 3.08 <! O .02 S.
8 + 1.36 0.79 1.72 i> 0.20 N.S
9 + 0.50 1.27 0.39 l> 0.80 N.S
10 + 1.56 1.24 1.26 > 0.30, N.S
11 + 0.26 1.05 0.25 > 0.90 N.S
12 + 2.44 0.73 3.34 <! 0.02 s.
13 + 3 .40 1.29 2.71 <J 0.05 s.
14 + 0.83 1.30 0.64 > 0.60 N.S
21 - O . 83 1.28 O. 65 > 0.60 N.S
28 + 0.16 1.11 0.14 > 0.90 N.S
35 + 1.58 1.36 1.16 > 0.30 N.S
S. = Significant.
N.S. = Not Significant.
87.
TABLE 16.
MEAN DIFFERENCE OF ALPHA^-GLOBULIN LEVELS (DAY O - DAY X)
OF SUSCEPTIBLE SHEEP INFECTED WITH ORF VIRUS - GROUP 3.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t p pretation
1 O.OO . 0.27 O.OO > 0.90 N.S
3 - 0.55 0.36 1.53
>
0.20 N.S
5 - 0.75 0.46 1.63 > 0.20 N.S
6 - 0.46 0.33 1.40 > 0.20 N.S
7 - 0.82 0.40 2.05 > 0.10 N.S
8 - 0.86 0.40 2.16 > O.IO N.S
9 - 0.34 0.47 0.72 > 0.50 N.S
10 - 0.31 O .36 O.86 > 0.50 N.S
11 - 0.62 0.27 2.31 > 0.10 N.S
12 - 0.39 0.38 1.01 > 0.40 N.S
13 - 0.77 0.33 2.34 > 0.10 N.S
14 - 0.41 0.29 1.43 > 0.20 N.S
21 - 0.24 0.47 0.52 > 0.70 N.S
28 + 0.03 0.46 0.06 > 0.90 N.S
35 0.14 0.55 0.26 > 0.90 N.S
N.S. = Not Significant.
TABLE 17.
MEAN DIFFERENCE OF ALPHA2-GLOBULIN LEVELS (DAY O - DAY X)








1 + 0.63 0.33 1.89 >0.20 N.S.
3 - 0.10 0.48 0.59 >0.60 N.S.
5 - 0.45 0.58 0.78 >0.50 N.S.
6 - 0.25 0.52 0.48 >0.70 N.S .
7 - 0.10 0.52 0.19 >0.90 N.S.
8 - 0.58 0.89 0.65 >0.60 N.S.
9 - 0.60 0.60 1.00 >0.40 N.S.
10 - 0 .41 0.33 1.25 >0.30 N.S.
11 - 0.38 0.42 0.89 >0.50 N.S.
12 - 0.64 0.48 1.34 >0.30 N.S.
13 + O.ll 0.70 0.16 >0.90 N.S.
14 - 0.13 0.34 0.38 >0.80 N.S .
21 - 0.53 0.78 0.68 >0.60 N.S.
28 + O.Ol 0.34 0.04 >0.90 N.S .
35 — 0.77 0.39 1.98 >0.10 N.S.
N.S. = Not Significant.
89.
TABLE 18.
MEAN DIFFERENCE OF BETA-GLOBULIN LEVELS (DAY O - DAY X)
OF SUSCEPTIBLE SHEEP INFECTED WITH ORF VIRUS - GROUP 3.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t p pretation
1 + 0.61 0.39 1.57 >0.20 N.S.
3 - 0.31 0.51 0.61 >0.60 N.S.
5 + 0.25 0.47 0.53 >0.70 N.S.
6 + 0.74 0.42 1.76 > 0.20 N.S.
7 + 0.64 0.65 O. 98 >0.40 N.S.
8 + 0.23 0.76 0.30 > 0 . 80 N.S.
9 + O. 95 0.60 1.58 >0.20 N.S.
io + 0.36 0.67 0.54 >0.70 N.S.
11 + 0.59 O. 58 1.01 >0.40 N.S.
12 - 0.16 0.80 0.20 > 0.90 N.S.
13 - 0.18 0.69 0.27 > 0.80 N.S.
14 + l.Ol 0.58 1.75 > 0.20 N.S.
21 + 0.40 0.93 0.43 >0.70 N.S.
28 + 1 .00 0.69 1.45 >0.20 N.S.
35 + 0.34 0.62 0.55 >0.60 N.S.
N.S. = Not Significant.
90.
TABLE 19.
MEAN DIFFERENCE OF GAMMAGLOBULIN LEVELS (DAY O - DAY X)
OF SUSCEPTIBLE SHEEP INFECTED WITH ORF VIRUS - GROUP 30
Days
Post Mean Standard Inter-
Challenge (X) Difference Error t p pretation
1 + 1.50 0.80 1.88 > 0 .20 2 • (/) 0
3 + 1.80 1.10 1.64 > 0.20 N.S.
5 + 0.70 1.30 0.54 > 0.70 N.S.
6 + 0.65 2.50 0.26 > C o O N.S.
7 + 0.45 1.00 0.45 > 0.70 N.S.
8 + 0.80 1 .20 0.67 > 0.60 N.S.
9 + 0.23 1 .50 0.15 > 0.90 N.S.
10 + 0.80 1 .40 0.57 > 0.60 N.S .
11 + 1.60 1.20 1.33 > 0.30 N.S.
12 + 0.60 1.50 0.40 > 0.80 N.S.
13 + 2 o50 1 .50 1.67 > 0.20 N.S.
14 + 1 .70 1 .30 1.31 > 0.20 N.S.
21 + 1.40 1 .40 1.00 > 0.40 N.S.
28 + 0.90 1.10 0.82 > 0.5O N.S.
35 + 0.20 1.30 0.15 > 0.90 N.S.
N.S. = Not Significant
TABLE 20.
LEVELS









0 21 0.1+5 >0.70 N.S.
1 21 0.33 >0.80 N.S.
3 17 0.08 >0.90 N.S.
5 17 0.38 >0.80 N.S.
6 ll+ 0.56 >0.60 N.S.
7 17 0.39 >0.80 N.S.
8 15 0.11 >0.90 N.S.
9 21 0.62 >0.60 N.S.
10 21 0.08 >0.90 N.S.
11 21 0.32 >0.80 N.S.
12 17 0.16 >0.90 N.S.
13 21 0.03 >0.90 N.S.
11+ 21 0.01+ >0.90 N.S.
21 21 0.77 >0.50 N.S.
28 21 1.19 >0.30 N.S.
35 21 1.08 >0.30 N.S.
N.S. = Not Significant.
TABLE 21.
MEAN DIFFERENCE OF IgM LEVELS (DAY 0 - DAY X) OF SHEEP
PRE-INFECTED WITH ORF VIRUS - GROUP I.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 — 0.23 0.19 1.45 >0.20 N.S.
2 - 0.88 0.31 2.84 <0.02 S.
3 - 0.87 0.46 1.86 >0.10 N.S.
4 - 0.95 0.56 1.70 >0.20 N.S.
5 - 0.55 0.28 1.96 >0.10 N.S .
6 - 0.39 0.27 1.44 >0.10 N.S.
7 + 0.08 0.33 0.23 >0.90 N.S.
8 + 0.20 0.23 0.87 >0 .50 N.S.
9 + 0.01 0.21 0.06 >0.90 N.S.
10 + 0.46 0.29 1.59 >0.20 N.S.
11 - 0.17 0.23 0.74 >0.50 N.S.
12 - 0.70 0.33 2.12 >0.10 N.S .
13 - 0.36 0.21 1.71 >0.20 N.S .
14 - 0.33 0.22 1.50 >0.20 N.S.
21 - 0.09 0.22 0.41 >0.70 N.S.
28 - 0.13 0.20 0.65 >0.60 N.S.






MEM DIFFERENCE IN IgG1 LEVELS (DAY 0 - DAY X) OF SHEEP RE¬










1 + 0.98 0.93 1.05 > 0.1+0 N.S.
2 - o.i+U 0.98 o.i+5 !> 0.70 N.S.
3 + 0.96 1.01 0.95 > 0.1+0 N.S.
b -2.1+8 1.52 1.63 > 0.20 N.S.
5 + 0.7U 1.16 0.61+ i> O•0 N.S.
6 - 1.1+2 1.68 0.85 > 0.50 N.S.
7 - 1.77 1.62 1.09 > 0c~\•0 N.S.
8 - 2.27 1.91 1.19 > 0cn•0 N.S.
9 - 3.07 1.66 1.85 l> 0.20 N.S.
10 - 3.53 1.77 1.99 > 0.10 N.S.
11 - I4.83 1.67 2.89 <! 0.02 S.
12 - 5-81 1.81 3.21 0.01 H.S.
13 - 5.21 1.77 2.9U <i 0.01 H.S.
lb - 6.27 1.89 3.32 < 0.01 H.S.
21 - 1+.11+ 1.67 2.1+8 <! 0.02 S.
28 - 1+.61 1.35 3.U1 <! 0.01 H.S.
35 - 3.28 1.37 2.39 < 0.05 s.
S. = Significant.
H. S. = Highly Significant.
N. S. = Not Significant.
TAISLE 23.
MEAN DIFFERENCES OF IgG2 LEVELS (DAY 0 - DAY X) OF SHEEP RE¬
INFECTED WITH ORF VIRUS - GROUP I.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 - 0.2 0.18 0.02 > 0.90 N.S.
2 - 0.31 0.29 1.76 > 0.10 N.S.
3 - 0.35 0.30 1.83 > 0.10 N.S.
1+ - 0.625 0.1+0 1.56 > 0.20 N.S.
5 - 0.575 0.30 1.92 > 0.10 N.S.
6 - 0.625 0.82 0.75 > 0.50 N.S.
7 - o.U3 0.26 1.65 0.20 N.S.
8 - 0.13 0.1+0 0.32 +> 0.80 N.S.
9 - 0.62 0.36 1.76 > 0.50 N.S.
10 - 0.675 0.51 1.32 > or^v•o N.S.
11 - 0.92 0.1+1+ 2.09 > 0.10 N.S.
12 - 0.83 0.31 2.68 < 0.05 S.
13 - 0.71 0.37 1.92 > 0.10 N.S.
11+ - 0. i+6 0.1+2 1.10 > O•o N.S.
21 - 0.27 0.31+ 0.79 > o•o N.S.
28 - 0.3I+ 0.39 0.87 > o-3"•o N.S.
33 0.07 0.32 • 0.22 > 0.90 N.S.
S. = Significant.
N.S. = Not Significant.
TAHEJ^.
MEM DIFFERENCE OF IgM LEVELS (DAY 0 - LAY X) OF UNCHALLENGED
PREVIOUSLY INFECTED SHEEP - GROUP 2.
Days
Post- Mean Standard. Inter-
Challenge (x) Difference Error t P pretation
1 - 0.20 . 0.08 2.50 >0.10 N.S.
2 + 0.12 0.20 0.60 >0.60 N.S.
3 + 0.06 0.22 0.27 > 0.80 N.S.
h - 0.12 a. 15 0.80 > 0.50 N.S.
5 + 0.06 0.30 0.20 >0.90 N.S.
6 + 0.06 0.22 0.27 > 0.80 N.S.
7 - 0.06 0.29 0.21 >0.90 N.S.
8 - 0.21+ 0.20 1.20 > 0.30 N.S.
9 - 0.20 0.25 0.80 >0.60 N.S.
10 - 0.38 0.2b 1.58 > 0.20 N.S.
11 - 0.30 0.27 1.11 > O.i+O N.S.
12 - 0.20 0.25 0.25 > 0.90 N.S.
13 - 0.36 0.17 2.11 > 0.10 N.S.
lii - 0.36 0.31 1.16 > 0.30
•
N.S.
21 - 0.18 0.26 0.70 > 0.60 N.S.
28 - 0.2U 0.26 0.93 > 0.40 N.S.
35 + 0.02 0.16 0.12 i> 0.90 N.S.
Table 25.
MEM DIFFERENCE OF IgG1 LEVELS (DAY 0
PREVIOUSLY INFECTED SEEEP - GROUP 2.
- DAY X) OF UNCHALLENGED
Days
Post- Mean Standard Inter-




















































N.S. = Not Significant.
Table 26.
MEAN DIFFERENCE OF IgGg LEVELS ( DAY 0 - DAY X) OF UNCHALLENGED
PREVIOUSLY INFECTED SHEEP - GROUP 2.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 + 0.27 • 0.15 1.83 > 0.20 N.S
2 + o.oU 0.10 o.l+o > 0.80 N.S
3 + 0.10 0.11 0.91 > 0.50 N.S
h + 0.08 0.12 0.67 > 0.60 N.S
5 + 0.00 0.19 0.00 > 0.90 N.S
6 - 0.21+ 0.11+ 1.71 > 0.20 N.S
7 - 0.02 0.97 0.21 > 0.90 N.S
8 + 0.00 0.19 0.00 > 0.90 N.S
9 + 0.02 0.11 0.18 > 0.90 N.S
10 - 0.02 0.10 0.20 > 0.90 N.S
11 - 0.22 0.21+ 0.92 >0.1+0 N.S
12 - 0.22 0.09 2.1+0 > 0.10 N.S
13 - 0.22 0.11+ 1.57 > 0.20 N.S
lb + 0.08 0.27 0.30 > 0.80 N.S
21 + 0.08 0.27 0.30 > 0.80 N.S
28 + 0.20 0.22 0.91 > 0.50 N.S
35 - 0.11+ O.lU 1.00 s> o.i+o N.S
N.S. = Not Significant.
TABLE 27.








0 21 1.03 +> 0.1+0 N.S.
1 21 0.79 > 0.50 N.S.
2 17 1.51+ > 0.20 N.S.
3 17 1.07 > 0.30 N.S.
1+ 13 2.87 < 0.05 S.
5 17 0.82 > 0.50 N.S.
6 17 1.86 > 0.10 N.S.
7 17 1.62 > 0.20 N.S.
8 17 2.29 <! 0.05 S.
9 21 1.93 0.10 N.S.
10 21 2.36 <1 0.05 S.
n 21 2.20 < 0.05 S.
12 17 2.29 < 0.05 S.
13 21 2.18 < 0.05 S.
11+ 21 2.66 < 0.02 S.
21 21 2.30 < 0.05 S.
28 21 3.22 <1 0.01 H.S.
39 21 2.72 < 0.02 ID •
S. = Significant.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE 28.




Challenge N t P pretation
0 21 0.1+3 > 0.60 N.S.
1 21 0.83 > 0.50 N.S.
2 17 1.63 > 0.20 N.S.
3 17 1.55 > 0.20 N.S.
k 13 0.99 > 0.1+0 N.S.
5 17 1.51 > 0.20 N.S.
6 17 0.97 > 0.1+0 N.S.
7 17 0.28 > 0.80 N.S.
8 17 0.37 > 0.80 N.S.
9 21 0.03 > 0.90 N.S.
10 21 0.28 > 0.80 N.S.
11 21 0.10 > 0.90 N.S.
12 17 1.18 >0.30 N.S.
13 21 0.33 > 0.80 N.S.
11+ 21 0.32 > 0.80 N.S.
21 21 o • ro > 0.90 N.S.
28 21 0.08 > 0.90 N.S.
35 21 0.52 >0.70 N.S.
N.S. = Not Significant.
TABLE '29.
COMPARISON OE 'THE DAILY MEANS OF IgG2 LEVELS BETWEEN GROUPS 1
AND 2 .
Days
Post- Degrees of Inter-
Challenge Freedom t P pretation
0 21 0.77 >o.5o N.S.
1 21 0.81+ >0.50 N.S.
2 17 0.93 >0.1+0 N.S.
3 17 0.99 >0.1+0 N.S.
b 13 2.06 >0.10 N.S.
5 17 0.86 > 0.1+0 N.S.
6 17 1.05 >0.1+0 N.S.
7 17 0.80 >0.50 N.S.
8 17 0.66 >0.60 N.S.
9 21 0.99 >0.1+0 N.S.
10 21 1.09 >0.30 N.S.
11 21 1.15 >0.30 N.S.
12 17 ' 0.90 >0.1+0 N.S.
13 21 1.12 >0.30 N.S.
lb 21 1.19 >0.30 N.S.
21 21 1.18 >0.30 N.S.
28 21 1.25 >0.30 N.S.
35 21 0.75 >0.50 N.S.
N.S. = Not Significant.
TABLE 30.
MEAN DIFFERENCE' OF IgM LEVELS (DAY O - DAY X) OF SUS¬










1 O.OO 0.16 0.00 > 0 . 90 N.S.
3 + 0.41 0.24 1.72 >0.20 N.S.
5 + 0.06 0.20 O. 31 > 0. 80 N.S.
6 + 0.18 0.33 0.53 >0.70 N.S .
7 + 0.15 0.25 0.60 >0.60 N.S .
8 + 0.18 0.32 0.57 > 0.60 N.S.
9 - 0.88 0.45 0.19 >0.90 N.S.
io - 0.23 0.37 0.61 > 0.60 N.S.
11 + 0.16 0.25 0.65 > 0.60 N.S.
12 + 0.10 0.34 0.29 > 0.80 N.S.
13 + 0.10 0.34 0.29 > 0.80 N.S.
14 + 0.06 0.30 0.19 > 0.90 N.S.
21 + 0.20 0.25 0.80 > 0.50 N.S.
28 + 0.20 0.21 0.95 > 0.40 N.S.
35 + 0.17 0.21 0.82 > 0.50 N.S.
N.S. = Not Significant.
TABLE 31.
MEAN DIFFERENCE OF IgG LEVELS (DAY O - DAY X) OF
SUSCEPTIBLE SHEEP INFECTED WITH ORF VIRUS - GROUP 3»
Days
Post- Mean Standard Inter-
Challenge (x) difference Error t p pretation
1 + 0.29 0.35 0.83 Oin•oA N.S.
3 + 0.58 2.38 2.38 <0.05 s.
5 + 0.36 0.72 0.49 > 0.70 N.S.
6 - 0.28 1.67 0.16 > 0.9O N.S.
7 - 0.48 0.69 0.69 > 0.60 N.S.
8 - 1.83 1 .05 1.74 > 0.20 N.S.
9 - 1.39 0.73 1.90 > O.IO N.S.
10 - 2.12 0.99 2.15 >0.10 N.S.
11 - 1.91 0.81 2.36 <0.05 s.
12 - 1 .18 0.58 2.03 >0.10 N.S.
13 - 1.17 1.G5 1.11 > 0.40 N.S.
14 1.64 0.89 1.84 >0.20 N.S.
21 - 1.73 O. 85 2.03 >0.10 N.S.
28 - 1 .00 0.81 1.18 >0.30 N.S.
35 - 0.11 1.39 0.08 >0 . 90 N.S.
S. = significant
N.S. = Not significant
TABLE 32.
MEAN DIFFERENCE OF IgG2 LEVELS (DAY O - DAY X) OF SUS¬










1 + 0.08 0.20 0.38 V O 0 00 O N.S.
3 - 0.40 0.28 1.45 > 0.20 N.S.
5 - 0.23 0.27 0.83 Oin•OA N.S.
6 - 0.68 0.31 2.18 j> O.IO N.S.
7 - 0.31 0.21 1.49 > 0.20 N.S.
8 - 0.32 0.18 1.76 > 0 .20 N.S.
9 - 0.81 0.30 2.71 o 0.05 S
10 - 0.71 0.25 2.85 o 0.05 s
11 - 0 .70 0.35 2.00 OooA N.S.
12 - 0.51 0.40 1.28 > 0.30 N.S.
13 - 0.60 0.41 1.46 > 0 .20 N.S.
14 - 0.70 0.31 2.90 <j 0.05 S
21 - 0.91 0.38 2.41 <1 0.05 s
28 - 0.69 0.30 2.29 O1—1•oA N.S.
35 - 0.86 0.25 3.43 <1 0.02 s
S = Significant
N.S. = Not significant
TABLE 33.
COMPARISON OP THE DAILY MEANS OP IgG1 LEVELS BETWEEN GROUPS 1
AND 3.
Days
Post- Degrees of Inter-
Challenge Freedom t P pretation
0 21 ' 1.3b >0.20 N.S
1 21 1.06 >0.30 N.S
3 17 0.96 >0.1+0 N.S
5 17 1.3U >0.20 N.S
6 lb 1.U3 >0.20 N.S
7 17 1.78 >0.10 N.S
8 15 2.71 ** 0.02 S.
9 21 1.93 >0.10 N.S
10 21 1.8U >0.10 N.S
11 17 1.99 >0.10 N.S
12 17 2.b7 • <! 0.05 S.
13 21 2.27 < 0.05 3.
lb 21 2.73 < 0.02 S.
21 21 2.10 < 0.05 S.
28 21 3.3b <1 0.01 H.S













of Freedom t p
Inter¬
pretation
0 21 0.68 >0.60 N.S.
1 21 1.32 >0.30 N.S.
3 17 2.b3 >0.05 S.
5 17 2.10 >0.05 S.
6 lb 0.88 >0.1*0 N.S.
7 17 1.21* >0.30 N.S.
8 15 1.17 >0.30 N.S.
9 21 1.02 >0.1*0 N.S.
10 21 1.5U >0.20 N.S.
11 21 1.51 >0.20 N.S.
12 17 2.17 >0.05 S.
13 21 1.56 >0.20 N.S.
11+ 21 1.2b >0.30 N.S.
21 21 1.85 >0.10 N.S.
28 21 0.78 >0.50 N.S.
35 21 1.15 >0.30 N.S.
N.S. = Not Significant.
TABLE 35.








0 21 1.11+ >0.30 N.S.
1 21 1.09 i>0.30 N.S.
3 17 1.08 >0.30 N.S.
5 17 1.06 >0.1+0 N.S.
6 17 1.21 >0.30 CO•^5
7 17 1.01 >0.1+0 N.S.
8 15 1.25 >0.30 N.S.
9 21 0.82 >0.50 N.S.
10 21 1.01+ >0.1+0 N.S.
11 21 1.21+ >0.30 N.S.
12 17 1.15 . >0.30 N.S.
13 21 1.28 >0.30 N.S.
11+ 21 0.81+ >0.50 N.S.
21 21 0.88 >0.1+0 N.S.
28 21 0.95 >0.1+0 N.S.
35 21 1.19 >0.30 N.S.
N.S. = Not Signficant.
TABLE 36.









0 21 2.62 <! 0.030 S.
1 21 2.62 < 0.050 S.
3 17 3.93 <J 0.010 H.S.
5 17 9.20 < 0.001 H.S.
6 17 1.99 > 0.100 N.S.
7 17 9.99 < 0.001 H.S.
8 17 U.70 < 0.001 H.S.
9 21 3.89 < 0.001 H.S.
10 21 3.70 < 0.010 H.S.
11 21 3.86 < 0.001 H.S.
12 17 3.97 < .0.001 H.S.
13 21 U.39 C 0.001 H.S.
U4 21 h.62 <! 0.001 H.S.
21 21 3.06 <1 0.010 H.S.
28 21 2.23 <! 0in0.0 S.
39 21 2.23 < 0.030 S.
S. = Significant.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE 37.
MEAN DIFFERENCES IN ANTIBODY TITRES (DAY 0
INFECTED WITH ORF VIRUS - GROUP 1.










1 0.00 0.00 0.00 > 0.900 N.S.
2 0.00 0.00 0.00 > 0.900 N.S.
3 - 0.25 0.13 1.92 > 0.100 N.S.
h - 0.25 0.13 1.92 > 0.100 N.S.
5 - 0.58 0.22 2.61+ < 0.050 S.
6 - 0.50 0.19 2.63 < 0.050 s.
7 - 1.16 0.27 1+.30 < 0.010 H.S.
8 - 1.83 0.23 7.96 < 0.001 H.S.
9 - 1.81 0.26 6.96 c 0.001 H.s.
10 - 1.9U 0.26 7.32 0.001 H.S.
11 - 2.25 0.21 10.1+0 <+ 0.001 H.S.
12 - 2.25 0.35 6.1+0 <i 0.001 H.S.
13 - 2.37 0.27 8.80 < 0.001 H.S.
lb - 2.25 0.29 7.63 < 0.001 H.S.
21 - 1.9U 0.25 7.76 < 0.001 H.S.
28 - 1.1+1+ 0.21+ 6.00 < 0.001 H.S.
35 - 1.37 0.20 6.85 < 0.001 H.S.
S. = Significant
H.S. = Highly Significant
N.S. = Not Significant
TABLE 39.
CORRELATION BETWEEN THE GAMMAGLOBULIN LEVELS AND ANTIBODY
TITRES OF SHEEP RE-INFECTED WITH ORF VIRUS - GROUP I.
Number of Correlation Inter-
Animal Coefficient (r) P pretation
751 + 0.11 >0.05 N.S
780 + 0.05 >0.05 N.S
7U9 + 0.55 * 0.05 S.
765 + 0.50 « 0.05 s.
767 + 0.57 < 0.05 S.
779 + o.U5 >0.05 N.S
768 + 0.60 < 0.01 H.S
691 - 0.01 >0.05 N.S
71+0 + 0.32 >0.05 N.S
712 - 0.18 >0.05 N.S
790 + 0.70 < 0.01 H.S
362 + 0.1b >0.05 N.S
852 - 0.31 >0.05 N.S
875 + 0.59 <0.05 S.
836 + 0.85 <0.01 H.S








CORRELATION BETWEEN THE IgG1 LEVELS AND ANTIBODY TITHES OP
SHEEP RE-INPECTED WITH ORE VIRUS - GROUP I.
Number of Correlation Inter-
Animal Coefficient (r) P pretation
751 - 0.62 < 0.01 H.S.
780 + 0.32 >0.05 N.S.
7U9 + 0.11 >0.05 N.S.
765 + .0.81 < 0.01 H.S.
767 + O.7J4. < 0.01 H.S.
779 + 0.86 <1 0.01 H.S.
768 + 0.82 <! 0.01 H.S.
691 + 0.62 <S 0.01 H.S.
7k0 + 0.32 >0.05 N.S.
712 + 0.53 <! 0.05 S.
790 + 0.7U <1 0.01 H.S.
362 + 0.30 t>0.05 N.S.
852 + 0.62 <1 0.05 S.
875 + 0.09 >0.05 N.S.
836 + 0.66 < 0.05 S.
838 + 0.33 >0.05 N.S.
S. = Significant.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE 1+2.
COMPARISON OF THE DAILY MEANS OF ANTIBODY TITHES BETWEEN
GROUPS 1 AND 2.
Days
Post- Degree of Inter-
Challenge Freedom t P pretation
0 19 l.ok > o.uoo N.S.
1 19 l.ob > o.Uoo N.S.
2 19 0.19 > 0.900 N.S.
3 15 1.27 > 0.300 N.S.
h 11 0.38 > 0.800 N.S.
3 15 3.01 <j 0.010 s.
6 15 1.15 !> 0.300 N.S.
7 15 l+.ll <i 0.001 H.S.
8 15 3.75 << 0.010 H.S.
9 15 2.96 < 0.010 . H.S.
10 19 2.77 C 0.020 H.S.
n 19 3.9U <j 0.001 H.S.
12 15 U.88 <3 0.001 H.S.
13 19 5.28 <1 0.001 H.S.
lk 19 5.66 <J 0.001 H.S.
21 19 5.29 <J 0.001 H.S.
28 19 1.27 << 0.001 H.S.
35 19 U.01+ <J 0.001 H.S.
S. = Significant.
N.S. = N°t Significant.
H.S. = Highly Significant.
TABLE 1+3.
GAMMAGLOBULIN Vs ANTIBODY TITRES GROUP 3.
Number
of
Animal N r p
Inter¬
pretation
39 16 + 0.283 > 0.05 N.S.
1+0 16 + 0.095 > 0.05 N.S.
52 15 + 0.671 < 0.01 s.
65 15 + 0.692 < 0.01 3.
67 15 - 0.1+2 > 0.05 in •
63 15 0.30 > 0.05 N.S.




0 7 - 0.1+1 > 0.05 N.S.
7 7 - 0.268 > 0.05 N,S.
11+ 7 - 0.35 > w0•0 N.S.
21 7 - 0.59 > 0.05 N.S.
28 7 - 0.23 > 0.05 N.S.
35 7 - 0.12 > 0.05 N.S.
Mean
Values 16 0.67 < 0.01 S.
S. = Significant.
N.3. = Not Significant.
TABLE 1+1+
IgG1 Vs ANTIBODY TITHES
No. of Sheep N r P
Inter¬
pretation
39 16 0.3b s> 0.05 N.S.
bo 16 0.6b > 0.05 N.S.
52 15 0.1b > 0.05 N.S.
65 15 ■ 0.61+ < 0.01 S.
67 15 0.15 > 0.05 N.S.
63 15 -0.16 > 0.05 N.S.
Days
Post-
Challenge N r p
Inter¬
pretation
0 7 —0.66 ► 0.05 N.S.
7 7 -0.1+1 > 0.05 N.S.
lb 7 -0.55 > 0.05 N.S.
21 7 -0.79 <! 0.05 S.
28 7 -0.83 < 0.05 3.
35 7 +0.11 > 0.05 N.S.
Mean






MEAN DIFFERENCE OF ANTIBODY TITRES (DAY O - DAY X)
OF SUSCEPTIBLE SHEEP INFECTED WITH ORF VIRUS - GROUP 3.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t p pretation
1 0.00 0.00 O.OO > 0.90C N.S
3 0.00 0.00 O.OO >0.900 N.S
5 o.oo O.OO O.OO > 0.900 N.S
6 - 0.50 0.50 l.OO > 0.400 N.S
7 - 0.28 0.29 1.00 >0.400 N.S
8 - 0.40 0.40 l.OO > 0.400 N.S
9 - 0.71 0.47 1.52 >0.200 N.S
10 - 0.86 0.46 1.86 >0.200 N.S
11 - 1.71 0.28 6.12 40.OOl H.S
12 - 1.86 0.34 5.46 <i 0.001 H.S
13 - 1.57 0.40 3.90 4 O.OIO H.S
14 - 1.86 0.24 7.75 4 O.OOl H.S
21 - 2.00 0.22 9.09 4 O.OOl H.S
28 - 2.00 0.41 4.84 <5 O.OOl H.S
35 __ 2.00 0.41 4.87 < O.OOl H.S
H.S. = Highly Significant,
N.S. = Not Significant.
TABLE 1+6.
MEAN DIFFERENCE OF ANTIBODY TITHES (DAY 0 - DAY X) OF UNCHALLENGED










1 0.00 0.00 0.00 > 0.90 N.S.
2 - 0.60 0.1+0 1.50 > 0.20 N.S.
3 - 0.1+0 0.1+0 1.00 > 0.1+0 N.S.
b - 0.1+0 0.1+0 1.00 > 0.1+0 N.S.
5 - O.l+o 0.U0 1.00 > 0.1+0 N.S.
6 - 0.1+0 0.1+0 1.00 > O.i+O N.S.
7 - 0.1+0 0.1+0 1.00 > 0.1+0 N.S.
8 - O.i+O 0.1+0 1.00 > O.l+o N.S.
9 - 0.1+0 0.1+0 1.00 > 0.1+0 N.S.
10 - 0.60 0.60 1.00 >0.1+0 ■ N.S.
11 - 0.60 0.1+0 1.50 > 0.20 N.S.
12 - 0.1+0 0.1+0 1.00 > 0.1+0 N.S.
13 - 0.1+0 0.1+0 1.00 >0.1+0 N.S.
11+ - 0.1+0 0.1+0 1.00 > o.i+o N.S.
21 - 0.1+0 0.1+0 1.00 >0.1+0 N.S.
28 - 0.1+0 0.1+0 1.00 >0.1+0 N.S.
35 - 0.1+0 0.1+0 1.00 > 0.1+0 N.S.
N.S. = Not Significant.
DISCUSSION
Serum Protein Patterns in Sheep before Infection and Re¬
infection with Orf Virus
The levels of total serum proteins, albumin and
globulin fractions reported in the literature range widely
my values fell within the extremes where comparisons were
meaningful (Table 47 )«
The total serum protein values determined in the
present work were higher than those recorded by Kuttler
and Marble (I960), Dobson 1966), Halliday (1966), Khalaf
(1978), and Shubber (1978), similar to those reported
by Becker and Smith (1950), Egan and Cuill (1971) and
Singh and Dutt (1974), and lower than those recorded by
Weaver (1974). The quantitative variations reported
have been attributed to variations in technique and
specific factors such as age, breed, nutritional state
and health of the animals (Becker and Smith 1950;
Ravaioli 1959; Perk and Lobl 1960). Perk and Lobl
(I960), for example, found that the total serum proteins
increased with age and that this increase was primarily
in the globulin fractions which they attributed to anti¬
genic stimulation from the diet, and from pathogenic and
non-pathogenic infections. In my studies, a significant
drop in the total serum proteins was observed in the un¬
challenged previously infected sheep during the period of
the experiment attributable perhaps to excitement from
handling because no corresponding decreases were observed







































































































































































total serum protein levels in the challenged sheep
remained the same or rose slightly,,
The gammaglobulin values detected in the sheep be¬
fore infection or re-infection were higher than those
reported by Dobson (1966) but approximated the values
published by Khalaf (1978), Shubber (1978), Halliday
(1966) and Perk and Lobl (1960) in mature clinically
normal rams and ewes.
In the immunoglobulin classes, the IgM values re¬
corded in the present study were lower than the values
reported by most authors (Table 47) but the IgGl and
IgG2 levels were within the ranges recorded by Ciupercescu
(1977), Khalaf (1978) and Shubber (1978),
Orf antibodies were detected in only eight out- of
the 21 previously infected sheep (38 percent), a finding
that is in agreement with Romero-Mercado (1969) who re¬
ported that in primary orf infections antibodies were low
and often transient.
Serum Protein Changes in Sheep after Infection and Re¬
infection with Orf Virus
The changes L observed in the serum protein patterns
in sheep after infection or re-infection with orf virus
indicated that antigenic stimulation had induced a.
1 humoral immune response.
Total serum protein values did not change signifi¬
cantly in either the infected susceptible sheep or chal¬
lenged previously infected sheep, Doxey (1971) reported
that in mature animals the total serum protein levels
were maintained at a constant level but could be rear¬
ranged in some acute infections and in early stages of
parasitisms, mainly as a result of changes in the glob¬
ulin fractions. Increase in globulin fractions after
infection was first reported by Earle (1935). Since
then, several authors have reported that globulin
fractions particularly the gamma-globulins rose in acute
infections (Campbell 1957; Vesselinovitch 1959; Perk
and Lobl I960). Vesselinovitch (1959), moreover,
noted that in some viral infections the total serum-
protein levels remained unaltered but the ratio of the
various protein fractions changed. Likewise, I found
that although the total serum protein contents did not
change, the gamma-globulin fraction increased signific¬
antly in the sheep challenged with orf virus. In con¬
trast, in infected susceptible sheep insignificant in¬
creases were detected. It is thus tempting to suggest
that the changes observed in the gamma-globulin fraction
of the susceptible and previously infected sheep chal¬
lenged with orf virus are due to antigenic stimulation
by orf virus.
Smith, Dawson, Wells and Burrells (1976) observed
that IgM concentration in sera of lambs infected with
parainfluenza 3 virus increased rapidly three days after
aerosol challenge and the increase coincided with the
appearance of serum antibody to the virus. In contrast,
I did not detect any significant changes in the IgM levels
in the sera of the susceptible sheep infected with orf
virus. The changes could have been qualitative but
the weakness of my study was that specific IgM orf
antibody activity was not investigated, hence valid con¬
clusions of lack of IgM participation cannot be drawn.
Smith and his colleagues (1976) also detected higher
concentrations of IgG in lambs three weeks after vac¬
cination with live parainfluenza virus 3 and a sharp
increase in the IgG levels in vaccinated lambs after an
aerosol challenge. Likewise, in the current study,
significant increases were noted in the IgGl and IgG2
levels of sheep re-infected with orf virus and less pro¬
nounced increases were detected in sheep exposed to orf
virus for the first time.
The rate of orf antibody production in infected
susceptible sheep was significantly sloxver than the rate
challenged
in the/previously infected sheep challonged and the anti¬
body titres of the primary response were significantly
lower than the titres attained in the secondary response
even in the previously infected sheep which had no detect¬
able antibodies at the time of challenge. In short,
challenge of previously infected sheep induced a classical
anamnestic reaction (Glenny and Sumersen 1921; Uhr and
Finkelstein 1967).
Romero-Mercado (1969) found that most lambs naturally
or experimentally infected with orf virus developed tran¬
sient orf antibodies detectable by precipitation tests
within two weeks and detectable by CFT within four weeks.
Lutu (1971) in contrast, reported that weaned lambs
developed orf antibodies detected by CFT in the first
week after challenge and attained peak titres at an
average of five weeks after challenge,, In the present
work, likewise I found that the 'onset' of orf antibodies
as detected by passive haemagglutination tests occurred
towards the end of the first week after primary infection
but, in contrast, the peak value of antibody titres was
reached three weeks later.
Romero-MercadOj (1969) and Lutu, (1971) found that re¬
infection of sheep with orf virus induced an anamnestic
antibody rise clearly demonstrable by precipitation tests
in the first week after challenge. Furthermore, Lutu
(1971) found that in the secondary response higher anti¬
body titres were obtained and peak values were attained
three to four weeks after challenge. The current data
likewise, showed that in the secondary immune response
to orf virus, antibodies appeared within five days after
challenge and reached a pea.k value in the second week. In
addition, the present work revealed that higher antibody
titres were detected in the anamnestic response.
The highly significant correlation between the gamma¬
globulin values and orf antibody titres in both the
primary and secondary orf immune response in the present
study strongly suggest that the increases detected in the
gamma-globulin levels were due to orf antibody production
and the equally significant correlation between the IgGl
levels and the orf antibody titres suggest that the anti¬
bodies were associated with IgGl.
Hence, in summary, infection of susceptible sheep
with orf virus induced a slow and weak primary antibody
response. Re-infection evoked a swift and powerful
secondary antibody response probably associated with the






Evidence has been accumulating on the importance
of the role played by cell-mediated immunity (CMI) in
the defence of the host against several viral infections,
especially membrane-associated viruses such as poxviruses
myxoviruses, herpesviruses and adenoviruses (Boulter 1969
Tompkins, Zarling, and Rawls 1970; Blanden 1974). One
theory put forward to explain the necessity of CMI was
that CMI promoted recovery from infection by eliminating
or restricting virus-infected cells whereas antibodies
ivhich are incapable of penetrating cells, provided
protection against virus infection by prohibiting the
establishment and the spread of the extracellular virus
(Bloom and Ragar-Zisman 1975),
Since the observation by Rich and Lewis (1932)
that the migration of cells from tissue explants of sen¬
sitized animals was inhibited by the sensitizing antigen
and the discovery by Landsteiner and Chase (1942; 1945)
that delayed hypersensitivity could be transferred to
normal recipients by sensitized cells from sensitized
donors, considerable advances have been made in the
techniques for studying cellular reactions in CMI. The
effect or mechanisms of CMI are complex and, as yet, are
incompletely understood. Lymphocytes and macrophages
are the major cell types involved in CMI; lymphocytes
possess immunological specificity and efficacy whereas
macrophages are the executors of CMI reactions (Elves,
Roath and Israels 1963; Pearmain, Lycette and Fitzgerald
1963; Mackaness 1969; Bloom 1971). It has also been
shown that thymus-dependent lymphocytes (T-cells) are
required for cell-mediated immune responses (Miller,
Marshall and White 1962; Jankovic, Waksman and Arnasson
1962; Good, Dalmasso, Martinez, Archer, Pierce and
Papermaster 1963; Paterson 1966; North 1973).
In 1963, Pearmann and his colleagues observed that
when a population of sensitized lymphocytes were stimu¬
lated by the sensitising antigen iri vitro, morphological
and biochemical changes occurred in the small lympho¬
cytes which culminated in an increase in their size and
their proliferation. This finding was corroborated by
Elves and his colleagues (1963). Furthermore, when
lymphocytes were stimulated by sensitizing antigen they
produced mediators known as lymphokines which were non-
antibody multifactorial amplifiers involved in non¬
specific recruitment and regulation of circulating lympho¬
cytes, macrophages and polymorphonuclear leucocytes (FMN)
(Dumonde, Wossencroft, Parayi, Matthew and Morley 1969).
The well-documented lymphokines are blastogenic
(mitogenic) factor (Kasakura 1970) which induces mitosis
and proliferation of other lymphocytes thus creating a
large population of sensitized lymphocytes, macrophage
migration inhibition factor (MIF) (Bloom and Bennet
1966; David 1966), leucocyte migration inhibition factor
(LIF) (Soborg and Bendixen 1967; Rocklin 1974; Benditzen
1977) lymphotoxins which induce cytotoxicity of target
cells (Ruddle and Waksman 1968), transfer factor which
converts non-sensitized lymphocytes to the antigen re¬
sponsive state (Lawrence 1969; 197^), and chemotactic
factors which lure macrophages and PMN leucocytes to the
site of infection (Nathan et al. , 1971; Repo et al.,
1978), Rocklin (1976) tried to explain the functions
of the lymphokines by suggesting that chemotactic factors
were synthesized to recruit the macrophages and micro-
phages to the reaction site and, once present, these cells
were then confined to the site by the migration inhibition
factors. Macrophages were then activated to an enhanced
phagocytic state by activating factor, indistinguishable
from MIF and other lymphocytes were recruited to partici¬
pate in the reaction by mitogenic factor and transfer
factor.
The relevance of in vitro models of CMI mechanisms
to in vivo events have been s tudied and parallelism has
been well-documented. The most common in vitro systems
used to demonstrate CMI are migration inhibition tests
and lymphocyte blast transformation tests. In addition,
the successful passive transfer of sensitized lymphocytes
or transfer factor to a susceptible recipient with non-
sensitized lymphocyte population, is a useful in vivo
indicator of CMI.
Migration Inhibition
Migration inhibition tests measure the effects on
target cell population (macrophages or PMN leucocytes)
of factors elaborated by sensitized lymphocytes when they
are stimulated by the sensitizing antigen. The basic
concept of inhibition of cell migration was first pioneered
by Rich and Lewis (1928) who had observed that when cells
in a plasma clot from tuberculous guinea pigs were
cultured in a medium containing tuberculin they were pre¬
vented from migrating, whereas, when cells from normal
guinea pigs^cultured in the tuberculin-containing medium
th Qy« were not prevented from migrating. George and
Vaughan (1962) developed a capillary tube method for
quantitating the migration of macrophages. Their
technique was based on observing the migration of sen¬
sitized peritoneal exudate (PE) cells, which comprised
approximately 70 percent macrophages and 20 percent
lymphocytes, from capillary tubes which were placed in
chambers containing medium. The tendency of the cells
to migrate was curtailed when the sensitizing antigen
was included in the medium. David, Al-askari, Lawrence
and Thomas (1964) quantified the migration inhibition
test using PE cells for assaying the macrophage migration
inhibition factor (MIF) and thus produced a meaningful
bench test which has been used to demonstrate CMI in vitro
with numerous antigens e.g0 PPD, histoplasmin, coccidion
( (Thor e_t al., 1968), lymphocytic choriomeningitis virus
and mumps virus (Tubergen and Oldstone 1971) and vaccinia
k
virus (Tomans e_t al. , 1970; Hutt 1975)).
In 1967, Soborg and Bendixen described an in
vitro test based on the inhibition of migration of
human peripheral leucocytes from capillary tubes. They
observed that when leucocytes from brucella-positive in¬
dividuals were cultured with brucella antigen their migr¬
ation was inhibited but the migration of leucocytes from
brucella-negative individuals was not inhibited. Later,
Rocklin (1974) managed to isolate and characterize the
leucocyte migration inhibition factor and found that it
was chemically different from MIF. Since then, the
leucocyte migration inhibition test has been successfully
applied to detect CMI to a variety of antigens. Moreno-
Lopez (1977), for example, used the test to show the in¬
volvement of CMI in parainfluenza-3 infection in cattle
and Hussain and Mohanty (1979) were able to detect a
CMI response to bovine rhinovirus type 1 in calves.
Lymphocyte Blast Transformation
Carstairs (1961) first showed that small lympho¬
cytes survived and divided in cultures of human leuco¬
cytes. The term 'blast-like' was coined by MacKinney,
Stohlman and Brecher (1962) to describe' the appearance
of the transformed lymphocytes in cultures since they
resembled lymphoblasts. The process of this trans¬
formation was termed blastogenesis because the transformed
cells were capable of mitosis and proliferation (Robbins
1964).
earlier had
In 1960, Nowe11,/3bserved that the addition of the
mitogen, phytohaemagglutinin (PHA), an extract from the
red bean, Phaseolus vulgaris, to cultures of normal
human leucocytes caused transformation of the lympho¬
cytes into blast-like cells. Similar responses to
other mitogens have been observed with normal lympho¬
cytes of other species including sheep (Burells and
Wells 1977), cattle (Muscoplat e_t al., 1974), pigs
(Viza et ad., 1970) and laboratory animals such as rats,
mice, rabbits and hamsters (Knight _et al_., 1965).
The PHA phenomenon has proved invaluable to immuno-
logists who found that certain antigens also induced a
similar transformation in lymphocytes from sensitized
individuals. Pearmain and his colleagues (1963) re¬
ported that in the presence of PPD, cultures of lympho¬
cytes taken from tuberculin-positive individuals produced
mitotic figures similar to those induced by PHA in normal
lymphocytes, whereas, cultures of lymphocytes from tuber-
/
culin-negative individuals did not show mitosis. Specific
antigen-stimulated blast-cells have been observed micros¬
copically with lymphocytes from sensitized individuals
and antigens from smallpox vaccine, poliovirus, mumps
virus, vaccinia virus, and herpes virus (Elves et al.,
1963; Smith et al., 1972; Rosenberg et al_., 1972;
Hutt 1975).
Lymphocyte transformation has also been shown to be
induced by a blastogenic factor which is elaborated by
sensitized lymphocytes on stimulation by the sensitizing
antigen (Kasakura and Loweinstein 1965; Gordon and
MacLean 1965; Kasakura 1970).
At present, the lymphocyte transformation test
measures the blastogenic response of lymphocytes to
specific secondary stimulation (i.e. antigens), non¬
specific stimulation (i.e. mitogens) and the primary
response to certain antigens on the cell surface (i.e.
allogeneic histocompatibility antigens as shown in the
mixed lymphocyte reactions). Although the blastogenic
response can be observed microscopically and quantified
by counting the proportion of enlarged blast-like lympho¬
cytes with polar staining nuclei and increased basophillic
cytoplasm, it is more convenient and precise to determine
the extent of blastogenesis by measuring the amount of a
DNA precursor taken up by these lymphocytes for DNA re¬
plication. This is done by adding radioactive thymidine
to the lymphocyte cultures and measuring the amount in¬
corporated into the DNA by scintillation counter. Lym¬
phocytes are separated from other blood or tissue con¬
stituents by density gradient technique developed by
Boyum (1968) using polysucrose-metrizoate mixture. In
this technique the polysucrose agglutinates thus increasing
the sedimentation rate of the red cells whilst the metri-
zoate salt provides the high density required for
separating the leucocytes.
Passive Transfer of CMI with Sensitized Lymphocytes
Delayed hypersensitivity reactions are characterized
by their inability to be transferred to normal animals
by serum from sensitized donors, regardless of the anti¬
body content of the serum, Zinsser and Mueller (1925)
first noted this characteristic of delayed hypersensiti¬
vity when studying allergies caused by bacteria and used
it as a criterion for separating allergies mediated by
cells such as tuberculin sensitivity from those mediated
by antibodies such as serum sickness.
Frequent uncritical attempts to confer passive sen¬
sitivity upon normal animals by transferring cellular
elements obtained from sensitized donors of the same
species have been made, Landsteiner and Chase (1942)
found that the transfer of suspensions of PE cells from
guinea pigs sensitized by picryl chloride, a chemical al¬
lergen, conveyed a marked delayed hypersensitivity to
normal guinea pigs, Lawrence (1949) showed that de¬
layed hypersensitivity to tuberculin antigens and strep¬
tococcal proteins could be transmitted to normal human
being recipients by intradermal injection of viable peri¬
pheral blood leucocytes from sensitive donors. Mackaness
(1969) also showed the immune response to infection with
Listeria monocytogenes, in mice gave rise to a population
of immunologically committed lymphoid cells which had the
capacity to confer protection and a proportionate level of
delayed hypersensitivity when transferred to normal mice.
Similarly, Blanden (1971) showed that spleen cells from
donor mice immunized intravenously with avirulent
ectromelia virus, conferred a specific cell-mediated




Attempts to detect the involvement of CMI responses
tnawo
in orf infections were made using indirect, migrationA
inhibition (MMI) tests, direct leucocyte migration in¬
hibition (LMI) tests, lymphocyte transformation tests
i
and passive transfer of sensitized lymphocytes to suscep¬
tible animals.
The indirect migration inhibition tests were carried
out using normal PE cells from guinea pigs to assay the
migration inhibition factor (MIF) and leucocytes from
normal sheep to assay LIF in cell-free supernate ob¬
tained from lymphoid cell cultures of sheep infected with
orf virus. Two sheep were re-infected with orf virus
by scarifying the right thigh and applying suspensions
of orf virus. After nine days the sheep were killed
hum-anely. Lymphocytes were harvested from the prefem-
oral and popliteal lymph nodes, the spleen and the thymus.
PE cells rich in macrophages were produced in two guinea
pigs „
The direct leucocyte migration inhibition test was
used for assessing the onset and duration of CMI in orf-
infected sheep. The following groups of sheep were
used:-
Group 3 consisted of eight susceptible sheep chal¬
lenged with orf virus by scarification; these sheep were
also used to study primary humoral responses (see Chapter
4).
Group 4 consisted of 14 previously infected sheep
challenged with orf virus by scarification.
Group 5 consisted of ten previously infected sheep
which were not challenged,.
Blood samples for leucocytes were collected twice
a week in heparinized vacutainers.
The lymphocyte transformation test was carried out
on lymphocytes from the following two groups of sheep:
Group 6 was made up of six previously infected sheep
challenged with orf virus.
Group 7 was also made up of six previously infected
sheep which ivere not challenged.
On days 0, 5, 10, 15, 20, 42, 63, post-challenge
blood was collected and lymphocytes for the test separated.
The passive transfer experiment involved the following
four groups of sheep
Group 8 consisted of four susceptible lambs which
were injected with lymphoid cells from sheep re-infected
xvith orf virus nine days previously. Twentyfour hours
after this treatment the lambs were injected with 1 ml of
a 20 percent orf scab suspension then immediately scarified
on the inner side of the right thigh.
Group 9 consisted of three susceptible lambs injected
with lymphoid cells from sheep which had not been infected
with orf virus. These lambs were similarly infected with
orf virus.
Group 10 consisted of three susceptible lambs not
given any cells and were infected with orf virus in the
same way as group 8,
Group 11 consisted of four previously infected
sheep which were scarified on the inner side of right
thigh and orf virus suspension applied,,
Lesion developments in the four groups of sheep
were compared.
In vitro Tests for CMI
Indirect migration inhibition tests: Two previously
infected sheep were killed on the nineth day after chal¬
lenge and their prefemoral and popliteal lymph nodes,
spleens and thymi were collected aseptically into Hank s'
balanced salt solution with heparin (HBSS-H) (50 units/
ml). Lymphocytes from the organs were harvested by
squeezing cut and teased pieces of the nodes, spleens
and the thymi separately through a sieve with a mesh
number of 20G. The cells were washed four times in
HBSS-H and their viability and total count determined by
the dye exclusion method using 0.3 percent Nigrosin dye.
A suspension of 3.5 million cells/ml was made in growth
medium consisting of RPMI 1640"*" in hepes buffer with 10
.percent heat-inactivated foetal calf serum and containing
100 units of penicillin and 100 mg of streptomycin. The
cells were distributed into tissue culture bottles and
cell-adapted orf virus was added to some of the bottles;
the rest were left as controls. The bottles were then
incubated at 37°C for 24 hours after which the cell-free
supernatant fluid was harvested and concentrated to 50
1 Flow Laboratories Ltd.
percent of the original volume by dialysis against 40
percent polyglycol ethylene. The concentrated super-
nate was dialyzed against RPMI 1640 medium, then replen¬
ished with 10 percent foetal calf serum and antibiotics
before storage at -20°C,
The production of a large number of PE cells was
induced in two guinea pigs by injecting them intraperi¬
toneal ly with a mixture of RPMI 1640 medium and incomplete
Freund's adjuvant. Four days later the guinea pigs were
anaesthetized with ether and exsanguinated. The animals
were then pinned out, their skins reflected and 20 ml
of warm HBSS-H introduced into the peritoneal cavity0
After gently kneading the abdomen, the cell-rich HBSS-H
was collected with a 20 ml syringe. The cells were
sedimented out by gentle centrifugation 150 g for 15
minutes, then washed three times in HBSS-H and once in
RPMI 1640 medium. After checking viability, a sus-
7
pension of 10 cells/ml was prepared in the RPMI 1640
growth medium and drawn into capillary tubes. One end
of the tube was sealed with Cristaseal"*" and then the tubes
2
were centrifuged at 2,OGOg for five seconds. The tubes
were cut precisely at the cell-fluid interface using a
diamond glass marker and then one tube containing the
3
cells was placed in each chamber of a migration plate ,
The end of the tube was fixed onto the chamber wall with
a blob of silicone grease and the tube itself was similarly
1 German Hawskley Ltd. 2. Microhaematocrit Centrifuge
3 Sterilin.
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fixed onto the floor of the chamber with a second blob
of grease, then the concentrated cell-free supernatant
fluid from storage warmed to 37°C in a waterbath was
added to each chamber. Control chambers contained the
supernatant fluid from the lymphocyte cultures into which
rims
orf virus was not added. The ytxarrt-s of the chambers were
greased and then the- chambers were sealed with square cover-
slips measuring 13 x 13cm and incubated at 37°C in an at¬
mosphere of 5 percent carbon dioxide for 24 hours.
Similarly, leucocytes harvested from ten ml of heparinized
blood from a normal sheep which had no history of having
suffered from orf infection were washed and processed in
the same way as the PE cells to assay the presence of LIF
in the cell-free supernatant fluid. The image of the
tube and the area of the migrating cells was viewed by a
photoenlarger"*" and thereby projected onto graph paper.
The outline of the cell migration pattern was traced out
and the area of cell migration determined by counting the
mm squares within the outline. The results were expres¬
sed by the migration index (MI) obtained from the equation
MI - Area migration of cells with lymphokine ^
Area of migration of cells without lymphokine
Direct leucocyte migration inhibition test : In this
test 14 previously infected sheep were challenged with orf
virus by scarification and blood for leucocyte separation
was collected into heparinized vacutainers by jugular
venepuncture. Erythrocytes were removed by inducing
1 De Vere 54 Varion.
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osmotic shock with sterile distilled water and restoring
the isotonicity within 30 seconds by the addition of 3.5
percent sodium chloride solution. The leucocytes were
then washed three times in HBSS-H and the number of the
viable cells counted by the dye exclusion method using
Nigrosin dye. The washed cells were then suspended in
RPMI 1640 growth medium at a concentration of approxim-
7
ately 10 cells/ml. The cell suspension was drawn into
capillary tubes, processed and fixed into migration
-2
chambers. In the chambers 0.1 ml of 10 cell-adapted
orf virus was added and in the control chambers only
growth medium was added. The area of migration of the
PMN cells was determined in the same way as for the in¬
direct test and the results were expressed as follows
MI - Area of migration of leucocyte with antigen
Area of migration of leucocyte without antigen
Lymphocyte transformation test : Ten ml of blood was
collected from sheep by jugular venepuncture into vacu-
tainers containing 50 units of preservative-free heparin.
The blood was thoroughly mixed with the heparin then cen-
trifuged at 1610 g for 30 minutes. The buffy coat formed
was harvested into siliconized test-tubes and diluted with
an equal volume of 0.15N sodium chloride solution before
being layered gently onto lymphocyte isolating fluid made
up of 9.6 percent sodium metrioate and 5.4 percent Ficoll
(lymphoprep) in conical centrifuge tubes in the proportion
of four parts of buffy coat suspension to three parts of
1. Nyegaard & Co., Oslo.
the "lymphoprep". The tubes were spun at 400 g for
30 to 40 minuteso The lymphocytes, which formed a
white band at the interface of the saline and "lymphoprep"
were carefully pipetted into siliconized glass universal
bottles then washed three times in HBSS-H0 The viable
cells were estimated using the Nigrosin dye exclusion
method and then suspended in growth medium composed of
RPMI 1640 in hepes buffer, 10 percent heat inactivated
horse serum"'", 200 mmol of glutamine, 100 units/ml of
penicillin and 100 mg/ml of streptomycin. The final
concentration of the cells was 10 cells/ml.
The lymphocytes suspension was distributed into
2
wells of a flat-bottomed tissue culture microplate using
a volume of 0.2 ml per well. The stimulant (PHA or
antigen) was added as required and then the plates in¬
cubated at 37°C in an atmosphere of 5 percent carbon
dioxide for the desired period, after which the cultures
3
were pulsed with titrialed thymidine of 5 Ci/mmol specific
activity at 2 yiCi per well. The culture growth was
terminated 18 to 24 hours later by the addition of cold
phosphate buffered saline (PBS) at pH 7.3.
The cultured and labelled lymphocytes were washed
twice in PBS and then precipitated with 6 percent trich¬
loroacetic acid aqueous solution overnight at 4°C. The
precipitate was dissolved in NCS solubilizer, a quaternary
4
ammonium base in toluene and then mixed with 5 ml of
scintillator in glass vials. The scintillator was toluene
1. Gibco Biocult Ltd. 2. Nunc Ltd.
3. Radiochemical, Amersham. 4. Am*ersham.
with two standard phosphors, the primary phosphor was
2f5-diphenyloxazole (PPG) at 0o5 percent and the secondary
phosphor was 1,4-bis-2-(5-phenyloxazolyl)-benzene (POPOP)\
The amount of tritiated thymidine incorporated into
the dissolved cell solution samples was determined by
2
using a beta-emmittmg scintillation counter . The
counter equipped with photomultiplier, picked up the
energy released into the scintillator when photons left
the radioisotope. The glass vials with the samples were
placed in the machine set to count automatically each
sample for one minute. A blank control containing the
solubilizer and the scintillator was also included.
A preliminary trial was run to check whether orf
antigen could stimulate sheep lymphocytes in vitro and
to ascertain the optimal conditions for stimulation. A
sheep which had recovered from orf was the source of sen¬
sitized lymphocytes and a susceptible lamb not yet in¬
fected with orf virus was the source of non-sensitized
lymphocytes. Lymphocytes were separated from blood
samples of the two animals by the use of the "lymphoprep"
method and their cultures set up in 96-well microplates.
Orf virus passaged eight times in lamb testis cells and
inactivated by 10 percent formalin was serially diluted
in PBS using the ten-fold steps and 20 n1 of each dilution
was added into two wells of cell cultures. PHA was put
into twelve other wells of cell cultures as positive con¬
trols and growth medium only added to the non-stimulated
1, BDH Chemicals. 2. Tracelab ICN.
cultures. The cultures were incubated for varying
periods over seven days, and 18-24 hours before the
end of each period tritiated thymidine was added.
Culture growth was then terminated by the addition of
cold PBS, processed and counted. Maximal transfor-
mation of 10 lymphocyte's/ml occurred when the orf
2
antigen diluted to 10~ incubated for five days
(Figure 9 and Table 51).
In the test proper two groups of previously infected
sheep consisting of six animals each were used. Pre¬
liminary investigations of the optimal conditions for
the lymphocyte culture system were determined using
different concentrations of PHA, whole blood and pure
lymphocyte cultures from the two groups of sheep. Peri¬
pheral lymphocytes were separated from blood samples
and cultured in 96-well tissue culture microplates. A
freeze-dried purified PHA:^* reconstituted in distilled
water to contain 0.4 ug/ul was added to the cultures as
follows : -
0.10 ul/ml, 0.25 ul/ml, 0.50 ul/ml, 0.75 ul/ml, 1.0 ul/
ml and 2.5 ul/ml. The cultures were set up in duplicate.
Two wells of cultures received only growth medium and
acted as non-stimulated cell controls. After three days
incubation period, the cultures were pulsed with triti¬
ated thymidine and harvested on the fourth day. They
were then processed and counted. The results obtained
as counts per minute (cpm) were calibrated on a graph
paper and the optimum concentration required to stimulate
lymphocytes from the sheep was worked out. Whole blood








Counts per minute of H Tdr uptake by
lymphocytes cultured with varying con¬
centrations of orf antigens-
Two days incubation period.
Three days incubation period.
Four days " "
Fivedays " "
Six days " "
Sevendays " "
-JO"5 10'3 10"4
Orf Antigen Dilution (ten-fold).
cultures were prepared as described by Bolbol (1975),
by diluting blood samples with RPMI 1640 groxvth medium
to contain 10 lymphocytes/ml then distributed into
microplate at 0.2 ml per well. • On harvesting the
lymphocytes after pulsing with tritiated thymidine, the
red cells were lysed by cold 3 percent acetic acid and
then the labelled lymphocytes were washed and processed
for counting,,
The optimal conditions for the PHA-dose response of
the lymphocytes obtained from the two groups of sheep
were found to be 0.25 ul/ml of culture for a concentration
6
of 10 lymphocytes/ml using pure lymphocyte cultures. The
count., at this concentration was found to be 35,933 -
12035 (Figure 10 and Table 51? ) .
The actual test to determine the onset of CMI in
the sheep re-infected with orf virus by assaying the
responsiveness of their lymphocytes to orf antigen in
vitro was carried out. One group, Group 6, was challenged
with orf virus by scarification and the second group,
Group 7 which was not challenged acted as the control.
Lymphocyte cultures were made from blood samples collected
on days O, 5, 10, 15, 20, 42 and 63 after challenge. Nine
cultures were prepared from each sample; three cultures
were stimulated by orf antigen ; three stimulated by PHA
and three left as non-stimulated cultures. After in¬
cubation period of four days, the cultures were pulsed
with tritiated thymidine and then their growth terminated
ure 10 Counts per minute of H^Tdr uptake




P HA (yuI/mI of culture)
on the fifth day. The cells were then harvested, and
processed for counting. Counting done, the results
were expressed as a stimulation index (SI) calculated
as follows
_ cpm of cultures with orf antigen
~
cpm of cultures not stimulated
Passive Transfer of CMI by Sensitized Lymphocytes:
Sensitized lymphocytes to orf virus were obtained
from the spleen, the thymus and prefemoral and popliteal
lymph nodes draining the booster area of a sheep which
had been challenged with orf virus by scarification and
which was killed on the ninth day when the MI was 45 per¬
cent and SI was 3.75. Non-sensitized lymphocytes were
Ml
obtained from an unchallenged sheep; /89 percent and SI
1.15. The lymphocytes were harvested as described in
the indirect migration inhibition test. A cell sus¬
pension of 10^ cells/ml was made in RPMI 1640 growth
medium. Four susceptible lambs (Group 8) with non-
sensitized lymphocyte population (SI below 1) were injected
with ten ml of the sensitized cell suspension, five ml in¬
travenously and five ml subcutaneously.
Three susceptible lambs of group 9 were similarly
injected but with non-sensitized lymphocytes. Another
three susceptible lambs (Group 10) were not injected with
any cells. Twentyfour hours after administration of
the cells all the lambs were injected intravenously with
1 ml of a 20 percent suspension of an orf scab and
immediately scarified on the inner side of the right
thigh. The animals were observed daily for the onset
and course of the lesions on the scarified area and
other parts of the body.
Four previously infected sheep were also challenged
with orf virus by scarification at the same time and the
onset and course of the lesions compared to those of the
lambs,
RESULTS
Indirect Migration Inhibition Tests
Lymphocytes from the spleens and popliteal and pre-
femoral lymph nodes from orf infected sheep produced
lymphokine, MIF, on stimulation with orf virus in vitro
because the areas of migration of the PE cells when
cultured in the supernates from the orf virus-stimulated
lymphocyte cultures from the two sheep ranged from 52 sq
mm to 62 sq mm whereas the areas of migration of the PE
cells cultured in the supernates from unstimulated lym¬
phocyte cultures from the same two sheep ranged from 111
sq mm to 126 sq mm. In addition, the cells in the super-
nate from the stimulated lymphocytes were clumped together
while those in the supernate from unstimulated lymphocytes
were dispersed and spred out (Plate 12).
There was little difference between MIF production by
the cells harvested from lymphnodes and those harvested
from spleens, the migratory indices being 46 and 50 per¬
cent from supernate from lymph node cells and 43 and 54
percent for the supernate from the spleen cells (Table 48).
Inhibition was also observed when normal sheep leu¬
cocytes were cultured in the same' cell-free supernates
from the orf virus-stimulated lymphocytes. The areas
of migration of the leucocytes ranged from 45 to 70 sq mm
for supernate from orf-stimulated lymphocytes and from 102
to 188 sq mm for the supernate from the unstimulated lym-
(Plate 13).
phocytes / Thus LIF was produced by the lymphocytes from
The migration of PE cells from Guinea
pigs cultured in:-
Cell-free supernate from lymphocyte
cultures stimulated by orf virus.
Cell-free supernate from lymphocyte
cultures not stimulated.
The migration of leucocytes from a
normal sheep cultured in:-
Cell-free supernate from lymphocyte
cultures stimulated by orf virus.
Cell-free supernate from lymphocyte
cultures not stimulated.
The migration of leucocytes from sheep
re-infected with orf virus when
cultured:-
Orf antigen containing medium.
Growth medium only.
 
the orf infected sheep.
There was no difference in the production of LIF
by the spleen cells or cells from lymph nodes, the mig¬
ratory indices being 47 and 40 percent for spleen c ells
supernate, and 37 and 39 for the lymph node cells super-
nate (Table 49).
On the basis of these preliminary findings, the
direct leucocyte migration inhibition test was adopted
to determine the onset and duration of CMI responses.
Direct Leucocyte Migration Inhibition (LMI) Tests
The CMI response as evaluated by the LMI tests was
detected in both susceptible sheep infected with orf
virus and sheep re-infected with orf virus (Figure 8
Appendix Tables 31-2&). One consistent feature noted
was the variation of the results from animal to animal,
day to day, and even within replicates of the same
animal on the same day.
In the 14 previously infected sheep which were chal¬
lenged with orf virus (group 4) the MI before challenge
was 79.0 percent indicating that the animals possessed
some sensitized lymphocytes due to previous exposure to
the virus. The indices decreased after challenge to
reach the minimum value of 45 percent 15 days after chal-
lenge, and these values remained bo 1 tm« 50 percent for at
least seven weeks (Figure 8).
Likewise, the MI obtained from ten previousl}/ in¬
fected sheep which were not challenged (Group 5) was 66-4
15£.
percent on the first day of observation but unlike
the challenged sheep of group 4 the indices fluctuated
between 66 and 85 percent during the duration of obser¬
vation. They were always below lOO percent indicating
the presence of some sensitized lymphocytes from previous
exposure to the virus (Figure 8).
Comparing the results of the challenged previously
infected sheep with those of the unchallenged previously
sheep
infected/showed that there was a significant difference
from day 4 through to day 63 (Table 50 )„
In contrast, the MI determined from eight susceptible
sheep (group 3) before they were infected with orf virus
was high being 94 percent but it dropped to 45 percent on
the sixth day after infection, returned to 80 percent on
day 8, and declined once more to 61 percent on day 35
(Figure 8) .
Comparison of the migratory indices obtained from the
infected susceptible sheep with those of the challenged
previously infected sheep revealed that the onset of the
CMI was similar in both primary and secondary immune re¬
sponses „
Lymphocyte Transformation Tests
The ability of orf antigen to stimulate lymphocytes
in vitro; The uptake of radioactive thymidine by peri¬
pheral blood lymphocytes from recently recovered sheep
was markedly higher when these lymphocytes were cultured
with orf antigen compared to the uptake of the radio¬
active thymidine by lymphocytes from the same animal
155-
Figure 8 The daily means of the Migration Indices
of
A - Previously infected sheep unchallenged (Group 5).
B - Susceptible sheep infected with orf virus
(Group 3).
C - Previously infected sheep challenged with
orf virus (Group 4).
cultured without any stimulant. Thus orf antigen was
able to stimulate sensitized lymphocytes in vitro
(Table 51). The counts per minute (cpm) for the orf-
stimulated lymphocytes was 1,393 and 464 for the unstim¬
ulated lymphocytes. There was no increase in the uptake
of the radioactive thymidine by the lymphocytes from sus-
iHe, mqxinuirw
ceptible lambs; cpm was 390 for lymphocyte cultured with
A.
orf antigen and 443 for unstimulated lymphocyte cultures
(Table 52 ) .
The detection of CM I in sheep re-infected xvith orf
virus: The results of the uptake of radioactive thymi¬
dine by orf-stimulated lymphocytes from previously infected
sheep in groups 6 and 7 were expressed by SI values which
were 1.06 to.11 for group 6 and 0.96 - 0.23 for group 7
before challenge. The SI values increased in the re¬
infected sheep to reach maximum of 4.34 - l.OO on the
tenth day after challenge and then declined gradually to
pre-challenge values nine xveeks later. In contrast, the
SI values for the unchallenged previously infected sheep
of group 7 were maintained more or less between 0.99 to
1.14 and these values were significantly different from
those of the challenged sheep from day 5 to day 42 after
challenge (Tables 53-55 and Figure 11).
The blastogenesis detected in the PHA-stimulated
lymphocytes was consistently higher than that detected
in the orf antigen lymphocytes or unstimulated lymphocytes.
155.
Figure 11 The daily means of the SI values of:-
A - Sheep re-infected with orf virus (Group 6).
B - Previously infected sheep not challenged
(Group 7).
Passive Transfer of CMI using Sensitized Lymphocytes
All the lambs and previously infected sheep reacted
to challenge with orf virus (Table 56 Plates 15 - 17).
The onsets of the papular, vesicular and pustular stages
were similar in the treated and untreated lambs and un¬
treated previously infected sheep but the onsets of scab
and resolution stages were highly significantly different
between the treated and untreated sheep (Table 56).
Further analysis using the Duncan's multiple-range
test at one percent level of probability revealed that
the experimental groups fell into the following two
distinct subsets in regard to the onset of scab stage:-
Groups 11 8, 9, 10
The mean onset for sheep in group 11 was 6 days and mean
onsets for sheep in group 8, 9, 10 was 8.3 days. In other
words, the onset of the scab formation in lambs injected
with the sensitized lymphocytes was similar to the onsets
of the scabs in the susceptible lambs treated with non-
sensitized lymphocytes and susceptible lambs not treated
with any cells.
Application of Duncan's multiple-range test at the
one percent level of probability also showed that the ex¬
perimental groups fell into two distinct subsets as follows
in regards to time of resolution :-
Groups 11, 8 9, 10
The mean time of resolution on groups 11 and 8 was 13.8
days and for sheep in groups 9, and 10 was 28.3 days. In
other words susceptible lambs injected with sensitized
lymphocytes healed as fast as re-infected sheep.
In addition, three lambs, one from the group of lambs
treated with non-sensitized lymphocytes and two from the
untreated group of lambs, developed secondary orf lesions
on the commissures five days after infection with orf
virus.
PLATE 15 Experimental orf lesion on the
skin of susceptible lamb treated
with sensitized lymphocytes before
infection. Eight days after in¬
fection.
PLATE 16 Experimental orf lesion on the
skin of a susceptible lamb treated
with non-sensitized lymphocytes.
«r
Eight days after infection.
/N
PLATE 17 Experimental orf lesion on the skin




AREA OF MIGRATION AND MIGRATORY INDEX OF P.E. CELLS FROM GUINEA PIGS
CULTURED IN CELL-FREE SUPERNATES OF LYMPHOCYTE CULTURES.
Source of NUMBER OF SHEEP
lymphocytes 691 767
Test Control MI Test Control MI
Lymph node
cells 62 124 50% 58 126 46 %
Spleen
cells 60 111 54?o 52 120 43?i
Test - contain supernates from orf stimulated lymphocyte culture.
Control - contain supernate from unstimulated lymphocyte culture.
TABLE 49
AREA OF MIGRATION AND MIGRATORY INDEX OF LEUCOCYTES FROM NORMAL SHEEP
CULTURED IN CELL-FREE SUPERNATES OF LYMPHOCYTE CULTURES.
Source of NUMBER OF SHEEP
.Lympnocy ues
691 767
Test Control MI Test Control MI
Lymph node
cells 45 115 39?o 70 188 31%
Spleen
cells 48 102 47 ?o 52 131 40?o
Test - contain supernates from orf stimulated lymphocytes.
Control - Contain supernate from unstimulated lymphocytes.
TABLE 50
COMPARISON OF THE DAILY MEANS OF MIGRATORY INDICES BETWEEN CHALLENGED





Freedom t P Interpretation
0 22 1.51 0.200 N.S.
2 6 1.66 0.200 N.S.
4 6 3.09 0.050 S.
5 12 0.69 0.600 N.S.
10 20 3.21 0.010 H.S.
15 18 5.48 0.001 H.S.
20 12 3.31 0.010 H.S.
42 12 7.15 0.001 H.S.
63 14 2.89 0.020 S.
S. = Significant.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE51.









































































UPTAKEOFH3TdrBYNON-SENSITIVELYMPHOC TESFR MASUSCE TIBLEGR UP.













































Uptake of Tdr by Lymphocytes from Sheep Re-infected with






0 39229 ±9632 2952 ±1348 2984.7 ± 1308 1.06
5 40567 + 23439 4244.5 ±924 1597.3 ±596 2.66
10 44015 + 20555 3209 ±1416 740 ±322 4.34
15 40515.5 + 30002 1998 ±790 1018 ±424 1.96
20 41465 ±32983 2990.6 ±1047 1151.3 ±341 2.60
42 26990.3 ±18770 1722.5 ±506 1267 ±492 1.36
63 62309 ±44290 1627.7 ±278 1507.2 ±153 1.08
TABLE 54. Uptake of Tdr by Lymphocytes from Unchallenged Previously





PHA—Mitogen Orf-antigen No antigen S.I.
0 17099 ±6469 1619.75 ±619 1694.75± 768 0.96
5 18875 ±9979 2251.1 ±914 2111.9 ± 454 1.07
10 13717.75±2178 1418 ± 317 1370± 93 1.04
15 21747.5 ±7367 1862 ±1092 1930.3 ±1236 0.96
20 38574 ±_25305 1555 ±779 1580.3± 664 0.98
42 32238 ±18899 1722 ±289 1635± 319 1.05
63 39024 ±20261 1639 ±142 1436 ±89 1.14
TABLE 55
COMPARISON OP THE SI VALUES BETWEEN THE CHALLENGED AND UNCHALLENGED






0 10 0.96 > o.Uoo N.S.
5 10 5.29 < 0.001 H.S.
10 8 7.91 < 0.001 H.S.
15 10 6.62 c 0.001 H.S.
20 10 1+.89 < 0.001 H.S.
1+2 10 3.71+ <! 0.010 H.S.
53 10 1.22 i> 0.300 N.S.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE56.






















































































SIGNIFICANCE OF DIFFERENCES IN THE ONSETS OF THE ORF LESIONS IN SHEEP
TREATED AND UNTREATED WITH SENSITIZED LYMPHOCYTES.
Lesion Degrees of Variance Inter¬
Stage Freedom Ratio P pretation
Papule 3, 10 2.80 0.05 N.S.
Vesiscle 3, 10 0.91 0.05 N.S.
Pustule 3, 10 0.24 0.05 N.S.
Scab 3, 10 10.80 0.01 H.S.
Resolution 3, 10 24.97 0.01 H.S.
H.S. = Highly Significant.
N.S. - Not Significant.
TABLE 5g.


































CMI responses are those specific immune reactions
which cam occur in absence of demonstrable antibodies and
can be transferred to normal susceptible recipients only
by the transfer of sensitized cells. Since the work
of Chase (1945) it has been established that the immuno¬
logical information for CMI responses resides in T-lympho-
cytes and macrophages are the main cell type executing the
responses. The activities and products of the T-cells
in vitro have provided insight into the CMI mechanisms in
vivo. The significance and relevance of in vitro systems
so far developed to in vivo mechanism has been firmly est¬
ablished by several workers who have observed a remarkable
correlation in the in vitro systems positivity and the
presence in the cell donor of a cell-mediated immune state
and no correlation with the presence or absence of cir¬
culating antibodies (Gppenheim 1968; Bendixen and Soborg
1969; Rocklin et_ al_., 1970; Bloom 1971; Elanden 1974).
In the current study, a consistent feature noted was
the marked variation in both LMI and lymphocyte trans¬
formation assays from day to day, animal to animal, and
even from within replicates of the same animal on the same
day. The variations might be due to non-specific
factors such as minor changes in technique, differences
in time of bleeding, time of setting up the cultures or
might be due to specific factors such as pathogenic or
non-pathogenic infections. For example, an enhancement
of PMN leucocyte migration instead of the expected in¬
hibition was observed in a sheep that had pasteurella
pneumonia (personal observation). Bolbol, (1975)
observed a similar variation when studying the effect of
Fasciola hepatica extracts on rabbits lymphocytes. Like¬
wise, Hutt (1975) obtained inconsistent results when
carrying out MIF tests to demonstrate delayed hypersen¬
sitivity in mice infected with vaccinia virus. However,
despite the variations, conclusions drawn from the results
obtained in the studies of CMI responses in orf infections
are believed to be valid.
Migration Inhibition
MIF and LIF were both produced by lymphocytes from
a recovered sheep when cultured in vitro in the presence
of orf virus because both PMN leucocytes were inhibited
in their migration. Moreover, only lymphocytes from
orf virus-infected sheep produced LIF in the direct tests.
Hutt (1975) earlier had found that spleen cells from mice
infected with vaccinia virus produced MIF which inhibited
the migration of guinea pig PE cells. Similarly, Shimizu
and his colleague (1977) showed that peripheral lympho¬
cytes from African swine fever virus-infected pigs elab¬
orated LIF in vitro in the presence of African swine fever
antigen.
Following the demonstration of LIF in the pilot ex¬
periment, LMI tests were carried out in sheep with primary
orf infection. The CMI responses appeared earlier than
the'humoral immune responses. The MI was high before
challenge indicating absence of sensitized lymphocytes
in the sheep. After infection, the indices dropped
reaching the lowest value on 10th day indicating the
appearance of sensitized lymphocytes in circulation.
The occurrence of CMI very early in a primary viral in¬
fection was also observed by Hussain and Mohanty (1979)
who found that lymphocytes from calves infected with
bovine rhinovirus type 1 exhibited typical CMI responses,
as detected by LMI tests, as early as the third day after
infection and before any humoral antibodies could be de¬
tected. Shimizu and his colleagues (1977) however,
discovered that pigs infected with African swine fever
virus developed CMI responses detected by LMI tests 20
days after infection. Their experimental design is open
to the criticism that the sampling gap was too big; the
first sample after infection was taken on the sixth day
and the next on the 20th day.
with
The duration of CMI response in sheep/the first ex¬
posure to orf virus was long; migratory indices were
still low in some sheep 90 days after infection, indicating
that sensitized lymphocytes remained in the sheep even
after complete recovery. Earlier, Hutt (1975) had also
found that in mice infected with vaccinia virus CMI re¬
sponses as detected by migration inhibition tests, were
apparent eight days after infection and were demonstrable
for a further 130 days after recovery from infection. How¬
ever, Hussain and Mohanty (1979) found that the CMI re¬
sponses in calves infected with rhinovirus diminished by
day 28 after challenge; this could be due to the avirulent
nature of their virus and the mild type of infection.
Lymphocyte Transformation
The data from lymphocyte transformation tests in¬
dicated that lymphocytes from sheep re-infected with orf
virus were specifically stimulated by orf antigen in
vitro resulting in blast transformation thus providing
evidence of CMI responses in infected sheep. The amount
of radioactive thymidine uptake by the orf antigen-stimul¬
ated lymphocytes was always lower than the amount taken
up by PHA-stimulated lymphocytes but always higher than
the amount taken by the unstimulated lymphocytes. Gold
and Peacock (1970) expressed the current belief that 5 to
30 percent of lymphocytes in a culture are transformed by
specific antigen because only relatively small numbers of
lymphocytes in the donor body become sensitized to the
antigen. On the other hand, non-specific stimulation
by the mitogen PHA causes 50 to 70 percent of the lympho¬
cytes in the culture to transform because both T-cell and
B-cells are being stimulated (Oppenheim and Rosenstreich
1976). My results are in agreement with these hypotheses
because stimulation by PHA was always greater than by
orf antigen.
The onset of the CMI responses as revealed by the
lymphocyte transformation test occurred before the humoral
immune responses in sheep re-infected with orf virus thus
confirming the results obtained by the LMI tests. High
SI values were recorded in the first week after re-infection
and reached peak values in the second week then declined
to pre-challenge values which also equalled those of the
unchallenged previously infected sheep by the nin-^th week.
The present results are similar to those obtained by
Moreno-Lopez (1977) who registered highest SI values in
calves re-vaccinated with parainfluenza 3 virus in the
second week after the second intranasal vaccination.
In contrast to the LMI tests results, the duration
of CMI responses as indicated by lymphocyte transformation
tests in sheep re-infected with orf virus was found to last
up to the 90th day after re-infection. A tentative ex¬
planation could be that a small number of sensitized lym¬
phocytes only are required to produce sufficient lympho-
kine to inhibit the migration of PMN leucocytes but, on
the other hand, a relatively large number of sensitized
lymphocytes are required for the blast transformation in
the presence of the sensitizing antigen.
Passive Transfer of CMI
CMI responses are passively transferred only with
sensitized lymphocytes or transfer factor and not with
serum (Bloom and Chase 1967; Lawrence 1971; Blanden 1974).
I therefore decided to inoculate susceptible lambs with
lymphoid cells from a recovering sheep and to challenge
these lambs with orf virus 24 hours later in attempt to
induce an accelerated reaction observed in re-infected
sheep. The onset of scab formation in the lambs in¬
oculated with sensitized lymphocytes was similar to that
of lambs which received non-sensitized lymphocytes and the
untreated lambs. Although the onset of scab formation
of stage
was significantly different from the onset/scab /in the
previously infected sheep challenged at the same time,
the time interval involved is narrow whereas the healing
interval was wide. The time of resolution in the ]ambs
injected with sensitized lymphocytes was statistically
similar to the resolution time of the sheep re-infected
with orf virus. Hence, the indication that a degree of
immunity was transferred was, in part, confirmed by the
observation that passively immunized lambs never showed
any evidence of secondary lesions in the mouth commissures
and lips whereas such lesions were found in 50 percent of
the lambs not passively immunized. My results are
similar to those obtained by Blanden (1970) who showed
that spleen cells from mice immunized with ectromelia
virus, conferred some degree of immunity to susceptible
mice speeding up their recovery after ectromelia virus
challenge.
In contrast, Gsman (1976) failed to transfer immunity
passively to susceptible lambs using spleen cells and thy¬
mic cells from a recovered lamb. His experimental de¬
sign can be critised because he used only two lambs.
Moreover, the source of sensitized cells may be crucial.
I used four lambs and collected sensitized cells from the
prefemoral and popliteal lymph nodes as well as from the
spleen and thymus of a mature sheep boosted just before
slaughter whereas Osman (1976) used cells from the spleen
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and the thymus only of a lamb which had recovered from
orf infection. Kircheiner and Weisser (1947) for ex¬
ample, found that cells from the spleen conferred less
sensitivity than peritoneal exudate cells.
Another factor considered critical was the number
of cells transferred; I used a cell concentration of
10 7
10 x 10 per lamb whereas Osman (1976) used 33 x 10
per lamb. Turk (1975), for instance, found out that
the proportion of sensitized donor cells at the test site
was related to the proportion of transferred cells in
the peripheral blood. The histocompatibility of the
donor and recipient cannot be criticized because same






The fact that immune responses could be suppressed
and virulence of pathogens enhanced by cytotoxic drugs
or hormones has proved useful in defining the mechanisms
by which the immune system works in the clearance of
pathogens and the recovery of the host. Several
workers have examined the effects of immunosuppressive
drugs on viral infections and found that members of her¬
pesvirus, poxvirus, arbovirus, myxovirus and picornavirus
groups have manifested enhanced virulence in host animals
receiving immunosuppressive therapy; Bugbee, Like and
Stewart (1960) for example, found that in cortisone-
treated rabbits there was a postponement of the skin
lesion development to vaccinia virus infection although
the virus was found to replicate in several organs and
even led to mortality. Similarly, Nathanson and Cole
(1971) reported that immunosuppression converted sublethal
West Nile virus infections in adult rats to lethal in¬
fections that were manifested by an increased number of
infected and destroyed cells of target organs and a pathol¬
ogical picture in which inflammatory response was re-
markedly reduced. Narita, Inui, Yabuki, Namba and
Shimizu (1979) also found that non-suppurative and pustular
vulvovaginitis were induced in calves treated with dexa-
methasone three months after recovery from primary infectious
bovine rhinotracheitis virus infection.
Suppression or destruction of lymphoid cells by
immunosuppressive drugs infection was also found to
alter both humoral and CMI responses to the pathogen
(Bach 1975). Claman (1972) and Zurier and Weissman
(1973) earlier reported that corticosteroid therapy sup¬
pressed antibody production to antigens, markedly so in
steroid-sensitive animals such as mice, rats and rabbits
and less markedly in steroid-resistant animals like man,
ferrets and guinea pigs. So far as I can ascertain
information on whether sheep are steroid-sensitive or
steroid-resistant is not available.
Zurier and Weissman (1973) also reported that immuno
suppression was more easily achieved in primary immune
responses compared with responses to subsequent antigenic
stimuli and that the early induction period of the anti¬
body response was much more vulnerable to steroid inter¬
vention. Wells (1976) noted that majority of the
patients receiving a standard dosage of corticosteroid
drugs had reduced levels of IgG in their serum.
Claman (1972) summarized from the small data
available concerning the effects of corticosteroids on
CMI tha^ CMI manifestations could be suppressed if large
doses or prolonged treatment of the steroid were given.
In ^neral, the reports comply in that corticosteroids
have no effect on the sensitization of lymphocytes by an
antigen nor do they have any effect on stimulation of sen
sitized lymphocytes by the sensitizing antigen to produce
lymphokines (Weston, Claman and Krueger 1973; Casey and
McCall 1971; Bach 1975) but the reports on the effects
of corticosteroids on PMN leucocytes and macrophages
are discordant. Weston and his colleagues (1973)
for example, found that Cortisol prevented non-sensitized
PE cells of guinea pigs from responding to macrophage
activation factor and Casey and McCall (1971) found that
macrophages migration inhibition was suppressed in vitro
if steroid was administered at the time of sensitization
of rabbits with BCG. Stevenson (1973) similarly, found
that corticosteroid stimulated the migration of leucocytes
in vitro.
It was decided to explore the effect of immunosup¬
pression on the clinical and immunological responses in
sheep infected and re-infected with orf virus in an attempt





A series of experiments was carried out to follow
the lesion development and humoral and c ell-mediated
immune responses in susceptible and previously infected
sheep treated with bethamethasone 24 hours before being
challenged with orf virus. The animals were allocated
to the following four groups
Group 12 consisted of eight susceptible sheep which
were injected with betamethasone before being infected
with orf virus,
Group 3 consisted of eight susceptible sheep un¬
treated with the betamethasone but infected with orf
virus,
Group 13 consisted of eight previously infected
sheep which were treated with betamethasone before being
challenged with orf virus and
Group 14 made up of eight previously infected sheep
not treated with betamethasone but challenged with orf
virus.
Immunosuppression
Sheep were weighed before isolation in crates. The
immunosuppressant used was soluble betamethasone"*" administered
intramuscularly at the dose of 1 mg/kg body weight. The
synthetic corticosteroid was injected into the animals
1 Betsolan soluble, Glaxo Ltd.
only once 24 hours before scarification and application
of the viruso The lesion development was examined
daily using the optical light.
Humoral Immune Response Studies
Total serum protein concentrations, densitometric
evaluations of serum, immunoglobulin levels and orf anti
body titres were determined as described earlier in
chapter four,
CMI Response Studies
Leucocyte migration inhibition tests as described
previously in chapter five were performed on the leuco¬
cytes from the susceptible sheep given the immunosup¬
pressive drug before challenge (group 12) and simultane
ously on leucocytes from untreated susceptible sheep in
fected with orf virus (group 3).
RESULTS
Clinical Response -
The treated and the untreated infected sheep had
no obvious systemic signs. The stages of the lesion
development took longer to appear in the treated sus¬
ceptible sheep compared to the appearance of the stages
in the untreated susceptible sheep. Papules and vesicles
were not evident until the eighth day after infection;
pustules appeared on the tenth day and scabbing started
on the twelfth day. Complete resolution took six weeks
in the treated susceptible sheep whereas it took four to
five weeks in the untreated susceptible sheep.
Similarly, the lesion development in the treated re¬
infected sheep took longer compared to that of the un¬
treated re-infected sheep. Resolution was three weeks
in the treated while it was two weeks in the untreated.
Humoral Immune Response Studies
Total serum protein concentrations: The total serum
protein contents of the eight susceptible sheep which were
given betamethasone treatment before being infected with
orf virus (group 12) ranged from 67 to 72 g/1 in sera
taken before the treatment and from 60 to 82 g/1 in the
sera taken after treatment and infection (Appendix Table
41 )» The mean values of the daily samples ranged from
66.10 - 2.90 to 71.CO ^ 4,30 g/1. There were no signi¬
ficant differences between the pre-treatment and post-
infection values (Table 59). Similarly, there were
no significant differences noted between the pre- and
post-infection values of the untreated susceptible sheep
which were infected with orf virus (Group 3) (Table 14).
Comparing the mean values of the daily samples of the
treated and untreated susceptible sheep revealed no signi¬
ficant differences (Table 60).
Estimations of the total serum proteins of the sera
from eight previously infected sheep treated with the
immunosuppressive drug before being re-infected with orf
virus (group 13) ranged from 66 to 84 g/1 in the sera
taken before the treatment with betamethasone and from
62 to 79 g/1 in the serum samples collected after treat¬
ment and challenge (Appendix Table 51) .
The mean differences between the pre-treatment and
post-challenge values were significantly lower from day
4 to day 12 (Table 61). In contrast, the mean differences
between the pre - and post-challenge values of untreated
sheep re-infected with orf virus (group 14) were not
significant (Table 62).. The total serum protein estimates
of the untreated re-infected sheep ranged from 63 to 77 g/1
the
in/pre-challenge sera and from 63 to 84 g/1 in the post-
challenge sera (Appendix Table 61) . The comparison of
the mean values of the daily samples from the treated and
untreated re-infected sheep revealed that on days 6, 9,
and 12 post-challenge there were significant differences
(Table 63).
Specific serum protein levels : The electro-
phoretic evaluations of the serum proteins of the treated
and untreated susceptible sheep infected with orf virus
(groups 12 and 3) are shown in Appendix Tables 42-46,
22-26. The mean differences between the pre- and post¬
infection values of albumin and alpha-1, alpha 2-, beta-,
and gammaglobulins of both the treated and the untreated
susceptible sheep were not significant (Tables 64-68
15-19). There were no significant differences between
the gammaglobulin daily means of the treated and the un¬
treated sheep (Table 69 Figure 12).
Assessment of specific serum protein levels (Appendix
Tables 52-56 62-66) in the sheep treated with beta¬
methasone before re-infection (group 13) and the un¬
treated but re-infected sheep (group 14) revealed that
the mean differences between the pre- and post-challenge
values of the albumin and alpha 1-, alpha 2-, and beta-
globulins were not significant (Tables 70-77).
The mean differences for the gammaglobulin values,
however, were significantly lower on days 2, 4, 6, 11, 12
and 13 after challenge of the treated re-infected sheep
(Table 78). A plot of the daily means reflects the
decreasing trend (Figure 13); the mean gammaglobulin values
in the pre-treatment sera was 19.0 - 2.5 g/1 but following
treatment with the immunosuppressive drug the values de¬
creased in spite of challenge with orf virus. By the




Figure 13 The daily means of gammaglobulin levels of:-
•'■<W 7 • 7r';V!$ -V," by' y77 -v'. Ojbyb-!-. ■
A - Previously infected sheep challenged with
orf virus (Group 14).
B - Previously infected sheep.treated with
corticosteroid before being challenged
S-'/'X', ' .• "v-\ yy'■ ■■ d % •'* b.b> .b -
with orf virus (Group 13).
Days Post Challenge
184.
YY.•*t . T.'%'g•-* .. • ,v' •
■
Figure 1? The daily means, of gammaglobulin levels of:-
' - :J. • '.. ' • ■ y Y^ . ;;YY V/,' <
A Susceptible sheep infected wiLh orf virus (Group 3).
B - Susceptible sheep treated with corticosteroid
before being infected with ori virus (Group 12).
|C;;C |„
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corded was 16.6 - 2.6 g/1. These low levels were
maintained throughout until day 35, the last day of the
experiment. Contrarily, the mean differences of
gammaglobulin values between the pre-, and post-challenge
values of the untreated re-infected sheep (group 14) were
not significant (Table 79 ) although the mean daily values
showed an increasing trend (Figure 13).
Contrasting the daily mean values of gammaglobulins
of treated re-infected sheep with the daily mean values
of the untreated re-infected sheep revealed that on days
12 and 13 after challenge there were significant dif¬
ferences (Table 80) .
Immunoglobulin concentrations: The levels of IgM,
IgGl and IgG2 in the pre- and post-challenge sera from
eight susceptible sheep treated with betamethasone before
being infected with orf virus (group 12) and of eight
susceptible sheep also infected with orf virus (group 3)
27-29
are shown in Appendix Tables 47-49/and plots of their
daily mean values are illustrated in Figure 14.
The IgM levels of the treated susceptible sheep ranged
from 1.2 to 4.7 g/1 in the pre-treatment sera and 1.4 to
5.7 g/1 in the post-challenge sera. The IgM mean values
of the daily samples in the treated group 12 sheep ranged
from 2.9 - 1.1 g/1 in the pre-treatment sera to 3.1 -
1.3 g/1 the highest value recorded aifter infection. The
differences between pretreatment and post-infection values
were not significant (Table 81) . Similarly, the
The daily means of IgM, IgG^ and
IgG2 levels in corticosteroid
treated and untreated susceptible
sheep infected with orf virus.
IgG1 levels in untreated infected
sheep (Group 3).
IgG^ levels in treated infected
sheep (Group 12).
IgG2 levels in untreated infected
sheep (Group 3).
IgG2 levels in treated infected
sheep (Group 12).
IgM levels in untreated infected
sheep (Group 3).
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differences between the pre- and post-infection values
of the untreated sheep of group 3 were not significant
(Table 30). The mean values of the daily samples of
the untreated sheep of group 3 ranged from 3.0 - 1.0 g/1
in the pre-infection sera to 3.3 - 1.0 g/1 the highest
value recorded on days 6 and 10 post-challenge. Com¬
parison of the mean IgM values of treated and untreated
susceptible sheep yielded no significant differences
(Table 82).
The mean differences between the pre-treatment and
post-infection values of IgGl of the treated susceptible
sheep of group 12 were not significant (Table 83).
The mean values ranged from 11.25 -5.0 g/1 in the pre-
treatment sera and 11.50 - 4.2 g/1, the highest values
recorded on day 21 after infection. In contrast, the
IgGl levels of the untreated sheep of group 3 increased
from 11.5 5.9 g/1 in the pre-infection sera to 13.6
- 5.6 g/1 on day ten after infection, and this increase
was statistically significant (Table 31).
The IgG2 levels of the treated susceptible sheep
ranged from 0.4 to 6.5 g/1 in the pre-treatment sera and
0.9 to 7.5 g/1 in the post-infections sera. The dif¬
ferences between the pre-treatment and post-infection values
were significant on days 21, 28 and 35 after infection.
(Table 84). UnLikewise, the differences between the pre-
and post-infections values of the untreated susceptible
sheep were not significant (Table 32).
Comparison of the daily means of IgGl and IgG2
between the treated and the untreated susceptible sheep
both infected with orf virus did not reveal any signifi¬
cant differences (Tables 85 and 86).
Changes in the levels of the IgM, IgGl and IgG2 in
the sera from eight previously infected sheep treated
with betamethasone prior to challenge with orf virus
(group 13) and from untreated eight previously infected
sheep re-infected with orf virus (group 14) are illustrated
in Figure 15 and the values are shown in Appendix Tables
57 - 59, and 67 - 69.
There were no significant changes in the IgM levels
of the treated sheep of group 13 (Table 87), the mean
values ranged from 4.2 - 1.4 g/1 in the pre-treatment
sera to 4.4 t 1.4 g/1 recorded on day 11 after challenge.
The IgM levels of the untreated sheep of group 14 also
did not show significant change when the mean differences
between the pre- and post-challenge values were calculated
(Table 88). The mean values of the IgM of the
untreated sheep of group 14 ranged from 3.7 - 1.3 to 4.4
-1.4 g/1. No significant differences were revealed
when the daily means of the IgM of the treated and the
untreated re-infected sheep were compared (Table 89).
The IgGl levels of the treated sheep of group 13 de¬
creased significantly on the second and fourth day after
challenge (Table 90). The mean IgGl levels dropped
from 12.3 i 0.7 g/1 in the pre-treatment sera to 9.3 t












Figure 15; The daily means of the IgM, IgG^ and IgG2
levels in the corticosteroid treated and untreated pre¬





IgG^ levels in the■ untreated sheep (Group 14),
IgG^ levels in the treated re-infected sheep
(Group 13).
IgG2 levels in the untreated reinfected sheep
(Group 14).
IgG2 levels in the treated re-infected sheep
(Group 13).
IgM levels in the untreated re-infected sheep
(Group 14).
IgM levels in the treated re-infected sheep
(Group 13) .
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the levels returned to the pre-treatment values on the
13th day. In contrast, the IgG2 levels in the same
serum samples increased significantly on days 12 through
to 21 after challenge (Table 91). The mean values of
the IgG2 in daily samples ranged from 3.2 t 1.8 g/1 in
the pre-treatment sera to 4.1 - 3,0 g/1 on day 6 after
challenge and then the levels were maintained at this
level until day 35.
However, the IgGl levels of the untreated sheep of
group 14 rose significantly from 12.1 - 2.7 g/1, mean
value of the pre-challenge sera, to 14.6 - 3.6 g/1, of
mean value of samples collected on the 11th day after
challenge, and gradually declined but the levels were
still higher than the pre-challenge value 35 days after
challenge (Table 92). Very slight changes were de¬
tected in the ^-9^2 levels (Table 93) .
Comparison of the daily means of IgGl and IgG2 be¬
tween treated and the untreated re-infected sheep re¬
vealed significant differences only on day 11 post-
challenge value for IgGl (Tables 94 and 95).
Orf antibodies; There were no measurable orf
antibodies in the pre-treatment sera from the eight sus¬
ceptible sheep treated with betamethasone before infection
with orf virus (group 12) and only minimal changes were
observed in the first and second xveek after infection
(Appendix Table 50). Antibodies started to appear in
the third week rising gradually and were still rising in
(Table 96 & Figure 16).
the fifth iveek when the experiment was terminated / There
were no correlations between the mean gammaglobulin values
191.
Figure 16 The daily means of orf antibody titres of:-
A - Susceptible sheep infected with orf virus (Group 3).
B - Susceptible sheep treated with corticosteroid
before being infected with orf virus (Group 12).
and the mean orf antibody titres in the same serum
samples (r^^= +G.49; P>0.05) and between the mean
IgGl levels and mean antibody titres (r^^.= + O.OG7;
P> 0.05) .
Similarly, the eight susceptible sheep not treated
with the betamethasone (group 3) had no detectable orf
antibodies in their pre-challenge sera and after infection
changes were minimal during the first week but, there-,
after, the titres rose to peak values in the fourth week
after infection (Appendix Table 30) .
Comparison of the daily mean antibody titres of the
treated susceptible sheep of group 12 and those of the
untreated susceptible sheep of group 3 revealed no signi¬
ficant differences (Table 97) but comparing the rate of
antibody production between the two groups showed that
the positions of the slopes of rate production were signi¬
ficantly different (F^g = 23.21; P< O.Ol) (Figure 17).
The slopes of the rate of antibody production were not
significant (F^g = 3.16; P> 0.G5).
None of the eight previously infected sheep treated
with betamethasone before challenge with orf virus
(group 13) had detectable orf antibodies in the sera
collected before treatment. After treatment and
challenge with the orf virus antibodies started to appear
in the second week after challenge and reached peak titres
J-i/e- Figure 18 ) .
a»it weeks after challenge (Appendix Table 50, Table 98,
Correlation between the daily mean gammaglobulin values
19 3 o
Figure 17. The rate of orf antibody production in
the corticosteroid treated and untreated susceptible
sheep infected with orf virus.
A: Infected untreated susceptible sheep (Group 3)

















Figure 18 The daily means of orf antibody titres of:-
A - Previously infected sheep challenged with orf
virus (Group 14)
B - Previously infected sheep treated with






















and the daily mean orf antibody titres in the same serum
sample were not significant (r^4) = + 0.06; P >0.05).
In contrast, the correlations of the daily means of IgGl
and IgG2 and the daily means of antibody titres were
positive and significant (r^3^ = + 0.64; O.Ol and
r^13^ = + 0.54; P<0.05 respectively).
Two out of the eight previously infected sheep not
treated with the immunosuppressive drug but challenged
with orf virus (group 14) had detectable orf antibodies
in the pre-challenge sera. After challenge, the anti¬
body titres rose to reach a peak value in the second week
which remained at this level in the third and fourth week
before gradually declining (Appendix Table 70). Cor¬
relation of the daily mean values of the gammaglobulin
and the mean antibody titres in the same serum samples
was positive and significant (r^4^= + 0.57; P<0.05).
Likewise, the correlations between the IgGl values and
the antibody titres was positive and significant (r,^^ =
+ 0.79; P< 0.01) (Table 99, Figure 18).
Comparing the mean orf antibody titres between the
treated and the untreated previously infected sheep
challenged with orf virus revealed a significant differ¬
ence from days 4 to 28 after challenge (Table 100). The
•onset' of antibody production between the two groups
were significantly slower in the treated sheep of group
13 and the peak values were reached much later too in
group 13 sheep (Figure 19). The antibody pro¬
duction dynamics in the two groups of sheep were signifi-
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Figure 19. The rate of orf antibody production in corticosteroid
treated and untreated previously infected sheep reinfected with orf
virus.
A - Untreated re-infected sheep (Group 14).
B - Treated re-infected sheep (Group 13).
10 20
Days Post-chal lenge•
cantly different (r ^ = 133.5; P <Co.01).
When the rates of antibody production in the un¬
treated previously infected sheep (group 14) and the
untreated susceptible sheep of group 3 were compared,
2
there were significant differences in the rate (^23 =
2
7.90; P O.Ol) and the positions of the slopes (^23 =
37.32; P 0.01). Contrarily, when the rate of anti¬
body production of the treated susceptible sheep and
treated previously infected sheep were compared there
were no significant differences in the slopes but the
positions of the slopes differed significantly =
0.45; P>0.05 and F^ = 256.25; P<0„01 respectively)
(Figure 20).
CMI Response Studies
The migratory index values for the eight susceptible
sheep treated with betamethasone before being infected
with orf virus were inconsistent (Appendix Table 34).
The values varied from 98 percent in assays carried out
before treatment and infection with the virus to 50 per¬
cent detected ten days after infection, then to 71 per¬
cent on day 14 and declined to 50 percent again on day
35, the last day of the experiment (Figure 21).
Comparing the results obtained from the infected
susceptible sheep given immunosuppressive drug before
infection with those from susceptible sheep infected with¬
out treatment revealed no significant difference between
them (Table 101).
Figure 20: The rate of orf antibody production
in sheep treated with corticosteroid before being in¬
fected or re-infected with orf virus.
A: Previously infected sheep (Group 13)-.;
B: Susceptible sheep (Group 12).






The daily means of the migration indices
of: -
Susceptible sheep infected with orf virus
(Group 3).
Susceptible sheep treated with corticosteroid
before being challenged with orf virus
(Group 12).
-1 o 10 20
Days Post Challenge
TABLE 59.
MEAN DIFFERENCES OP TOTAL SERUM PROTEIN CONTENTS (DAY 0 - DAY X)
OP SUSCEPTIBLE SHEEP TREATED WITH CORTICOSTEROID BEPORE BEING
INFECTED WITH ORP VIRUS - GROUP 12.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 + 0.50 0.63 0.79 0.50 N.S
3 + 2.25 2.1+5 0.92 > 0.1+0 N.S
5 + 2.87 1.1+7 1.96 > 0.10 N.S
7 + 3.75 0.91+ 3.99 <+ 0.01 S.
8 + 2.25 1.01 2.22 > 0.10 N.S
9 + 1.00 2.03 0.1+9 > 0.70 N.S
10 - 1.50 2.1+0 0.62 > 0.60 N.S
li - 1.12 2.18 0.52 > 0.70 N.S
12 - 0.50 2.06 0.21+ > 0.90 N.S
13 0.00 1.75 0.00 > 0.90 N.S
11+ + 1.37 1.85 0.71+ > 0.50 N.S
21 - 1.75 1.63 1.07 > 0.1+0 N.S
28 - 1.75 2.00 0.87 > 0.50 N.S
35 - 0.87 2.00 0.1+1+ > 0.70 N.S
S. = Significant.
N.S. = Not Significant.
TABLE 60.
COMPARISON OP THE DAILY MEANS OP TOTAL SERUM PROTEIN CONTENTS
BETWEEN GROUPS 3 and. 12.
Days
Post- Degrees of Inter-
Challenge Freedom t P pretation
0 13 1.2k >0.30 N.S.
1 13 0.88 >0.1+0 N.S.
3 13 0.18 >0.90 N.S.
5 13 2.03 >0.10 N.S.
7 13 1.01 >0.1+0 N.S.
8 9 1.91 >0.10 N.S.
9 13 0.31 >0.80 N.S.
10 13 0.01+ >0.90 N.S.
n 13 0.25 >0.90 N.S.
12 13 0.06 >0.90 N.S.
13 13 1.59 >0.20 N.S.
lk 13 0.80 >0.50 , N.S.
21 13 0.53 >0.70 N.S.
28 13 0.33 >0.80 N.S.
35 13 0.9U >0.1+0 N.S.
N.S. = Not Significant.
TABLE 61.
(DAY 0 - DAY X)
MEAN DIFFERENCE OF TOTAL SERUM PROTEIN CONTENTS/OF PREVIOUSLY
INFECTED SEEEP TREATED WITH CORTICOSTEROID BEFORE BEING CHALLENGED








1 + 5.oo 1.39 3.60 < 0.01 H.S.
2 + oo•-4" 2.02 1.98 >0.10 N.S.
b + 5.5o 1.69 3.25 <4 0.02 S.
■
6 + 8.00 2.12 3.77 <4 0.01 H.S.
8 + 6.37 1.7U 3.66 <4 0.01 H.S.
9 + 6.37 2.81+ 2.81+ <4 0.05 S.
10 + 7.00 2.86 2.44 <4 0.05 S.
11 + 6.75 2.1+14- 2.77 <i 0.05 S.
12 + 5.00 1.91 2.62 <4 0.05 S.
13 + 6.00 2.69 2.23 >0.10 N.S.
lb + 3.75 2.35 1.60 >0.20 N.S.
21 + 5.62 2. li| 2.63 <j 0.05 S.
28 + 5.75 2.76 2.03 >0.10 N.S.
35 + 7.37 2.32 3.17 <4 0.02 S.
S. = Significant.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE 62.
MEAN DIFFERENCE OF TOTAL SERUM PROTEIN CONTENTS (DAY 0 - DAY X)
OF SHEEP RE-INFECTED WITH ORF VIRUS - GROUP ll+.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 - 1.75 ■ 1.51+ 1.11+ >0.30 N.S
2 - 1.37 1.00 1.37 >0.30 N.S
h + o•O 1.51 0.33 >0.80 N.S
6 + 1.37 l.l+l 0.97 >0.1+0 N.S
8 + 2.12 2.11 1.00 >0.1+0 N.S
9 + 1.25 1.63 0.77 >0.50 N.S
10 + 0.20 2.06 0.10 >0.90 N.S
11 + 1.75 - 1.93 0.91 > 0.1+0 N.S
12 - 1.62 1.57 o*~\o•rH V o • ■p- o N.S
13 + 2.00 2.35 0.85 >0.50 N.S
lh - 1.37 1.88 0.73 > 0.50 N.S
21 + 1.62 2.05 0.79 > 0.50 N.S
28 + 1.50 1.81+ 0.81 V o . vno N.S
35 + 0.71 1.23 CO"LT\•o > 0.60 N.S
N.S. = Not Significant.
TABLE 63.
COMPARISON OF THE DAILY MEANS OF TOTAL SERUM PROTEIN CONTENTS








0 0.76 > 0.5 N.S.
1 iu 1.38 > 0.2 N.S.
2 iu l.ll > 0.3 N.S.
k Ik 1.05 > 0.1+ N.S.
6 lk 2.27 < 0.05 S.
8 lk 1.03 > 0.1+ N.S. '
9 Ik 2.51 <4 0.05 S.
10 8 0.57 > 0.6 N.S.
11 lk 1.61 > 0.2 N.S.
12 lk 2.17 <4 0.05 S.
13 lk 0.1+9 > 0.7 ■ N.S.
lk lk 1.67 > 0.2 N.S.
21 ik 1. 21+ > 0.3 N.S.
28 lk 1.63 > 0.2 N.S.
35 lk 1.63 > 0.2 N.S.
S. = Significant.
N.S. = Not Signicant.
TABLE 61+.
MEM DIFFERENCE OF ALBUMIN LEVELS (DAY 0 - DAY X) OF SUS¬
CEPTIBLE SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING INFECTED
WITH ORF VIRUS - GROUP 12.
Days
Post- Mean Standard Inter-
Challenge (X) difference Error t P pretation
1 - 0.55 0.82 0.68 >0.600 N.S.
3 + 3.02 1.62 1.87 >0.100 N.S.
5 + C\JCT\• 1.27 3.09 < 0.020 s.
6 + 1+.27 0.1+1 10.1+3 <0.001 H.S.
7 + 2.76 l.hh 1.92 >0.100 N.S.
8 + 1.79 1.03 1.73 >0.200 N.S.
9 + 2.01+ 1.55 1.31 >0.300 N.S.
10 + 0.56 1.56 0.36 >0.800 N.S.
11 + 1.09 0.38 2.86 < 0.050 S.
12 + 2.1+1 2.31 1.01+ >0.01+0 N.S.
13 + 2.9U 1.83 1.60 >0.200 N.S.
11; + 1.21+ 1.39 0.89 >0.1+00 N.S.
21 - 0.30 1.76 0.17 >0.900 N.S.
28 + 1.56 1.19 1.31 >0.300 N.S.








MEM DIFFERENCE OF ALPHAS-GLOBULIN (BAY 0 - LAY X) OF SUSCEPTIBLE
_SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING INFECTED WITH ORF
VIRUS - GROUP 12.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 - 0.32 0.29 1.12 t> 0.30 N.S
3 - 0.71 0.60 1.19 > 0.30 N.S
5 - 0.75 0.U9 1.53 > 0.20 N.S
6 - 0.76 0.20 3.81 <J 0.02 S.
7 - 0.1+7 0.1+2 1.13 >• 0.30 N.S
8 - 0.60 0.50 1.20 > 0.30 N.S
9 - 0.77 0.53 1.1+6 > 0.20 N.S
10 - 0.19 0.39 0.1+8 > 0.70 N.S
11 - 0.27 0.59 0.1+7 > 0.70 N.S
12 — 0.86 0.39 2.21 > 0.10 N.S
13 - 0.146 o.i+o 1.16 s> O•O N.S
11+ - 0.26 0.37 0.71 > 0.50 N.S
21 + 0.06 0.36 0.17 > 0.90 N.S
28 + 0.05 0.37 0.13 t> 0.90 N.S






MEM DIFFERENCE OF ALPHA2-GLOBULIN LEVELS (DAY 0 - DAY X) OF
SUSCEPTIBLE SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING IN¬
FECTED WITH ORF VIRUS - GROUP 12.
Days
Post- Mean Standard. Inter-
Challenge (x) Difference Error t P pretation
1 + 0.56 0.56 1.00 >0.09 N.S.
3 - 0.25 0.83 0.30 >0.80 N.S.
5 - 0.01 0.65 0.02 >0.90 N.S.
6 - 0.20 0.56 1.16- >0.30 N.S.
7 - 1.26 1.18 1.07 >0.1+0 N.S.
8 + 0.21 0.71+ 0.29 >0.80 N.S.
9 - 0.97 0.68 1.1+3 >0.20 N.S.
10 - 0.95 0.73 1.30 >0.30 N.S.
11 + 0.21+ 0.62 0.38 >0.80 N.S.
12 - 0.70 0.79 0.89 >0.1+0 N.S.
13 - 1.11+ 0.81 1.1+0 >0.20 N.S.
11+ - 0.59 0.60 0.98 >0.1+0 N.S.
21 - 1.05 0.78 1.35 >0.30 N.S.
28 - 0.89 0.71 1.25 >0.30 N.S.
35 _ 1.15 0.92 1.25 >0.30 N.S.
N.S. = Not Significant.
TABLE 67.
MEAN DIFFERENCE OF BETA-GLOBULIN LEVELS (DAY 0 - DAY X) OF
SUSCEPTIBLE SHEEP TREATED WITH CORTICOSTEROIDS BEFORE BEING
INFECTED WITH ORF VIRUS - GROUP 12.
Days
Post- Mean Standard
Challenge (x) Difference Error t
1 + 0.01 0.25 0.05 > 0.90 N.S.
3 + 0.37 0.52 0.72 > 0.50 N.S.
5 - 0.10 o.i+5 0.22 > 0.90 N.S.
6 + 0.39 0.55 0.70 > 0.60 N.S.
7 - 0.61 0.51+ 1.13 > O•o N.S.
8 - 0.61+ 0.57 1.12 t> 0.30 N.S.
9 - 0.76 0.14.6 1.66 > 0.20 N.S.
10 + 0.06 0.1+9 0.13 > 0.90 N.S.
11 - 1.16 0.82 1.1+2 > 0.20 N.S.
12 - 1.36 0.76 1.79 t> 0.20 N.S.
13 . - 1.61+ 0.71 2.30 :> 0.10 N.S.
11+ - 0.06 0.69 0.09 > 0.90 N.S.
21 + 0.20 0.51 0.39 > 0.80 N.S.
28 - 0.50 0.59 0.85 > 0.50 N.S.
35 - 0.29 0.31+ Q.8U > 0.50 N.S.
Inter-
P pretation
N.S. = Not Significant.
TABLE 68.
MEM DIFFERENCE OF GAMMAGLOBULIN LEVELS (DAY 0 - DAY X) OF
SUSCEPTIBLE SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING







1 + 0.50 0.80 0.63 >0.60 N.S.
3 + 0.70 0.80 0.88 >0.50 N.S.
5 + 0.23 0.80 0.29 >0.80 N.S.
6 + 2.10 1.10 1.91 >0.10 N.S.
7 + 0.20 0.70 0.29 >0.80 N.S.
8 + 0.35 0.90 • 0.39 >0.80 N.S.
9 + 0.55 0.90 0.61 >0.60 N.S.
10 + 1.10 1.00 1.10 >0.1+0 N.S.
11 + 0.60 0.70 0.86 >0.50 N.S.
12 + 3.50 3.20 1.09 >0.1+0 N.S.
13 + 0.10 0.90 0.11 >0.90 N.S.
lii + 0.30 1.10 0.27 >0.80 N.S.
21 + 0.20 1.30 0.15 >0.90 N.S.
28 + 1.90 1.70 1.12 >0.30 N.S.
35 + 2.15 2.00 1.08 >0.1+0 N.S.
N.S. = Not Significant.
TABLE 69.
COMPARISON OP THE DAILY MEANS OP GAMMAGLOBULIN LEVELS BETWEEN
GROUPS 3 AND 12.
Days
Post- Degrees Inter-
Challenge of Freedom t P pretation
0 13 1.1+3 > 0.20 N.S.
1 13 0.97 > o.i+o N.S.
3 13 0.27 > 0.80 N.S.
5 13 1.88 > 0.10 N.S.
6 5 0.1+2 >0.70 N.S.
7 13 1.52 oCvi.oA N.S.
8 9 1.36 > 0.20 N.S.
9 13 1.50 > 0.20 N.S.
10 13 1.09 > 0.30 N.S.
11 13 1.53 ** 0.20 N.S.
12 13 1.01 > 0.1+0 N.S.
13 13 1.63 oOJ.oA N.S.
11+ 13 1.53 V O • rv> o N.S.
21 13 1.28 ^0.30 N.S.
28 13 0.58 ^0.60 N.S.
35 13 0.21 >0.90 N.S.
N.S. = Not Significant.
TAISLE 70.
MEAN DIFFERENCE OF ALBUMIN LEVELS ( DAY 0 - DAY X ) OF PREVIOUSLY
INFECTED SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING CHALLENGED
WITH ORF VIRUS - GROUP 13.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 + U.07 2.27 1.79 >0.20 N.S.
2 + 0.1+75 2.25 0.21 >0.90 N.S.
1+ + 0.1+25 2.1+7 0.17 >0.90 N.S.
6 + 1+.81 2.11+
'
2.25 >0.10 N.S.
8 + 3.83 1.65 2.32 ^0.05 S.
9 + 3.26 1.51 2.16 >0.10 N.S.
10 + 3.51+ 2.27 1.60 >0.20 N.S.
11 + 2.31+ 1.31+ 1.71+ >0.20 N.S.
12 + 2.29 1.30 1.76 >0.20 N.S.
13 + 3.91 2.27 1.72 0CM.OA N.S.
11+ + 3.17 2.31 1.37 >0.30 N.S.
21 + 1.10 1.63 0.67 >0.60 N.S.
28 + 0.78 2.17 0.36 >0.80 N.S.
35 + 3.1+1+ 1.61+ 2.10 >0.10 N.S.
S. = Significant.
N.S. = Not Significant.
TABLE 71.
MEAN DIFFERENCE OF ALPHAS-GLOBULIN LEVELS (DAY 0 - DAY X) OF
PREVIOUSLY INFECTED SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING
CHALLENGED WITH ORF VIRUS - GROUP 13.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 + 0.16 0.28 0.58 > 0.60 N.S.
2 + 0.35 0.67 0.52 >0.70 N.S.
k + 1.03 0.79 1.30 >0.30 N.S.
6 + 0.78 0.53 1.1+6 >0.26 N.S.
8 + 0.06 0.71 0.08 >0.90 N.S.
9 + 0.61 0.52 1.18 >0.30 N.S.
10 + 0.72 0.51+ 1.33 >0.30 N.S.
11 + 0.12 0.19 0.63 >0.60 N.S.
12 + 0.1+1 0.1+1+ 0.91+ > 0.1+0 N.S.
13 + 0.60 0.3U 1.76 >0.20 N.S.
11+ + 0.35 0.26 1.35 >0.30 N.S.
21 + 0.31 0.35 0.89 >0.30 N.S.
28 + 0.26 0.38 0.68 >0.60 N.S.
35 + 0.90 0.1+8 1.86 >0.10 N.S.
N.S. = Not Significant.
TABLE 72.
MEAN DIFFERENCE OF ALPHA2-GLOBULIN LEVELS (DAY 0 - DAY X) OF
PREVIOUSLY INFECTED SHEEP TREATED WITH CORTICOSTEROID BEFORE
BEING CHALLENGED WITH ORF VIRUS - GROUP 13.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 + 0.1+2 0.56 0.76 > 0.50 N.S.
2 + 1.30 0.57 2.28 > 0.10 N.S.
k + 0.87 0.55 1.58 > 0.20 N.S.
6 + 1.26 0.75 1.68 > 0.20 N.S.
8 + 0.82 0.68 1.20 > 0.30 N.S.
9 + 1.29 0.78 1.69 > 0.20 . N.S.
10 + 1.22 0.78 1.56 > 0.20 N.S.
n + 0.71 0.60 1.18 > 0.20 N.S.
12 + 0.80 0.50 1.60 > 0.20 N.S.
13 + 0.57 0.53 1.08 > O-It•O N.S.
lb + 0.7U 0.U3 1.71 > 0.20 N.S.
21 + 1.16 0.99 1.17 f> 0.30 N.S.
28 + 1.15 0.81 1.1+2 > 0.20 N.S.
35 + 0.52 0.55 0.95 > 0.U0 N.S.
N.S. = Not Significant.
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TABLE 73.
MEAN DIFFERENCE OF BETA-GLOBULIN LEVELS (DAY 0 - DAY X)
OF PREVIOUSLY INFECTED SHEEP TREATED WITH CORTICOSTEROID










1 - 0.21 0.46 0.46 >0.70 N.S.
2 - 0.41 0.37 1.11 >0.40 N.S.
4 + 0.46 0.48 0.96 >0.40 N.S.
6 - 0.30 0.92 0.33 V o * oo o N.S.
8 + 0.29 0.38 0.76 >0.50 N.S.
9 - 0.03 0.32 0.08 >0.90 N.S.
10 + 0.04 0.67 0.06 >0.90 N. S ..
11 + O.IO 0.58 0.17 >0.90 N.S.
12 - 0.74 0.65 1.13 >0.30 N.S.
13 + 0.44 0.51 0.87 >0.50 N.S.
14 - 0.83 0.66 1.25 >0.30 N.S.
21 + 0. 30 0.55 0.54 >0.70 N.S.
28 + 0. 20 0.33 0.60 >0.60 N.S.
35 + 0.44 0.32 1.37 >0.30 N.S.
N.S. = Not Significant.
TABLE 71+.
MEM DIFFERENCE OF ALBUMIN LEVELS (DAY 0 - DAY X) OF SHEEP RE¬
INFECTED WITH ORF VIRUS - GROUP 11+.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 - 1.1+1 . 1.06 1.33 >0.30 N.S.
2 - 0.1+9 1.89 0.26 >0.90 N.S.
1+ - 1.73 1.89 0.91 >0.1+0 N.S.
6 + 2.9I+ 2.10 1.1+0 0CM.OA N.S.
8 + 3.71+ 2.1+3 1.51+ >0.20 N.S.
9 + 2.02 2.11+ 0.91+ >0.1+0 N.S.
10 + O.96 2.81 0.31+ >0.80 N.S.
11 - 0.20 2.31 0.09 >0.90 N.S.
12 + 1.11+ 1.78 0.61+ >0.60 N.S.
13 + 1+.87 2.92 1.67 >0.20 N.S.
11+ + 1.50 2.1+6 0.61 >0.60 N.S.
21 + 0.71+ 2.83 0.26 >0.90 N.S.
28 + 0.05 3.1+2 0.01 >0.90 N.S.
35 + 1.1+7 2.86 0.51 >0.70 N.S.
N.S. = Not Significant
TABLE 75.
MEAN DIFFERENCE OF ALPHAS-GLOBULIN LEVELS (DAY 0 - DAY X)
OF SHEEP RE-INFECTED WITH ORF VIRUS - GROUP ll+.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 - 0.01 0.37 0.03 > 0.90 N.S.
2 - 0.78 0.62 1.25 > 0.30 N.S.
k + 0.21+ 0.50 0.1+8 > 0.70 N.S.
6 - 0.79 0.50 1.58 > 0.20 N.S.
8 - 0.59 0.31+ 1.73 > 0.20 N.S.
9 - 0.1+8 0.31 1.53 > 0.20 N.S.
10 + 0.08 0.57 0.11+ > 0.90 N.S.
11 + 0.15 0.29 0.51 > 0.70 N.S.
12 - 0.13 0.1+2 0.31 > 0.80 N.S.
13 - o.l+l 0.53 0.78 > 0.50 N.S.
11+ . - 0.75 0.51 1.1+7 > 0.20 N.S.
21 + 0.25 0.38 0.66 > 0.60 N.S.
28 - 0.05 0.21+ 0.20 > 0.90 N.S.
35 - 0.36 0.63 0.57 > 0.60 N.S.
N.S. = Not Significant.
TABLE 76.
LEVELS
MEAN DIFFERENCE OF ALPHAg-GLOBULU/ (DAY 0 - DAY X) OF SHEEP RE¬










1 + 0.19 0.68 0.28 > 0.80 N.S.
2 + 0.08 1.0 0.08 > 0.90 N.S.
k + 0.91 0.70 1.30 > 0.30 N.S.
6 + 0.67 0.92 0.69 > 0.60 N.S.
8 + 0.73 0.66 1.10 > 0.1+0 N.S.
9 - 0.11+ 0.79 0.17 > 0.90 N.S.
10 + 0.78 0.90 0.87 > 0.50 N.S.
11 + 1.79 0.67 2.67 0.05 s.
12 + 0.56 0.92 0.61 > 0.60 N.S.
13 + 0.71 1.19 0.60 K. 0.60 N.S.
11+ + 0.50 0.81 0.62 0.60 N.S.
21 + 0.71 0.68 1.01+ > 0.1+0 N.S.
28 + 1.26 0.96 1.31 > 0.30 N.S.
35 + 0.11+ 1.11 0.13 t> 0.90 N.S.
S. = Significant.
N.S. = Not Significant.
TABLE 77.
MEAN DIFFERENCE OF BETA-GLOBULIN LEVELS (DAY 0
SHEEP RE-INFECTED WITH ORF VTRUS - GROUP 11+.
- DAY X) OF
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 + 0.51 0.67 0.76 > 0.50 N.S.
2 - 0.25 0.77 0.32 > 0.80 N.S.
k + -iti—1•O 1.01 0.11+ > 0.90 N.S.
6 - 1.00 o.i+3 2.32 < 0.05 s.
8 - 0.87 0.50 1.75 > 0.20 N.S.
9 - 0.53 0.61 0.86 > 0.10 N.S.
10 + 0.16 0.87 0.18 > 0.90 N.S.
11 + 0.51 0.1+1 1.25 > o•o N.S.
12 - 0.10 0.57 0.17 > 0.90 N.S.
13 + 0.21 0.60 0.35 t> 0.80 N.S.
111 - 0.10 0.75 0.13 > 0.90 N.S.
21 - 0.88 0.88 1.00 > 0.1+0 N.S.
28 - 0.59 1.05 0.56 > 0.60 N.S.




MEAN DIFFERENCE OF GAMMAGLOBULIN LEVELS (DAY 0 - DAY X) OF
PREVIOUSLY INFECTED SHEEP TREATED WITH CORTICOSTEROID BEFORE








1 + 1.55 1.05 1.1+8 i> 0.20 N.S.
2 + 2.60 0.62 1+.15 ^ 0.01 H.S.
b + 3.00 1.10 2.73 <J 0.05 s.
6 + 2.30 1.00 2.30 <10.05 S.
8 + 2.20 1.10 2.00 > 0.10 N.S.
9 + 2.20 1.10 2.00 > 0.10 N.S.
10 + 2.90 1.50 1.93 > 0.10 N.S.
11 + 2.50 0.90 2.78 <i 0.02 s.
12 + 2.25 0.95 2.35 <! 0.05 S.
13 + 2.1+0 0.92 2.61 < 0.05 S.
lb + 1.11+ 1.29 0.88 > 0.50 N.S.
21 + 1.37 0.80 1.72 > 0.20 N.S.
28 + 2.15 1.20 1.79 > 0.20 N.S.
35 + 2.60 1.1+0 1.86 > 0.10 N.S.
S. = Significant.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE 79.
MEM DIFFERENCE OF GAMMAGLOBULIN LEVELS (DAY 0 - DAY X) OF










1 - 0.08 0.23 0.33 > 0.80 N.S.
2 - 0.35 1.10 0.32 > 0.80 N.S.
b - 0.80 1.50 0.53 > O.70 N.S.
6 - 0.15 0.50 0.30 > 0.80 N.S.
8 - 0.65 0.80 0.81 > 0.50 N.S.
9 - 1.30 1.10 1.18 > 0.30 N.S.
10 - 1.70 1.65 1.03 > 0.I4.0 N.S.
11 - 0.70 1.00 0.70 > 0.60 N.S.
12 - 2.50 1.30 1.92 > 0.10 N.S.
13 - 2.90 1.50 1.92 > 0.10 N.S.
lb - 2.05 1.80 1.11; > 0.30 N.S.
21 - 0.60 1.00 0.60 > 0.60 N.S.
28 - 0.60 1.20 0.50 > 0.70 . N.S.
35 - 2.30 1.70 1.35 > 0.30 N.S.
N.S. = Not Significant.
TABLE 80.
COMPARISON OP THE DAILY MEANS OP GAMMAGLOBULIN BETWEEN GROUPS 13
AND Ik.
Days
Post- Degrees of Inter-
Challenge Preedom t P pretation
0 !1+ 0.19 > 0.90 N.S.
1 11+ 0.67 > 0.60 N.S.
2 11+ 1.61+ > 0.20 N.S.
h 11+ 0.90 > 0.90 N.S.
6 11+ 1.1+7 > 0.20 N.S.
8 11+ 1.67 0C\J.OA N.S.
9 11+ 1.73 V O . ro O N.S.
10 10 0.93 j> 0.1+0 N.S.
11 11+ 1.59 > 0.20 N.S.
12 11+ 2.15 CO.05 S.
13 11+ 2.76 <+0.02 S.
11+ 11+ 1.71+ > 0.20 N.S.
21 11+ 1.28 >0.30 N.S.
28 11+ 0.28 . >0.80 N.S.
39 13 1.1+6 OCM•0A N.S.
S. = Significant.
N.S. = N t Significant.
TABLE 81.
MEAN DIFFERENCE OF IgM LEVELS (DAY 0 - DAY X) OF SUSCEPTIBLE
SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING INFECTED WITH










1 + 0.13 0.22 0.57 > 0.60 N.S.
3 + 0.26 0.20 1.31 >0.30 N.S.
5 + 0.31 0.20 1.56 oCM.oA N.S.
6 - 0.07 0.35 0.21 >0.90 N.S.
7 + 0.29 0.23 1.25 >0.30 N.S.
8 + 0.12 0.11 1.06 >0.1+0 N.S.
9 - 0.09 0.20 0.1+1+ >0.70 N.S.
10 - 0.16 0.27 0.60 >0.60 N.S.
11 + 0.01 0.29 0.01+ >0.90 N.S.
12 + 0.06 0.20 0.31 >0.80 N.S.
13 + 0.01 0.23 0.05 >0.90 N.S.
11+ - 0.05 0.32 0.16 >0.90 N.S.
21 - 0.03 0.21+ 0.10 >0.90 N.S.
28 - 0.20 0.25 0.80 >0.50 N.S.
35 - 0.21+ 0.39. 0.61 >0.60 N.S.
N.S. = Not Significant.
TABLE 82.
COMPARISON OF THE DAILY MEANS OF IgH LEVELS BETWEEN GBOIJPS 3 AND 12
Days
Post-. Degrees of Inter-
Challenge Freedom t P pretation
0 13 0.28 >0.80 N.S.
1 13 0.1+1 >0.70 N.S.
3 13 0.63 >0.60 N.S.
5 13 0.63 >0.60 N.S.
6 5 0.17 >0.90 N.S.
7 13 0.68 >0.60 N.S.
8 9 0.29 >0.80 N.S.
9 13 0.16 >0.90 N.S.
10 13 0.31+ >0.80 N.S.
11 13 0.17 >0.90 N.S.
12 13 0.36 >0.80 N.S.
13 13 0.17 >0.90 N.S.
11+ 13 0.35 >0.80 N.S.
21 13 0.1+3 >0.70 N.S.
28 13 i—1C\i•o >0.90 N.S.
35 13 0.21 >0.90 N.S.
N.S. = Not Significant.
TABLE 83.
MEAN DIFFERENCE OF IgG LEVELS (DAY 0 - DAY X) OF SUSCEPTIBLE
SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING INFECTED WITH
ORF VIRUS - GROUP 12.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 + 0.61+ 0.65 0.98 +> 0.1+0 N.S.
3 + 0.35 0.62 0.56 > 0.60 N.S.
5 + 0.1+6 o.ib 0.62 > 0.60 N.S.
6 + 0.85 I—1CvJ•i—1 0.10 !> 0.60 N.S.
7 + o.i+5 0.1+9 0.92 !> 0.1+0 N.S.
8 + 0.39 0.91 0.1+3 > 0.70 N.S.
9 + 0.61+ 0.81+ 0.76 > 0.50 N.S.
10 - 0.15 0.58 0.26 > 0.90 N.S.
11 + 0.17 1.11+ 0.15 > 0.90 N.S.
12 + 0.56 0.93 0.60 >0.60 N.S.
13 + 0.81 0.86 0.91+ !> o.l+o N.S.
11+ + 0.1+0 0.93 0.1+3 >0.10 N.S.
21 + 0.21+ 1.27 0.19 >0.90 N.S.
28 - 0.09 1.18 0.08 >0.90 N.S.
35 - 0.16 1.12 0.11+ >0.90 N.S.
N.S. = Not Significant.
TABLE 8k.
MEAN DIFFERENCE OF IgG2 LEVELS (DAY 0 - DAY X) OF SUSCEPTIBLE
SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING INFECTED WITH
ORF VIRUS - GROUP 12.
Days
Post- Mean Standard. Inter-
Challenge (X) Difference Error t P pretation
1 - 0.07 0.11+ 0.51+ >0.70 N.S.
3 + t—o•o 0.21 0.36 >0.80 N.S.
5 - 0.07 0.20 0.37 >0.80 N.S.
6 - 0.37 0.29 1.29 >0.30 N.S.
7 - o.J+i 0.21+ 1.72 >0.20 N.S.
8 - 0.53 0.1+1+ 1.21 >0.30 N.S.
9 - o.l+i o.3U 1.21 >0.30 N.S.
10 - 0.35 0.31 1.13 >0.30 N.S.
11 - 0.1+0 0.31+ 1.76 >0.20 N.S.
12 - 0.80 0.33 2.21+ >0.10 N.S.
13 - 0.51 0.1+5 1.11+ >0.30 N.S.
lit - 0.76 o.h3 1.77 >0.20 N.S.
21 - i.5i 0.36 1+.20 < 0.01 H.S.
28 - 1.83 0.55 3.32 < 0.02 S.

















0 13 0.09 >0.90 N.S.
1 13 o.i+9 >0.70 N.S.
3 13 0.1+1+ >0.70 N.S.
5 13 0.20 >0.90 N.S.
6 5 0.1+1 >0.70 N.S.
7 13 0.52 >0.70 N.S.
8 9 0.53 >0.70 N.S.
9 13 1.36 oC\J«oA N.S.
10 13 1.05 >0.1+0 N.S.
11 13 0.83 >0.50 N.S.
12 13 0.82 >0.50 N.S.
13 13 1.11+ >0.30 N.S.
lb 13 1.23 >0.30 N.S.
21 13 0.88 >0.1+0 N.S.
28 13 0.97 >0.1+0 N.S.
35 13 0.26 >0.80 N.S.
N.S. = Not Significant.
TABLE 86.
COMPARISON OF THE DAILY MEANS OF IgG2 LEVELS BETWEEN GROUPS 3
AND 12.
Days
Post- Degrees of Inter-
Challenge Freedom t P pretation
0 13 1.18 > 0.30 N.S.
1 13 0.95 > 0.30 N.S.
3 13 1.58 > 0.20 N.S.
5 13 1.1+7 > 0.20 N.S.
6 5 0.8U > 0.50 N.S.
7 13 1.20 > 0.30 N.S.
8 9 1.1+7 > 0.20 N.S.
9 13 1.70 > 0.20 N.S.
10 13 1.61 > 0.20 N.S.
11 13 1.32 > 0.30 N.S.
12 13 0.97 > 0.1+0 N.S.
13 13 1.26 > 0.30 N.S.
11+ 13 1.35 > 0.20 N.S.
21 13 0.53 > 0.60 N.S.
28 13 0.00 > 0.00 N.S.
35 13 0.1+0 >0.70 N.S.
N.S. = Not Significant.
TABLE 87.
MEAN DIFFERENCE OF IgM LEVELS (DAY 0 - DAY X) OF PREVIOUSLY
INFECTED SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING










1 + 0.88 0.70 1.26 >0.30 N.S.
2 + 1.09 0.69 1.58 > 0.20 N.S.
1+ + 1.01+ 0.70 1.1+9 > 0.20 N.S.
6 - 0.26 0.69 0.38 > 0.80 N.S.
8 + 0.01+ 0.51+ 0.07 >0.90 N.S.
9 - 0.09 0.1+0 0.22 >0.90 N.S.
10 + 0.35 0.55 0.61+ >0.60 N.S.
11 + 0.06 0.28 0.22 >0.90 N.S.
12 + 0.1+9 o.l+l 1.19 >0.30 N.S.
13 + 0.15 0.65 0.23 >0.90 N.S.
11+ - 0.7U 0.95 0.78 >0.50 N.S.
21 - 0.23 0.72 0.31 >0.80 N.S.
28 - 0.36 0.65 o.55 >0.60 N.S.
35 - 0.21 0.72 0.29 >0.80 N.S.
N.S. = Not Significant.
TABLE 88.
MEAN DIFFERENCE OF IgM LEVELS (DAY 0
WITH ORF VIRUS - GROUP 14.
- DAY X) OF SHEEP RE-INFECTED
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 + 0.15 . 0.31 0.48 > 0.70 N.S
2 + 0.08 0.20 0.40 > 0.70 N.S
4 + 0.38 0.26 1.44 V o . (V) o N.S
6 - 0.06 0.37 0.17 > 0.90 N.S
8 - 0.06 0.30 0.21 > 0.90 N.S
9 + 0.05 0.27 0.18 > 0.90 N.S
10 + 0.10 0.33 0.30 > 0.80 N.S
11 + 0.10 0.41 0.24 >0.90 N.S
12 - 0.01 0.50 0.03 > 0.90 N.S
13 + 0.41 0.39 1.06 > 0.40 N.S
14 - 0.05 0.50 0.10 > 0.90 N.S
21 + 0.19 0.37 0.51 > 0.70 N.S
28 - 0.09 • 0.63 0.14 >0.90 N.S
35 + 0.29 o.44 0.65 >0.60 N.S
N.S. = Not Significant.
TABLE 89.
COMPARISON OP THE DAILY MEANS OP IgM LEVELS BETWEEN GROUPS 13
AND ll+.
Days
Post- Degrees of Inter-
Challenge Preedom t P pretation
0 lb 0.19 >0.90 N.S
1 lb 1.07 >0.1+0 N.S,
2 lb 0.17 >0.90 N.S
b lb 0.73 >0.50 N.S
6 lb 0.91 > o.l+o N.S
8 lb 0.10 > 0.90 N.S
9 lb 0.00 >0.90 N.S
10 10 0.00 > 0.90 N.S
11 lb 0.3U > 0.80 N.S
12 lb 0.32 > 0.80 N.S
13 lb 0.81 > 0.50 N.S
1U lb 1.36 > 0.20 N.S
21 lb 0.1+8 > 0.70 N.S
28 lb 0.93 >o.l+o N.S
35 13 O.23 > 0.90 N.S
N.S. = Not Significant.
TABLE 90.
MEAN DIFFERENCE OF IgG1 LEVELS (DAY 0 - DAY X) OF PREVIOUSLY
INFECTED SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING








1 + 1.53 0.71+ 2.06 >0.10 N.S.
2 + 2.25 0.58 3.88 <10.01 H.S.
1+ + 3.01+ 0.98 3.10 < 0.02 S.
6 + 1.05 0.82 1.28 >0.30 N.S.
8 + 1.71+ 0.76 2.29 >0.10 N.S.
9 + O.69 0.1+9 1.1+1 >0.20 N.S.
10 + 1.53 1.11 1.39 >0.20 N.S.
11 + 1.86 0.79 2.35 <!0.05 S.
12 + 1.61 0.95 1.69 >0.20 N.S.
13 + 0.21+ 0.66 0.36 >0.80 N.S.
11+ + 0.19 0.68 0.28 >0.80 N.S.
21 - 0.58 0.1+5 1.28 >0.30 N.S.
28 - 0.79 0.73 1.08 > 0.1+0 N.S.
35 + 0.09 0.60 0.15 > 0.90 N.S.
S. = Significant.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE 91.
MEAN DIFFERENCE OF IgG2 LEVELS (DAY 0 - DAY X) OF PREVIOUSLY
INFECTED SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING
CHALLENGED WITH ORF VIRUS - GROUP 13.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 - 0.20 0.18 1.11 o.OA N.S.
2 - 0.11+ 0.27 0.52 Ot—.OA N.S.
1+ - 0.1+5 0.21 2.11+ > 0.10 N.S.
6 - 0.95 0.1+8 1.98 > 0.10 N.S.
8 — 0.66 0.33 2.01 > 0.10 N.S.
9 - 0.91+ 0.1+2 C\J•CM oi—!.OA N.S.
10 - 0.1+0 0.1+1+ 0.91 O.OA N.S.
11 - 0.63 0.33 1.89 Oi—I•OA N.S.
12 - 0.81 0.3U 2.39 A O . o vn. S.
13 - O.89 0.35 2.51+ <! 0.05 S.
11+ - 0.7U 0.35 2.11 > 0.11 N.S.
21 - 0.69 0.20 3.1+9 i—io.oV H.S.
28 - 0.81+ 0,1+1+ 1.90 > 0.01 N.S.
35 - 0.I+9 0.1+6 1.06 O-3"•oA N.S.
S. = Significant.
H.S. = Highly Significant.
N.S. = Not Significant.
TABLE 92.
MEAN DIEFERENCE OE IgG1 LEVELS (DAY 0 - DAY X) OF SHEEP HE-
INFECTED WITH OEF ViRTJS - GROUP 11+.
Days
Post- Mean Standard Inter-
Challenge (x) Difference Error t P pretation
1 + 0.80 0.9U 0.85 >0.50 N.S.
2 + 1.5U 1.10 1.1+0 >0.20 N.S.
h + 1.3U 1.07 1.25 >0.30 N.S.
6 + 0.68 1.11+ 0.59 >0.60 N.S.
8 - 0.05 0.90 0.05 >0.90 N.S.
9 - i.5i 0.82 1.81+ oC\J•oA N.S.
10 - 1.22 1.60 0.76 >0.50 N.S.
11 - 2.53 0.90 2.80 <f 0.05 S.
12 - 2.33 0.90 2.60 <j 0.05 S.
13 - 1.29 0.92 1.1+0 >0.20 N.S.
lb - 1.35 0.79 1.71 >0.20 N.S.
21 - 1.26 1.17 1.08 >0.1+0 N.S.
28 - 1.10 o.5U 2.01+ >0.10 N.S.






MEAN DIFFERENCE OF IgG2 LEVELS (DAY 0 - DAY X) OF SHEEP RE¬










1 + 0.51 0.1+1 1.21+ > 0.30 N.S.
2 + o.l+o 0.1+1 0.98 > o.l+o N.S.
1+ + 1.10 0.29 3.93 > 0.01 H.S.
6 + 0.26 0.33 0.80 > 0.1+0 N.S.
8 - 0.1+9 0.53 0.92 > 0.1+0 N.S.
9 + 0.11 0.19 0.59 > 0.60 N.S.
10 + 0.07 0.50 0.13 s> 0.90 'N.S.
11 + 0.21+ 0.1+7 0.51 > 0.70 N.S.
12 + 0.05 0.59 0.08 > 0.90 N.S.
13 + 0.5U o.J+5 1.19 > 0.30 N.S.
Ik + 0.33 0.1+7 0.72 > 0.50 N.S. '
21 + 0.36 0.52 0.70 > 0.60 N.S.
28 + 0.20 0.52 0.38 > 0.80 N.S.
35 + 0.59 0.68 0.86 > 0.50 N.S.
N.S. = Not Significant.
TABLE 9U.
COMPARISON OF THE DAILY MEANS OF IgG1 BETWEEN GROUP 13 and lit
Days
Post- Degrees of Inter-
Challenge Freedom t P pretation
0 li; 0.20 > 0.90 N.S
1 11+ 0.1+9 >0.70 N.S
2 11+ 0.31+ >0.80 N.S
1+ 11+ 1.08 >0.30 N.S
6 11+ 0.63 > 0.60 N.S
8 11+ 1.63 >0.20 N.S
9 11+ 1.80 >0.10 N.S
10 10 1.10 >0.30 N.S
11 il+ 2.68 •^o.os s.
12 11+ 1.68 oC\l.oA N.S
13 11+ 0.76 >0.50 N.S
lb 11+ 1.35 > 0.20 N.S
21 11+ 0.1+3 +> 0.70 N.S
28 11+ 0.12 > 0.90 N.S
35 13 1.05 > 0.1+0 N.S
S. = Significant.
N.S. = Not Significant.
TABLE 95.
COMPARISON OP DAILY MEANS OP IgGg BETWEEN GROUPS 13 AND 11+
Days
Post- Degrees of Inter-
Challenge Preedom t P pretation
0 lb 0.85 > 0.50 N.S.
1 lb 0.82 > o.5o N.S.
2 lb 0.56 > 0.60 N.S.
1+ lb 0.61+ > 0.60 N.S.
6 lb 0.81 > 0.50 N.S.
8 lb 1.07 > 0.1+0 N.S.
9 lb 1.01 > 0.1+0 N.S.
10 10 0.98 > 0.1+0 N.S.
11 11+ 1.07 > 0.1+0 N.S.
12 11+ 0.62 > 0.60 N.S.
13 11+ 0.67 ► 0.60 N.S.
11+ 11+ 1.28 ► 0.30 N.S.
21 11+ 1.76 +> 0.10 N.S.
28 11+ 1.30 !> 0.30 N.S.
35 11+ 1.39 > 0.20 N.S.
N.S. = Not Significant.
TABLE 96.
MEAN DIFFERENCE OF ANTIBODY TITRES (DAY 0 - DAY X) OF SUS¬
CEPTIBLE SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING IN¬
FECTED WITH ORF VIRUS - GROUP 12.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 0.00 0.00 0.00 > 0.90 N.S.
3 0.00 0.00 0.00 > 0.90 N.S.
5 +0.50 0.33 1.50 > 0.20 N.S.
6 -0.50 0.29 1.72 > 0.20 N.S.
7 -0.38 0.36 1.06 > 0.1+0 N.S.
8 -0.33 0.21 1.59 > 0.20 N.S.
9 -0.50 0.39 1.28 > 0.30 N.S.
10 -0.62 0.36 1.71+ > 0.20 N.S.
11 -0.69 0.37 1.86 > 0.10 N.S.
12 -0.69 0.37 1.86 > 0.10 N.S.
13 -0.56 0.35 1.61 > 0.20 N.S.
11+ -0.56 0.35 1.61 > 0.20 N.S.
21 -0.81 0.39 2.08 > 0.10 N.S.
28 -0.88 0.35 2.51 < 0.05 s.








COMPARISON OF THE DAILY MEAN ANTIBODY TITRES BETWEEN GROUPS 3 AND
12
Days
Post- Degrees of Inter-
Challenge Freedom t P pretation
0 13 0.28 >0.8 N.S
1 13 0.28 >0.80 N.S
3 13 0.28 > 0.80 N.S
5 13 1.32 >0.30 N.S
6 5 0.00 j> 0 • 00 N.S
7 13 0.70 >0.50 N.S
8 9 0.11+ > 0.90 N.S
9 13 0.1+5 >0.70 N.S
10 13 o.5o >0.70 N.S
11 13 1.07 >0.30 N.S
12 13 1.1*3 oCM.OA N.S
13 13 2.35 <i 0.05 S.
11+ 13 2.03 > 0.10 N.S
21 13 0.59 > 0.60 N.S
28 13 0.81+ > 0.50 N.S
35 13 0.65 > 0.50 N.S
S = Significant.
H.S. = Not Significant.
TABLE 98.
MEAN DIFFERENCE OF ORF ANTIBODIES (DAY 0 - DAY X) OF PREVIOUSLY
INFECTED SHEEP TREATED WITH CORTICOSTEROID BEFORE BEING
CHALLENGED WITH ORF VIRUS - GROUP 13.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 + 0.50 0.32 1.50 O•0A N.S
2 0.00 0.00 0.00 > 0.90 N.S
b + 0.25 0.59 C\J•0 > 0.70 N.S
6 -O.I3 0.61 0.20 OON•OA N.S
8 - 0.13 0.61 0.20 > 0.90 N.S
9 - O.63 0 • 1+2 1.50 OON.OA N.S
10 - 0.88 0.58 1.51 Oon.OA N.S
11 — 0.88 0.58 1.51 OON•OA N.S
12 - 0.71 0.39 1.82 > 0.20 N.S
13 - 1.38 0.53 2.59 « 0.05 S.
lb - 1.38 O.ij.2 3.30 < 0.02 S.
21 - I.63 0.37 b.39 < 0.01 H.S
28 - 1.63 0.1+2 3.87 < 0.01 H.S








MEM DIFFERENCE OF MTIBODY TITRSS (DAY 0 - DAY X) OF SHEEP RE¬
INFECTED WITH ORF VIRUS - GROUP li+.
Days
Post- Mean Standard Inter-
Challenge (X) Difference Error t P pretation
1 0 . 00 0.00 0.00 !> 0.900 N.S
2 0.00 0.00 0.00 >0.900 N.S
h - 0.50 0.32 1.55 > 0.20 N.S
6 - 0.88 0.29 3.oi A O • O rv> O ^ •
8 - 1.25 0.31 U.03 A O • OHO H.S
9 - 1.38 0.37 3.72 <1 0.010 H.S
10 - 1.50 0.32 U.69 0iH0.0V H.S
11 - 1.88 o.l+o U.69 <! 0.010 H.S
12 - 1.88 o.l+o I4.69 <1 0.010 H.S
13 - 2.00 0.38 5.26 ,0.001<i H.S
lh - 2.1+0 0.37 6.1+9 <1 0.001 H.S
21 - 2.1+0 0.37 6.1+9 <0.001 H.S
28 - 2.1+0 0.37 6.1+9 0.001 H.S








COMPARISON OF THE DAILY MEANS ANTIBODY TITHES BETWEEN GROUPS
13 AND lk.
Days
Post- Degrees of Inter-
Challenge Freedom t P pretation
0 14 1.82 > 0.10 N.S
1 14 1.84 > 0.10 N.S
2 14 0.91 > 0.40 N.S
k 14 3.04 ** 0.01 s.
6 14 2.52 < 0.05 s.
8 14 3.26 0.01 s.
9 14 2.19 < 0.05 s.
10 14 2.11 0 0.10 N.S
11 14 2.64 <1 0.02 S.
12 14 3.22 0 0.01 S.
13 14 2.70 <j 0.02 S.
lb 14 3.10 <- 0.01 S.
21 14 3.91 < 0.01 s.
28 14 3.37 <1 0.01 s.
35 14 1.05 > 0.40 N.S
S. = Significant.
N.S. = Not Significant.
TABLE 101.
COMPARISON OP THE DAILY MEANS OP MIGRATORY INDICES BETWEEN THE










before treatment 11+ 1.1+0 !>0.20 N.S
- 1
after treatment 10 1.01 >0.1+0 N.S
2 11+ 0.60 >0.60 N.S
5 10 0.1+1+ >0.70 N.S
8 11+ 0.08 >0.90 N.S
10 2 0.10 >0.90 N.S
11+ 13 0.57 >0.60 N.S
21 13 0.1+3 >0.70 N.S
28 9 0.1+0 >0.70 N.S
35 12 1.21 >0.30 N.S
N.S. = Not Significant.
DISCUSSION
My explorative study of the effects of immuno¬
suppression on orf, summarized in Table 102,showed that
corticosteroid treatment delayed the onset of the lesions
and prolonged the course of the lesions in the treated
sheep compared to the untreated sheep irrespective of
whether the sheep was susceptible or previously infected.
The postponement of the onset of the lesions and the
subsequent prolonged course were attributable to anti¬
inflammatory effects and immunosuppressive activity of
the corticosteroids (Nathanson and Cole 1971; Narita,
et al„, 1979). Complete healing in the treated sus¬
ceptible sheep occurred in the sixth week after infection
compared to the four weeks taken by the untreated infected
susceptible sheep. Similarly, in the treated re¬
infected sheep healing occurred in the third week in con¬
trast to the two weeks taken by the untreated re-infected
sheep. The findings support Glasgow (1970) who re¬
ported that immunosuppressive drugs enhanced poxvirus
virulence and Osman (1976) who found that corticosteroid
therapy before challenge caused sheep to react severely
to orf virus. Shope, Muscaplat, Chen and Johnson (1976),
similarly, observed that dexamethasone treated calves
with no detectable neutralizing antibodies to bovine viral
virus
diarrhoea /developed a fatal viraemia while the untreated
did not.
TABLE102.















































The prolonged course of the lesions in the treated
susceptible sheep was mirrored by the slower onset of
detectable antibodies which reached lower peak titres
at much later time compared to the untreated infected
susceptible sheep. ■ The expected drops in the IgM and
IgGl levels of the treated infected susceptible sheep
were not observed and although slight insignificant in¬
creases were detected in the untreated infected susceptible
sheep, the increases were not significantly different
from the levels of the treated infected susceptible
sheep. Significant increases were detected in the IgG2
levels in both the treated and the untreated infected
susceptible sheep. This might be due to the lympho¬
cytes responsible for producing IgG2 being resistant to
corticosteroid toxicity.
In the treated re-infected sheep depression of the
gammaglobulin and IgGl levels were observed while in the
untreated re-infected sheep the gammaglobulin and IgGl
levels were raised as expected. The rate of antibody
production, likewise, was significantly slower in the
treated re-infected sheep compared to the untreated re¬
infected sheep. In contrast, the expected drop in the
IgG2 levels in the treated re-infected sheep was not ob¬
served instead a significant raise was detected which
was not observed in the untreated re-infected sheep. A
likely explanation here might again be the selective re¬
sistance of lymphocytes to corticosteroid toxicity. As
246.
expected no changes were observed in the IgM levels of
the treated and the untreated re-infected sheep.
with
The present findings are in agreement/ the ob¬
servation made by Zurier and Weissman (1973) that the
induction phase of antibody production was more prone
to steroid suppression. However, my results diverge
from their concept that primary antigen responseswere
more vulnerable to steroid interference than secondary
antigen response. My data indicated that humoral
immune responses were suppressed in both primary and se¬
condary infections although much more obvious in the
secondary infections. A tentative explanation here
could be that the effects of the corticosteroid in both
primary and secondary reactions were the same and that
the effects in secondary reactions were more obvious
because the humoral immune responses in secondary reactions
were also more pronounced. On the other hand, the one
dose treatment of the immunosuppressive drug used in my
study might not have been effective enough for susceptible
sheep especially the course of orf being much longer in
primary infections, by the time the virus multiplication
in the lesions maximise, the effects of the corticosteroid
h ave wo rn off.
The corticosteroid did not seem to have any effect
on the CMI responses because the LMI tests performed in
the treated susceptible sheep infected with orf virus
gave similar positive indications to those performed in
the untreated susceptible sheep also infected with orf
virus, I failed to find any information in the
literature on the effects of corticosteroids on CMI in
sheep but Davies and Carmichael (1973) reported that in
cattle which were infected with infectious bovine rhino-
tracheitis virus and three months later treated with
dexamethasone for five days, the CMI, as measured by
lymphocyte transformation tests, was suppressed during
the time of recrudescence of the infection. Again a
likely explanation for my findings might be the fact
that the one dose-treatment was not enough to suppress
CMI responses. Earlier Claman (1972) had also observed
that even in the steroid-resistant animals the CMI mani¬
festations could be suppressed when large doses or pro¬
longed treatment were carried out. In addition, my
experiments are open to criticisms in that I did not in¬
vestigate CMI in treated previously infected sheep. It
will be interesting to examine the effects of corti¬
costeroid on CMI responses in treated previously infected
sheep especially because I found that CMI played a great
role in the abrupt clearance of the virus in the acceler¬
ated reactions.
Unfortunately, in these experiments control groups
of sheep treated with corticosteroid without infection or
re-infection were not included. In addition, surveys
carried out in other species, suggest that there is a
species heterogeneity in the response of lymphoid cells
and their immunologic reactions to corticosteroids and
remarkable heterogeneity within the lymphoid cells com¬
partment even in a given species. I venture to suggest
that another form of immunosuppression should be used
and examination of the growth of the virus in the iramuno
suppressed sheep be carried out at the same time. Never
theless, my results point to humoral factors as being
important in the recovery from orf virus infections.
CHAPTER SEVEN
GENERAL DISCUSSION
When suspensions of orf scabs were applied to
freshly scarified skins of susceptible sheep of any age,
prominent orf lesions that evolved through the classical
pox stages of macule, papule, vesicle, pustule and scab
resulted. Likewise, when orf scab suspensions were
applied to freshly scarified skins of previously infected
sheep, the resulting lesions progressed very rapidly
through the typical pox stages, healing occurring within
three weeks (Boughton and Hardy, 1934; Hart e_t al . , 1949;
Schmidt, 1962; Osman, 1976) (Figure 22). Osman (1976)
likened the phenomenan to the well-known accelerated
immune response that occurs in man re-vaccinated against
smallpox. In addition, he found that virus replication
occurred in both the primary and the accelerated reactions
and that the growth curves of the virus in both infected
and re-infected sheep, as measured by the number of virus
particles in the epidermal layers of the scarified skin,
was essentially the same initially. He showed that the
number of virus particles in the epidermal layers of
scarified skin of susceptible sheep rose exponentially to
reach maximum titres in four days then levelled for a
period of three weeks before it declined gradually over a
period of another three weeks. The number of virus
particles in the scarified skins of previously infected
sheep also rose exponentially reaching a maximum five
days after re-infection but the titre was significantly
lower than in the susceptible sheep. The titre was only
Figure 22 Onsets of the lesion stages in experi¬



















maintained at this level for three days when it decreased
abruptly (Figure 23,).
Glover (1933) believed that sheep recovering from
orf virus infections developed a 'solid' immunity.
Osman (1976) and I found that recovered sheep reacted
when challenged with the virus despite the presence of
detectable humoral antibodies.
Romero-Mercado (1969) was the first to link the ap¬
pearance of scabs in both primary and accelerated orf
reactions to the development of demonstrable humoral anti¬
bodies. An examination of my data confirms this re¬
lationship of the lesion evolution and humoral immune re¬
sponse in both primary and accelerated reactions such
that the onset of the scab stage coincided with the ap¬
pearance of humoral antibodies and the resolution of the
lesions was associated with the occurrence of peak anti¬
body titre (Figures 24 and 25).
Furthermore, when my findings were related to those
of Osman (1976) on the growth curves of the virus in
primary reactions in susceptible sheep, the appearance of
detectable humoral antibodies was found to coincide with
the onset of the exponential decline of the virus titre.
A more dramatic relationship was noted when my data on
the humoral immune responses in re-infected sheep was
compared with the growth pattern of the virus in previously
infected sheep (Osman 1976). The exponential increase
of the antibody titre coincided with the abrupt disa¬
ppearance of the virus. Hence, there is an implication
Figure 23 Growth curves of
of susceptible and previously
with permission from Dr. Omar
orf virus in the skins
infected sheep. Redrawn
A.II. Osman's thesis (1976)
Days Post - sea rification
Figure 24 Relationship between orf lesion stages and
antibody titres in infected susceptible sheep.
Figure 25 Relationships between orf lesion stages
and antibody titres in re-infected sheep.
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that the clearance of the virus from the scarified skins
of both susceptible and previously infected sheep is as¬
sociated with the humoral immune response Figures 26 and 27).
Osman (1976) believed that the progressive clinical
and pathological changes occurring in sheep experimentally
infected or re-infected with orf virus were a result of
tkr active virus multiplication. He tentatively
suggested that the presence of antibodies in previously
infected sheep were enhancing virus multiplication and
causing the accelerated reaction to re-infection largely
because Kapikian and his colleagues (1969), Kim and his
colleagues(1969), Chanock and his colleagues (1970) and
Smith and his co-workers (1975) had noted this phenomenon
in infants and calves infected with respiratory syncytial
virus. His attempts, however, to induce an accelerated
reaction by injecting susceptible sheep with hyperimmune
serum intravenously prior to infecting them with orf virus
by scarification failed.
The concept that CMI may be a critical determinant
of host resistance to poxvirus infections was first
suggested by Pirquet (1907) who speculated that hyper¬
sensitivity contributed to lesion of primary local
vaccinia virus infection. Later, McKinnon and Defries
(1931) concluded that delayed hypersensitivity was the
dominant factor in revaccination reactions to smallpox.
The suggestions were not widely accepted. However, after
the work of Broom (1947) who showed that accelerated re-
Plate 26 Super imposition of the daily means of
antibody titres and the growth curve of orf virus in




































Figure 27 Super imposition of the daily means of
the antibody titres and the growth curve of orf virus
in previously infected sheep as determined by Osrnan (1976)
0 10 20 30 40
Days After Challenge.
vaccination reactions to vaccinia virus could occur in
man in the absence of demonstrable antibody and could
be elicited by heated non-infectious virus, and further
work by Pincus and Flick (1963) who observed that anti-
mononuclear serum inhibited the development of the skin
lesions to vaccinia virus though the virus replicated
and antibodies were formed, many medical immunologists
believed that CMI contributed to primary vaccination
and was mainly responsible for the accelerated reactions
after re-vaccination to smallpox. Accelerated reactions
were, therefore, termed allergic reactions (Allison 1967).
The facts that the accelerated reactions had similar
pathogenesis as the primary lesion (Pincus and Flick 1963)
and that re-vaccination was accompanied with virus multi¬
plication (Kaplan and Morton 1975) have been ignored.
With regard to orf, Osman (1976) failed to incrim¬
inate CMI involvement in the one attempt he carried out
of transferring lymphoid cells from recovered sheep to
susceptible lambs before being infected with orf virus.
In the current study, in contrast, I found that injecting
susceptible lambs with lymphoid cells from recovering
sheep induced an accelerated response. Furthermore, an
examination of the relationship between the CMI responses
and the growth curves of orf virus in accelerated re¬
actions determined by Osman (1976) revealed that the
highest stimulation index was obtained when the virus
titre was expected to drop abruptly (Figure 28). Similarly,
Figure 28 Superimposition of the daily means of the
31 values and the growth curve of orf virus in previously
infected sheep as determined by Osman (1976).




the abrupt clearance of the virus occurred when the
(Figure 29).
migratory indices were approaching 50 percent / There¬
fore, it seems not unreasonable to suggest that CMI
responses in sheep re-infected with orf virus play a
role in the accelerated clinical reactions and virus
clearance. However, the comparison between the growth
curves of the virus in primary reactions and CMI responses
were not so clear-cut; there was an indication that the
migratory indices were declining at the same time as the
virus titreswere waning (Figure 30). More work is re¬
quired to establish the CMI responses in primary reactions
to orf virus.
Observations in man and animals have shown that some
pathogenic viruses can suppress the cellular and humoral
immune responses in the host. Penhale and Pow (1970)
for example, found that rinderpest virus suppressed the
humoral immune response of rabbits to chicken erythro¬
cytes; and Mellman and Wetton (1963) found that the at¬
tenuated measles virus vaccine suppressed the CMI response
of man to tuberculin. Hence, the immunologic dys¬
function caused by the viruses are reflected by the
changes in the physiologic and immunologic functions of
lymphocytes and macrophages since it is the interaction
between the antigen and these cells or their products
which generate immunity. However, in my study of orf
immunology, I did not observe impairment of lymphocyte
or macrophage function. Lymphocytes from infected
sheep were stimulated with orf antigen in vitro resulting
Figure 29 Super imposition of the daily means of
the migratory indices and the growth curve of orf virus
in previously infected sheep as determined by Osman (1976)
Days Post-challenge
Figure 30 Superimposition of the daily means of
Migratory indices and the growth curve of orf virus in
infected susceptible sheep as determined by Osman (1976).
Days Post-challenge
in blastogenesis and production MIF and LIF as early as
the fourth day after challenge,, In addition, anti¬
body production was induced in vivo because orf anti¬
bodies were detected in the sera of infected and recovered
sheep.
In the attempts to explore the effects of immuno¬
suppression on orf infections I found that the duration
of the lesions was longer in the treated sheep than in
the untreated sheep irrespective of whether the sheep
was susceptible or re-infected. The prolonged course
of lesion in the susceptible sheep was mirrored by slower
onset of detectable antibodies and the titres attained
were slightly lower than those of untreated susceptible
sheep. Similarly, the longer course of the lesion in
the treated previously infected sheep compared to the
untreated previously infected sheep was reflected in the
poor and delayed anamnestic antibody response, depression
of the levels of serum proteins and IgGl,
There was no evidence of the CMI responses being
suppressed in the immunosuppressed susceptible sheep.
However, my experiments are open to the criticism that
I did not investigate CMI in immunosuppressed previously
infected sheep. It would be interesting to monitor
the growth and clearance of the virus in treated sus¬
ceptible and previously infected sheep in relation to
the humoral and CMI responses.
The speculation that local skin immunity rather
than systemic immune response was operating in orf in¬
fections has been made (Anon. 1978) but as yet has not
been proven. One could always argue, however, that
because antibodies in the skin are believed to come from
the blood by transduction (Heremans 1968) there is
systemic as well as local involvement. Nevertheless,
the concept of local immunity is an attractive proposition
re-infection.
and could explain why sheep are refractory to / Schmidt
(1967) found that only 83 percent of the re-infected
sheep reacted to the virus and Osman (1976) found that
only 94.7 percent of the re-infected sheep had acceler¬
ated reactions whilst 5.3 percent were refractory.
Fenner and White (1970) had also noticed this non-reacting
phenomenon in subjects re-vaccinated against smallpox at
the previous site and had found that antibody levels in
these refractory individuals did not change so concluded
that the booster was not successful. In my study how-
ever, all the 38 previouslv infected sheep reacted to
re-infection with an accelerated reaction. Moreover,
if local immunity was the operative mechanism how does
one explain the accelerated reactions observed in re¬
infected sheep at different sites since every new site
inoculated will be expected to have a primary reaction.
In conclusion, I venture to postulate that both
humoral immune and CMI responses are implicated in virus
clearance with the humoral immune response being perhaps
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pH 8.6, ionic strength 0.075
Hank's balanced salt solution: HBSS is supplied by
Wellcome Co. as a sterile lOx concentrate without sodium









A single strength of the solution is prepared by diluting
the 100ml of the concentrate with 900 ml of DDW and adding
8ml of 4.4 percent sodium bicarbonate.
To prepare HBSS-H, 0.1ml of 5,000 units/ml heparin
solution is added to 100ml of HBSS.
Lymphocyte Buffer
Solution A
Anhydrous D. glucose lg/1.
CaCl2 2H20 0.0074 g/1.
•MgCl2 0.1992 g/1.
KC1 0.4026 g/1.
Tris hydroxyaminomethone 17.565 g/1.
Solution B
NaCl 8 .19g/l.
Mix one volume of solution A with nine volumes of solution




Add 28 ml of KH2P04 to 100 ml of Na2HP04 and adjust
pH 7.2.
Phosphate Buffered Saline
Purchased from Oxoid Co. in form of tablets containing
Sodium Carbonate 8g/l.
Potassium Chloride 0.2g/l.
Disodium hydrogen phosphate 1.15g/l.
Potassium dihydrogen phosphate 0.2g/l.
10 tablets are dissolved in 1 litre of DDW and autoclaved
for 10 minutes at 101b per sq in (115°C).
Sodium Bicarbonate 4.4%
A sterile 4.4% W/V solution of sodium bicarbonate
with phenol red indicator is made in DDW. The solution





pH adjusted to 8.00 by IN HC1.
Media Preparation
Growth medium for lamb testes and calf testes cell
cultures was prepared as follows
Eagle's Medium in Earle's salts 10 mis.
New born calf serum 10 mis.




Sodium Bicarbonate (4.4%) 2.5 mis.
Made up to 100 ml by sterile deionized water.
Maintenance medium: was made up as above except
the new born calf serum was reduced to 5 ml and sodium
carbonate increased to 3 mis.
286.
Growth medium for Vero cell cultures: was pre¬
pared as follows:-
TC 19 9 lOmls
Foetal calf serum lOrnls
Penicillin 1000 i.u.
Streptomycin ... 500 ug.
made up to lOOmls by sterile deionized water.
Maintenance medium: for vero cells was made in
the same way except foetal calf serum added was reduced
to 5%.
Tryptose Phosphate Broth: this was commercially pur¬




Na2HP04 2 . 5g
29.5g of the mixture is dissolved in a one litre of DDW.
and then the solution is sterilized by autoclaving for
15 minutes at 151b per sq in (121°C).
Stains
0.3% Nigrosin Dye prepared as follows:-
Nigrosine 0.3g
PBS 100ml






Alserver Solution; The solution is prepared as follows
Sodium Citrate ' 8g
Dextrose 20 . 5g
NaCl 4 . 2g
Citric acid 0.55g
DDW 1 1.
Sterilized by autoclaving 10 p.s.i. for 10 minutes and
stored at 4°C.
Cleaning Solution - The solution used for cleaning phor
slide after staining consisted oft-
Glacial acetic acid 70ml
Ethyl acetate 30ml
5% Acetic Acid Solution; made up oft-
Glacial acetic acid 50ml
DDW 950ml o
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38.004 84 39 15 26.4052 938.641 07.483
36.104.36
1
47.009 732 285 6.6 802 134.540 08 2935.31 1
35.606.73
2
48.0030 559 167 6.34 03 105 5.60N D.
37.955.04
3
30.9097 843 2.48 331.60N D..3.424 52 36 9
34.805.74
4
N.D.36.204 941 58 17.95 60N D.
38.051.97
5
30.4046 63 1251.0N D.30. 025 42 2
36.416.68
6
31.7040 59.23 12 902 .6135N D.
37.716.10
7
34.807 441 90.603 28 35 0N D.17.03 5
34.706.71
8
47.2039 3080 954.12 806N D.
38.106.2
9
43.4038 95 77 53.022 89 01046
37.707.36
10
29.303 76 58 1407 64.3 95 42 0
36.128.23
11
31.105 547 639.902 7521 4833 1
36.609.26
12
42.906 57 354 833 68.02N D.27.4031 35 7
38.908.32
13
43.90450 84.336 17 02 2214 5.76
38.708.04
14
43.802 45 143 .06 9.4028 79 234 64312 0
37.205.56
21
45.607 09 8423.723142.30404 865 9
36.057.80
28
44.702 55 930 826.3837.409 74 5
37.806.56
35
36.4034 65 74 22 .97 02D0 05
35.655.99











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































ORF ANTIBODY TITRES* OF SHEEP WHICH HAD DETECTABLE ANTIBODIES BEFORE
RE-INFECTION WITH ORF VIRUS (GROUP I)
Days
Post-
NUMBER OF SHEEP STATISTICS
Challenge 751 780 765 767 768 691 790 362 Mean s.d.
0 3 3 3 3 3 3 4 4 3.25 0.46
1 3 3 3 3 3 3 4 4 3.25 0.46
2 3 3 3 3 3 3 4 4 3.25 0.46
3 4 3 3 3 3 3 N.D. N.D. 3.17 0.41
4 N.D. N.D. N.D. 3 3 3 5 5 3.80 1.10
3 4 3 3 3 3 -3 • N.D. N.D.
6 4 3 3 3 3 3 5 5 3.62 0.92
7 4 4 3 4 4 4 N.D. N.D. 3.83 0.41
8 5 4 4 4 5 4 6 6 4.75 0.89
9 5 4 4 6 5 4 6 7 5.12 1.12
10 5 5 4 6 5 4 7 6 5.25 1.04
11 5 5 5 5 5 5 7 7 5.50 0.93
12 5 5 5 6 6 5 N.D. N.D. 5.33 0.52
13 5 4 5 6 6 5 6 6 5.38 0.74
14 5 4 5 5 6 6 5 5 5.12 0.64
21 4 4 5 4 5 6 5 5 4.75 0.71
28 4 4 4 4 4 4 5 5 4.25 0.46
35 4 4 4 4 4 4 5 5 4.25 0.46
S.D. = STANDARD DEVIATION.




ORE ANTIBODY TITHE* OP SHEEP WHICH HAD NO OR ONLY TRACES OP
ANTIBODIES BEFORE RE-INFECTION WITH ORP VIRUS (GROUP l).
Days NUMBER OP SHEEP STATISTICS
Post-
Challenge 71+9 779 71+0 712 852 875 836 838 Mean s.d.
0 2 0 0 0 2 2 2 2 1.25 1.03
1 2 0 0. 0 2 2 2 2 1.25 1.03
2 2 0 0 0 N.D. N.D. N.D. N.D. 0.50 1.00
3 2 0 N.D. N.D. 2 2 3 3 2.00 1.10
1+ N.D. 0 0 0 N.D. N.D. N.D. N.D. 0.00 0.00
5 3 2 N.D. N.D. 2 2 1+ 3 2.67 0.82
6 3 2 0 0 N.D. N.D. N.D. N.D. 1.25 1.50
7 1+ 3 N.D. N.D. 2 2 1+ 1+ 3.17 0.98
8 1+ 1+ 2 2 N.D. N.D. N.D. N.D. 3.00 1.15
9 h 1+ ' 2 2 2 2 5 1+ 3.12 1.25
10 1+ 1+ 2 2 2 2 5 1+ 3.12 1.25
11 1+ 1+ 3 3 3 3 5 1+ 3.62 0.1k
12 1+ 5 N.D. N.D. 3 2 5 1+ 3.83 1.11
13 1+ 5 1+ 3 3 3 5 1+ 3.88 0.83
11+ 1+ 5 1+ 3 3 3 5 1+ 3.88 0.83
21 1+ 1+ 1+ 2 3 1+ 1+ 1+ 3.62 0.71+
28 3 1+ 3 2 2 1+ 1+ 3 3.12 0.83
35 3 3 3 2 2 1+ 1+ 3 3.00 0.76
s.d. = standard deviation
N.D. = Not Done.
* log2
APPENDIX TABLE 11.
TOTAL SERUM PROTEIN CONTENTS' OP UNCHALLENGED PREVIOUSLY INFECTED




NUMBER OF SHEEP STATISTICS
22 38 39 376 co CO co Mean s.d.
0 69 67 65 70 75 69.2 3.77
1 72 66 67 68 69 68.1+ 2.30
2 66 61 67 66 68 65.0 2.61+
3 68 66 63 68 7b 67.8 1+.02
1+ 62 63 62 69 61 61+.6 3.21
5 63 65 62 63 65 VO•vo 1.31+
6 71 71 63 65 72 68.1+ 1+.10
7 71 63 65 69 71+ 68.1+ 1+.1+5
8 69 65 6b 67 69 66.8 2.28
9 70 67 63 65 68 66.6 2.70
10 71 69 65 61 65 66.2 3.90
11 69 63 65 63 72 66.1+ 3.97
12 68 66 61 63 67 65.0 2.92
13 67 67 68 68 61+ 66.8 1.61+
11+ 65 66 6b 69 7U 67.6 1+.01+
21 68 66 6b 68 71+ 68.0 3.71+
28 68 68 65 68 76 69.O 1+.12






ALBUMIN LEVELS* OF UNCHALLENGED PREVIOUSLY INFECTED SHEEP OF
GROUP 2
__
NUMBER OF SHEEP STATISTICS
Post-
Challenge 22 38 39 376 833 Mean s.d.
0 1+3.0 33.5 22.5 32.2 29.1+ 32.12 7.1+2
1 14+. 2 32.2 31+. 8 31.8 29.1 31+.1+ 5.83
2 1+3.8 28.3 33.3 30.2 28.0 32.7 6.51+
3 31.6 32.3 31.1+ 30.8 29.1+ 31.1 1.09
b 33.0 31.1+ 32.0 31.9 27.5 31.2 2.13
3 31.1+ 29.1 29.2 22.0 22.6 26.9 1+.27
6 39.5 35.3 31+.0 32.6 30.2 3l+-3 3.1+6
7 39.9 33.0 31+. 6 31+.0 30.9 31+. 5 3.31+
8 37.1+ 32.3 39.2 26.9 22.9 31.7 6.88
9 1+1.6 31+.0 33.6 27.5 2U.6 32.3 6.58
10 36.7 31+.7 31+. 3 28.9 20.1 30.9 6.71
11 39.1+ 27.0 31+.0 29.6 21+.3 30.9 5.96
12 35.1 33.6 36.3 23.9 28.7 31.5 5.15
13 31.2 33.9 35.8 31+.1 32.1+ 33.5 1.75
11+ 33.2 35.2 36.5 1+0.2 28.0 31+.6 1+.50
21 32.7 31+.1 31+.6 35.1 29.1+ 33.2 2.29
28 36.5 38.2 35.6 30.1+ 31.1+ 31+.1+ 3.36
35 ■ 37.1+ 1+3.8 3U.6 35.9 29.9 36.12 1+.67
s.d. = standard deviation.
* = g/l.
APPENDIX TABLE 13.
ALPHAS-GLOBULIN LEVELS* OP UNCHALLENGED PREVIOUSLY INFECTED SHEEP
GROUP 2.
Days NUMBER OF SHEEP STATISTICS
Post-
illenge 22 38 39 376 833 Mean s.d.
0 2.10 U.o 2.6 3.5 3.8 3.20 0.82
1 1.1+0 2.6 2.0 2.6 2.8 2.28 0.58
2 3.0 1.2 2.6 1.3 2.7 2.16 0.8U
3 2.0 3.1 3.7 2.7 2.9 2.88 0.62
U 2.5 3.1 2.5 3.5 i+.o 3.12 0.65
5 6.3 3.9 3.1 u.u 2.6 U.06 1.U3
6 2.1 2.8 2.5 2.6 U.3 2.86 0.8U
7 2.1 3.2 2.6 1.1+ i+.U 2.7U 1.1U
8 2.8 3.5 2.6 3.0 3.9 3.16 0.53
9 2.1 U.U 2.6 1.8 3.3 2.8U 1.01+
10 2.0 2.6 2.6 3.1 3.9 2.8U 0.71
n 2.1 3.35 2.6 3.8 U.3 3.23 0.89
12 2.7 U.o 5.U 3.1 U.O 3.8U 1.0U
13 3.3 2.0 2.7 1+.8 2.6 3.08 1.07
11+ 3.3 2.7 2.6 •3.5 3.7 3.16 0.U9
21 2.0 2.7 2.6 2.7 U.U 2.88 0.90
28 2.0 5.U 1.9 2.7 3.1 2.22 0.68

















0 6.90 8.0 9.0 11.9 9.0 9.0 1.85
1 7.20 9.2 10.0 10.1 8.3 8.97 1.21
2 8.6 11.0 9.0 8.5 6.8 8.78 1.50
3 8.5 7.5 9.2 10.0 9.3 8.90 0.95
1+ 8.1 6.9 9.2 9.7 8.7 8.52 1.08
5 10.0 8.1+ 9.3 10.0 7.7 9.08 1.01
6 9.9 8.5 9.1+ 8.5 8.6 8.98 0.61+
7 9-2 7.0 9.1 9.0 8.1 8.1+8 0.91+
8 9.9 8.3 7.8 7.3 7.8 8.22 1.00
9 9.0 7.6 8.1+ 8.8 7.2 8.20 0.77
10 8.8 9.0 6.5 ' 10.0 6.5 8.16 1.58
11 8.0 8.8 10.1+ 9.1+ 8.7 9.06 0.90
12 9.1 7.2 10.9 9.1+ 8.0 8.92 1.1+1
13 9.5 8.7 10.1 12.3 6.1+ 9.1+0 2.11+
11+ 7.8 9.3 9.0 7.6 7.1+ 8.22 0.87
21 9.5 8.0 9.0 9.5 7.1+ 8.68 0.91+
28 7.1+ 8.9 9.7 11.5 8.1+ 9.18 1.51+
35 9.2 6.5 9.0 9.3 8.5 8.50 1.16
s.d. = standard deviation.
* = g/l.
APPENDIX TABLE 15.
BETA-GLOBULIN LEVELS*OF UNCHALLENGED PREVIOUSLY INFECTED SHEEP -
GROUP 2
Days NUMBER OF SHEEP STATISTICS
Post-
.lenge 22 38 39 376 833 Mean s.d.
0 1+.2 1+.0 2.6 1+.9 6.0 1+.31+ 1.25
1 5.1 3.3 3.3 5.1+ 5.5 1+.53 1.11
2 6.6 1.8 3.8 6.6 l+.l 1+.58 2.03
3 5.3 3.1 1+.3 2.7 3.6 3.80 1.01+
1+ 8.1 3.8 1+.9 3.5 i+.O U. 86 1.89
5 5.0 3.9 1+.3 8.8 5.8 5.57 1.91+
6 1+.9 1+.2 3.1 3.9 5.7 1+.37 0.98
7 5.7 3.8 3.9 1+.2 5.9 1+.70 1.02
8 1+.2 3.5 3.2 1+.3 v. 1+.6 3.96 0.59
9 1+.9 3.5 3.9 1+.1+ 5.8 1+.50 0.90
10 6.3 3.5 3.2 2.5 5.2 1+.11+ 1.56
11 5.5 3.8 3.9 3.8 5.1 1+ -1+2 0.81
12 5.1+ 2.6 6.6 3.1 5.1+ 1+.62 1.70
13 7.1+ 3.3 3.1+ 1+.9 20 6 1+.33 1.91
11+ 5.9 2.6 2.6 l+.l 1+.1+ 3.93 1.37
21 6.1 2.0 3.8 6.1 5.1+ 1+.68 1.77
28 6.8 l+.l 3.2 5.1+ 5.1+ 1+.98 1.38
35 5.6 2.6
'






GAMMAGLOBULIN LEVELS^ OP UNCHALLENGED PREVIOUSLY INPECTED SHEEP
GROUP 2.
5ayf NUMBER OP SHEEP STATISTICSPost-
Challenge 22 38 39 376 833 Mean s.d.
0 13.2 17.1+ 15.5 17.5 27.1 18.11+ 5.31
1 11+.5 18.1+ 16.7 17.6 23.6 18.2 3.37
2 15.9 16.5 15.1+ 15.7 23.2 17.3 3.30
3 15.1 16.2 16.0 16.1 25.1 17.7 1+. 16
1+ 12.U 17.6 16.0 17.1+ 21+.1 17.5 1+.21+
5 13.0 19.1+ 16.2 17.6 21+. 5 18.1 1+.26
6 ll+.l 19.8 11+. 8 15.0 23.0 17.3 3.89
7 16.1+ 16.5 13.8 13.9 21+. 3 17.0 1+.29
8 15.0 18.7 15.0 15.0 30.7 18.1 6.80
9 11+. 5 17.5 ll+.O 16.5 25.5 17.6 1+.61+
10 15.5 18.7 13.6 17.1 26.7 18.3 5.05
11 13.8 18.9 11+.1+ 15.7 21+.6 17.5 1+.1+1+
12 11+.9 19.7 11+.5 17.5 18.1 16.9 2.20
13 16.7 18.8 15.5 16.5 17.9 17.09 1.28
11+ 15.0 15.9 16.5 15.6 23.6 17.3 3.50
21 17.7 16.6 11+.7 11+.6 22.1 17.1 3.07
28 11+.9 15.7 11+.2 17.6 23.0 17.1 3.51+
35 15.5 17.5 15.1+ 16.6 19.9 17.2 2.11+
s.d. = standard deviation.
= g/1.
APPENDIX TABLE 17.
IgG1 LEVELS* OP UNCHALLENGED PREVIOUSLY INFECTED SHEEP - GROUP 2
5ay! NUMBER OP SHEEP STATISTICSPost-
Challenge 22 38 39 276 833 Mean s.d.
0 11.10 12.70 13.5 12.70 12.70 12.55 0.86
1 12.70 11.10 12.70 12.70 13.5 12.55 0.86
2 11.90 11.90 11.90 13.5 13.5 12.55 0.86
3 11.10 11.90 12.70 11.90 11.9 11.92 0.55
b 11.90 12.70 1U-3 11.90 11.9 12.55 1.02
5 12.70 11.90 11.90 13.5 lit. 3 12.86 1.02
6 11.10 11.90 13.5 12.70 13.5 12.55 1.02
7 11.90 11.10 12.76 12.70 13.5 12.I+0 0.90
8 11.10 11.10 11.92 13.5 13.5 12.2b 1.19
9 11.90 11.90 12.76 12.70 lb.3 12.71 0.96
10 12.70 10.30 11.92 12.70 1U.3 12.39 1.1+2
11 12.70 11.10 1U.27 11.90 11+.3 12.86 1.1+0
12 11.90 11.90 11+.27 11.10 13.5 12.55 1.29
13 11.10 11.10 12.70 11.92 13.5 12.08 1.02
11+ 11.10 11.90 12.70 12.70 13.5 12.39 0.89
21 10.30 11.90 12.70 11.10 13.5 11.92 1.21+
28 10.30 11.90 12.70 11.10 13.5 11.92 1.2b
35 11.90 12.70 12.70 11.10 13.5 12.39 0.89
s.d. = standard deviation.
* = g/1.
APPENDIX TABLE 18.
IgG2 LEVELS* OP UNCHALLENGED PREVIOUSLY INFECTED SHEEP - GROUP 2.
NUMBER OF SHEEP STATISTICS
Post-
Challenge 22 .38 39 376 833 Mean s.d.
0 5.91+ 1+.1+5 1+.1+5 1+.82 1+.08 1+.75 0.72
1 5.17 1+.1+5 1+.1+5 1+.1+5 1+.08 1+.-52 0.1+0
2 5.57 1+.1+5 1+.1+5 1+.61+ 1+.1+5 1+.71 0.1+9
3 5.57 1+.1+5 I+.08 1+.61+ 1+.1+5 1+.61+ 0.56
1+ 5.56 1+.1+5 1+.1+5 1+.1+5 1+.1+5 U.67 0.50
5 5.57 1+.1+5 1+.1+5 1+.1+5 1+.82 1+.75 0.1+9
6 5.91+ 1+.51+ 1+.82 1+.82 1+.82 1+.99 0.55
7 5.56 1+.51+ 1+.1+5 1+.82 1+.1+5 1+.76 0.1+7
8 5.56 1+.1+5 1+.1+5 1+.1+5 1+.82 1+.75 0.1+8
9 5.57 1+.1+5 1+.5U 1+.61+ 1+.1+5 1+.71 0.1+8
10 5.56 1+.1+5 1+.5U 1+.82 1+.1+5 1+.76 0.1+7
11 5.56 1+.1+5 1+.1+5 5.91+ 1+.1+5 1+.97 0.72
12 5.91+ 1+.82 1+.82 1+.82 1+.1+5 1+.97 0.56
13 5.91+ 1+.82 1+.1+5 1+.82 I+.82 1+.97 0.56
11+ 1+.82 1+.1+5 1+.82 1+.82 1+.1+5 U.67 0.20
21 I+.82 1+.U5 1+.82 1+.82 1+.1+5 U.67 0.20
28 1+.82 1+.1+5 1+.51+ 1+.82 I+.08 1+.51+ 0.31
35 5.91+ 1+.1+5 1+.1+5 1+.82 I+.82 1+.90 0.61
s.d. = standard deviation.
* = g/1.
APPENDIX TABLE 19.
IgM LEVELS* OP UNCHALLENGED PREVIOUSLY INPECTED SHEEP - GROUP 2.
Days NUMBER OP SHEEP
Post-
Challenge 22 38 39
STATISTICS
376 833 Mean s.d.
0 3.16 3.16 3.16 3.1+6 1+.07 3.1+0 0.395
1 3.16 3.16 3.1+6 3.86 1+.37 3.1+0 0.58
2 2.56 2.86 3.77 3.16 I+.07 3.28 0.63
3 2.56 2.86 3.77 3.16 1+.37 3.31+ 0.73
1+ 2.86 3.16 3.76 3.1+6 1+.37 3.52 0.58
5 2.86 2.26 3.1+6 3.16 1+.97 3.31+ 1.01
6 2.86 2.56 3.1+7 3.16 I+.67 3.3U 0.82
7 2.86 2.86 3.16 3.16 5.27 3.1+6 1.02
8 2.86 3.16 3.1+7 3.77 1+.97 3.65 0.81
9 2.86 3.16 3.77 3.16 1+.97 3.58 0.81+
10 3.16 3.16 3.76 3.1+7 5.27 3.76 0.88
11 2.86 3.1+6 3.76 3.16 1+.97 3.-61+ 0.81
12 2.86 3.16 I+.07 3.16 1+.96 3.61+ O.87
13 3.16 3.1+6 3.76 3.1+6 I+.67 3.70 0.58
lb 2.86 3.1+6 1+.07 3.16 1+.96 3.70 . O.83
21 3.16 3.16 1+.37 3.16 1+.07 3.58 0.59
28 3.16 2.86 U-37 3.1+6 1+.37 3.61+ 0.70






ORE ANTIBODY TITHES OF UNCHALLENGED PREVIOUSLY INFECTED SHEEP -
GROUP 2
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 22 38 39 376 833 Mean s.d.
0 2 2 2 0 2 1.6 0.89
1 2 2 2 0 2 1.6 0.89
2 2 2 2 2 3 2.2 o.i+5
3 2 2 2 2 2 2.0 0.00
b 2 2 2 2 2 2.0 0.00
5 2 2 2 2 2 2.0 0.00
6 2 2 2 2 2 2.0 0.00
7 2 2 2 2 2 2.0 0.00
8 2 2 2 2 2 2.0 0.00
9 2 2 2 2 2 2.0 0.00
10 2 2 2 3 2 2.2 0.1+5
11 2 2 2 2 3 2.2 0.1+5
12 2 2 2 2 2 2.0 0.00
13 2 2 2 2 2 2.0 0.00
lb 2 2 2 2 2 2.0 0.00
21 2 2 2 2 2 2.0 0.00
28 2 2 2 2 2 2.0 0.00
35 2 2 2 2 2 2.0 0.00
s.d. = standard deviation.
= log2.
APPENDIX TABLE 21.
TOTAL SERUM PROTEIN CONTENTS*OP SUSCEPTIBLE SHEEP INPECTEL WITH
ORP VIRUS - GROUP 3
NUMBER OP SHEEP STATISTICS
Post-
Challenge 39 1+0 52 65 67 63 68 Mean s.d.
0 67 68 67 73 71 81 71 71.1 1+.5
1 69 67 70 71 69 73 65 69.3 2.1+
3 58 62 65 73 70 69 66 66.2 1+.7
5 68 69 73 69 65 75 68 69.2 3.2
7 61+ 61+ 65 67 66 67 67 66.7 3.2
8 71 81 71 67 66 71+ 69 90.7 1+.9
9 70 78 70 68 65 69 63 68.7 1+.5
10 70 77 71+ 70 61+ 69 66 70.1+ 1+.2
11 69 73 73 70 63 77 68 70.7 1+.2
12 71 68 71+ 70 61+ 73 71+ 69.6 1+.3
13 71 72 75 77 71 69 69 72.0 3.0
11+ 68 73 72 69 68 68
'
65 69.O 2.7
21 71+ 71+ 81 69 68 71 66 71.9 5.0
28 66 66 71+ 77 69 72 68 70.3 1+.2




ALBUMIN LEVELS' OF SUSCEPTIBLE SHEEP INFECTED WITH ORE VIRUS.-
GROUP 3
NUMBER OP SHEEP STATISTICS
Post-































































































65 67 63 68
STATISTICS
Mean s.d.
0 3.30 4.10 2.70 2.20 3.50 1.60 4.30 3.16 0.93
1 3.40 3.30 2.10 1.40 4.10 2.90 3.90 3.16 0.99
3 4.10 3.70 3.30 4.4o 3.50 3.50 3.90 3.71 0.39
5 U.io 4.io 5.10 2.80 2.60 3.80 3.40 3.91 0.99
6 4.30 3.oo 3.30 3.30 3.30 3.40 4.00 3.62 0.53
7 4.50 3.20 3.60 2.70 4.00 3.70 4.10 3.99 1.02
8 5.70 4.90 3.50 2.10 3.30 2.90 3.80 4.02 1.38
9 2.80 3.io 3.70 2.10 3.80 2.80 3.20 3.50 1.33
10 3.50 3.90 1.50 3.50 3.10 3.40 4.10 3.60 1.19
11 3.50 4.4o 3.00 4.20 3.2 3.10 4.50 3.79 0.65
12 5.oo 4.10 2.20 3.90 3.60 2.20 3.40 3.49 1.01
13 5.oo 3.60 3.60 3.50 4.80 2.70 3.90 3.87 0.79
14 4.io 4.4o 3.20 2.10 3.40 3.50 3.90 3.51 0.75
21 4.4o 3.70 3.70 3.10 3.50 2.90 ro • O 3.34 0.73
28 3.30 3.30 3.70 3.10 3.50 2.90 2.10 3.13 0.52
35 4.io 3.50 3.20 3.70 2.70 3.50 2.00 3.24 0.70




ALPHA2 - GLOBULIN LEVELS*" OF SUSCEPTIBLE SHEEP INFECTED WITH ORF
VIRUS - GROUP 3
?ayf NUMBER OF SHEEP STATISTICSPost-
Challenge 39 1+0 52 65 67 63 68 Mean s.d.
0 9.1+0 12.30 8.00 8.80 8.50 9.70 8.50 9.30 1.33
1 9.60 12.70 7.00 7.80 8.90 8.70 7.80 8.69 1.86
3 12.20 11.20 6.50 9.50 9.80 9.70 8.60 9.60 1.69
5 13.00 13.00 7.30 9.00 9.20 8.30 10.20 9.76 2.17
6 11.00 11.50 5.90 9.30 12.20 10.00 8.70 9.56 1.83
7 11.50 11.60 6.bo 10.80 9.90 8.80 7.60 9.1+0 1.87
8 12.80 15.50 1+.90 12.30 8.50 8.30 7.50 9.89 3.1+0
9 12.70 12.50 6.70 10.50 9.00 8.90 7.30 9.90 2.28
10 10.50 12.1+0 8.00 9.10 7.50 9.30 10.10 9.72 1.59
11 11.80 11.70 7.1+0 8.1+0 8.30 9.50 10.1+0 9.69 1.60
12 12.00 11.60 8.20 •9.30 10.00 9.70 8.90 9.96 1.39
13 12.10 12.20 5.80 7.60 9.50 7.50 9.70 9.20 2.1+1
lb 10.90 10.90 8.10 9.00 8.10 9.90 9.20 9.1+1+ 1.18
21 111. 00 10.30 8.10 10.00 7.60 10.00 8.90 9.81+ 2.10
28 10.50 11.30 7.60 10.00 7.60 10.00 8.90 9.1+1 1.1+3
35 12.30 12.50 7.70 9.60 9.1+0 9.70 9.30 10.10 1.73
s.d. = standard deviation.
= g/l.
APPENDIX TABLE 25.










65 67 63 68
STATISTICS
Mean s.d.
0 U.OO 5.5o U.OO U.Uo 6.1+0 7.30 5.oo 5.11 1.21
1 U.8o U.70 U.20 3.60 6.20 U.Uo 3.90 U-50 0.79
3 5.20 6.20 5.20 5.10 1+.90 U.90 5.90 5-U2 0.52
5 5.50 U.80 5.10 5.50 1+.60 6.00 3.U0 U.86 0.86
6 1+.30 1+.20 U.60 U.70 i+.oo 5.U0 3.U0 U.37 0.58
7 5.8o 3.20 U.30 5.1+0 1+.60 3.70 U.io U.U7 0.85
8 7.10 7.30 U. 20 3.1+0 3.90 U.io 3.80 U.89 1.53
9 U.90 6.30 3.70 3.50 3.80 3-Uo 3.30 U.16 1.02
10 5.60 6.20 U.UO 5.60 5.00 3.io 5.20 U.75 1.20
11 U.90 5.80 U.UO 1+.90 1+.50 3.70 5.5o U.52
'
l.OU
12 U.90 U.io 5.20 6.20 7.80 3.30 6.20 5.39 1.50
13 5.oo 5.70 5.00 5.50 7.50 3-Uo 5.8o 5.U1 1.22
lk U.8 2.90 U.80 2.80 5.1+0 U. 20 U.60 U. 21 1.00
21 l.ko 3.70 U.80 1+.60 1+.90 2.90 5.5o U.83 1.U2
28 U.oo 3.30 U.Uo 1+.60 U.90 2.90 5.50 U.23 0.91
35 U.80 1+.20 1+.50 6.70 5.U0 U.60 U.oo U.89 0.92




GAMMAGLOBULIN LEVELS OP SUSCEPTIBLE SHEEP INFECTED WITH ORF VIRUS -
GROUP 3
Days NUMBER OP SHEEP STATISTICS
Post-
Challenge 39 UO 52 65 67 63 68 Mean s.d.
0 15.U 13.7 26. k 23.5 16.3 27.9 21+. 2 21.0 5.7
1 13.7 13.1+ 28.5 20.7 17.2 25.0 19.6 19.7 5.6
3 10.5 11+.1+ 26.2 18.3 16.1 23.6 27.0 19.1+ 6.3
5 13.7 16.5 31.6 16.6 16.1+ 25.6 23.5 20.6 6.5
6 12.2 13.9 N.D. N.D. N.D. 25.6 32.1 20.9 9.5
7 li+.l 16.1 26.2 20.7 15.9 31+.6 23.1+ 21.6 7.2
8 17.0 18.7 28.2 20.9 17.2 N.D. N.D. 20.1+ 1+.6
9 16.2 17.2 30.8 20.5 16.1+ 31.6 18.2 21.6 6.7
10 15.3 19.3 32.6 21.7 15.1+ 32.3 19.9 22.1+ 7.3
11 ll+» 6 16.8 31.9 23.8 16.3 30.5 21+.3 22.3 8.0
12 16.3 16.1+ 31.7 23.1 16.0 33.6 23-7 22.0 7.1+
13 15.0 15.1 36.6 25.5 18.5 32.6 21.9 22.6 8.5
11+ 11+. 9 15.3 3U.6 23.6 17.7 31.1+ 22.0 22.0 7.7
21 13.2 16.2 32.0 21+. 9 16.9 33.9 20.1+ 22.5 8.0
28 17.1 16.6 28.8 27.8 15.2 28.7 19.8 22.0 6.2








IgG1 LEVELS* OP SUSCEPTIBLE SHEEP INFECTED WITH ORF VIRUS - GROUP 3.
NUMBER OP SHEEP STATISTICS
Post-
Challenge 39 1+0 52 65 67 63 68 Mean s.d.
0 5.1 i+.o 12 .0 8.2 11+.0 21.0 17.1+ 11.7 6.3
1 6.2 9.6 12.8 8.2 13.9 21.0 19.7 11.9 9.6
3 1+.6 6.7 12.8 9.0 13.9 22.7 16.6 12.3 6.2
5 9.7 7.3 12.8 8.2 13.9 17.2 ' 19.7 11.9 1+.1+
6 6.2 8.1+ N.D. N.D. N.D. 20.1 13.9 12.2 6.2
7 8.0 7.3 12.8 9.7 13.9 20.1 19.7 12.1+ 1+.9
8 11.2 6.7 13.9 10.9 13.1+
'
N.D. N.D. 11.1 2.8
9 10.0 7.3 13.9 9.7 19.7 21.0 19.6 13.3 1+.6
10 12. 1+ 7.1 12.8 9.7 19.7 29.1+ 19.6 ll+.l 9.8
11 7.8 7.3 16.6 9.7 19.7 29.2 19.7 ll+.O 6.3
12 6.7 7.8 11.3 8.2 11+.9 22.8 16.6 12.6 9.8
13 7.8 10.1+ 11.3 9.00 19.7 20.1 19.6 12.8 1+.1+
11+ 8.9 8.7 12.0 11.3 19.7 19.2 17.1+ 13.3 1+.2
21 8.1+ 9.0 12.8 11.3 19.6 21.0 19.7 13.1+ 1+.1+
28 9-9 9.0 12.8 11.3 13.0 17.1+ 19.7 12.7 3.1








IgG2 LEVELS* OP SUSCEPTIBLE SHEEP INFECTED WITH ORF VIRUS - GROUP 3,
?ayf NUMBER OF SHEEP STATISTICSPost-
Challenge 39 1+0 52 65 67 63 68 Mean s.d.
0 2.5 l.U 6.1 3.1+ U.l 7.5 5.1 U.U 2.0
1 2.5 l.k 6.6 2.0 U.l 7.8 5.1 U.3 2.2
3 1.9 2.5 7.8 3.9 U.U 8.2 5.1 U.6 2.1
5 3.0 2.5 1+.8 3.0 u.u 7.8 5.U U.6 1.7
6 3.0 3.0 N.D. N.D. N.D. 7.8 5.U U.8 2.3
7 2.5 3.0 6.6 3.U U.U 7.8 5.U U.6 1.8
8 2.5 2.5 6.1 3.9 u.u N.D. N.D. U.O l.U
9 2.5 U.o 7.5 U.3 U.7 7.8 5.8 5.1 1.8
10 1.9 3.6 6.6 U.3 U.7 8.2 5.8 5.0 1.9
11 3.0 3.5 5.7 U.3 U.7 9.6 5.U 5.0 2.1
12 3.5 3.5 6.6 3.9 U.7 8.2 5.8 U.8 1.9
13 3.5 3.5 6.6 U.3 U.U 8.5 6.1 U.9 2.0
111 3.5 3.5 6.6 3.0 u.u 8.9 6.5 5.2 2.2
21 3.0 1+.0 5.7 5.2 U.7 7.8 6.1 5.1 1.5
28 3.0 3.5 5.7 3.8 U.U 8.7 5.8 5.0 2.0








igM LEVELS' OP SUSCEPTIBLE SHEEP INFECTED WITH ORE VIRUS - GROUP 3
Jayf NUMBER OP SHEEP STATISTICSPost
Challenge 39 l+O 52 65 67 63 68 Mean -s.d.
0 2.6 3.3 3.1' 1.6 1+.2 1+.0 l+.o 3.3 0.93
1 2.6 2.8 2.7 1.6 3.7 1+.5 1+.2 3.2 1.0
3 1.6 1.6 2.1+ 2.0 3.9 l+.o 1+.2 2.8 1.2
5 2.6 2.3 2.2 1.8 1+.5 1+.2 1+.2 3.1 1.1
6 1.9 2.6 N.D. N.D. N.D. 1+.7 l+.o 3.3 . 1.3
7 2.3 2.1 1.8 2.0 1+.5 1+.2 1+.2 3.0 1.2
8 2.1 2.8 1.8 1.8 1+.2 N.D. N.D. 2.6 0.9
9 1.6 2.8 1.3 1.8 5.6 1+.0 1+.2 3.0 1.5
10 2.6 2.9 1.8 2.1+ 5.0 1+.0 3.7 3.2 1.0
11 2.1 2.8 1.6 1.8 1+.2 l+.o l+.o 2.9 1.1
12 2.3 2.6 1.8 2.2 1+.6 1+.0 1+.2 3.2 1.0
13 2.6 1.1+ 2.7 1.1+ 1+.5 l+.o 1+.2 3.0 1.2
11+ 2.8 2.3 1.8 2.7 1+.2 l+.o 1+.6 3.2 1.1
21 2.3 2.3 2.0 1.8 5.0 l+.o l+.o 3.1 1.3
28 2.1 2.3 2.7 2.0 1+.6 l+.o l+.o 3.2 1.2








ORE ANTIBODY TITRES*OE SUSCEPTIBLE SHEEP INFECTED WITH ORE VIRUS
GROUP 3
NUMBER OP SHEEP STATISTICS
Post-
Challenge 39 1*0 52 65 67 63 68 Mean s.d.
0 2 2 2 0 0 0 0 0.86 1.07
1 2 2 2 0 0 0 0 0.86 1.07
3 2 2 2 0 0 0 0 0.86 1.07
5
.
2 2 2 0 0 0 0 0.86 1.07
6 2 2 N.D. N.D. N.D. 0 2 1.50 1.00
7 2 2 2 0 0 0 2 1.11+ 1.07
8 2 2 2 2 0 N.D. N.D. 1.60 O.89
9 2 2 2 3 0 0 2 1.57 1.13
10 3 2 2 3 0 0 2 1.71 1.25
11 3 3 3 2 2 2 3 2.57 0.53
12 3 3 3 3 2 2 3 2.71 0.1+8
13 3 3 3 3 2 2 3 2.71 0.1+8
11+ b 3 3 2 2 2 3 2.71 0.76
21 b 3 2 3 2 2 2 2.57 0.79
28 b 1+ 2 1+ 2 2 2 2.86 1.07








MIGRATION INDICES OE LEUCOCYTES FROM UNTREATED SUSCEPTIBLE SHEEP
INFECTED WITH ORF VIRUS - GROUP 3.
Dayf NUMBER OF SHEEPpost-
Challenge 39 1+0 52 . 65 67 63 68- Mean s.d.
1+8 hrs. 93.1+ 89.7 100.7 9l+.0 80.5 90.0 10.20 91+ 7.0
0 100.0 90.3 101.0 _ - 98 5.0
2 87.9 122.0 120.9 55.1 l+l+.l 56.6 56.2 87 1+1.0
9 - - 73.3 13.2 50.5 91.1 53.1+ 62 29.0
8 128.0 80.8 90.5 60.0 1+5.2 75.6 91+.0 80 25.0
10 - - - 17-.7 72.3 - - 1+5 39.0
11+ 70.0 75.8 75.1 76.1+ 68.1+ 55.0 1+8.0 67 11.0
21 83.3 55.0 86.9 61 JO 92.0 22.0 36.0 62 27.0
28 56.8 79.0 101.0 61.0 76.O - 75 17.0
35 83.6 71+.3 — 59.5 61+.0 1+7.0 37.0 61 17.0
APPENDIXTABLE32.












































































































































































MIGRATION INDICES OF LEUCOCYTES FROM PREVIOUSLY INFECTED SHEEP NOT
CHALLENGED - GROUP 5.
Days
Post-
Llenge 779 740 775 877 82 69 84 51 32 34 Mean s. d.
0 100 80 75 53 43 59 84 74 52 44 66.4 19.0
2 97 71 88 - - - - - - - 81.7 13.0
4 92 78 72 86 - - - - - - 82.0 9.0
5 87 71 - - - - - - 63 65 71.5 11.0
10 97 73 69 72 41 55 89 57 - - 69.3 18.0
15 83 82 - - 69 59 83 73 56 76 72.6 11.0
20 - - - - 61 61 72 55 67 84 66.7 10.0
42 - - - - 94 86 81 79 - - 85.0 6.7
63 _ __ 83 76 95 77 91 64 81.0 11.0
- = NOT DONE
s.d.= STANDARD DEVIATION.
APPENDIXTABLE31;.





















































































































TOTAL SERUM PROTEIN CONTENTS OP SUSCEPTIBLE SHEEP - TREATED WITH
CORTICOSTEROID BEPORE BEING INPECTSD WITH ORP VIRUS - GROUP 12.
Days
Post-
Challenge 37 38 36 51 66 69 32 61+ Mean s.d.
0 67 68 68 68 69 72 69 71 69.0 1.7
1 70 67 68- 68 69 69 68 69 68.5 0.9
3 66 60 71 70 63 82 60 62 66.7 7.5
5 69 69 66 70 62 67 67 65 66.1 2.9
7 68 63 67 65 63 67 62 67 65.3 2.3
8 67 6k 66 71 61+ 66 67 69 67.1 2.1
9 77 73 66 67 65 65 66 65 68.0 1+.5
10 79 76 65 75 62 67 69 71 70.5 5.8
n 79 77 68 68 61+ 71 68 66 70.1 5.3
12 77 77 67 68 67 66 66 68 69.5 1+.7
13 75 73 63 70 65 73 68 65 69.O 1+.1+
lb 76 70 61 69 67 71 61+ 63 67.6 1+.9
21 75 71 69 77 69 71 66 68 70.7 3.6
28 72 72 69 79 70 67 71+ 65 71.0 1+.3
35 77 68 71 76 68 68 65 66 69.9 1+.1+
s.d. = standard deviation.
* = g/1.
APPENDIX TABLE 1+2.
ALBUMIN LEVELS" OF SUSCEPTIBLE SHEEP TREATED WITH CORTICOSTEROID
BEFORE BEING INFECTED WITH ORF VIRUS - GROUP 12
Days NUMBER OF SHEEP STATISTICS
Post-





































































ALPHA1 - GLOBULIN LEVELS OF SUSCEPTIBLE SHEEP TREATED WITH































































































































































































ALPHA2 - GLOBULIN LEVELS OF SUSCEPTIBLE SHEEP TREATED WITH
























































































































































s.d.. = standard deviation.
* = g/l.
APPENDIX TABLE 2+6.
BETA-GLOBULIN LEVELS OE SUSCEPTIBLE SHEEP TREATED WITH CORTICOSTEROID
























































































































































































s.d. = standard deviation.
APPENDIX TABLE 1+6.
*
GAMMAGLOBULIN LEVELS OF SUSCEFTIBLE SHEEP TREATED WITH CORTICOSTEROID
BEFORE BEING INFECTED WITH ORE VIRUS - GROUP 12.
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 37 38 36 51 66 69 32 61+ Mean s.d.
0 11+. 7 12.9 19.0 23.1 19.2 20.1 19.1+ 19.8 18.5 3.2
1 16.8 12.0 19.1 23.1 20.6 15.2 19.6 17.9 18.0 3.1+
3 15.7 11.9 21.3 21+.5 19.5 21+. 7 17.5 18.5 19.2 1+.3
5 17.3 11+.1+ 20.5 21+.5 18.5 19.8 11+.9 20.1 18.8 3.3
6 16.3 11+. 9 N.D. N.D. N.D. N.D. 21+. 3 19.6 18.8 1+.2
7 11+. 9 16.5 20.2 22.2 18.8 18.0 16.8 19.3 18.3 2.3
8 16.0 12.9 18.6 21+. 1 20.0 15.3 N.D. N.D. 17.8 i+.O
9 16.9 16.0 18.5 21.6 19.1+ 15.0 16.8 19.6 18.0 2.2
10 15.9 17.1+ 18.3 27.0 20.9 15.3 20.8 21.1+ 19.6 3.8
11 16.5 16.1 17.7 23.2 19.1 17.7 22.3 20.1+ 19.1 2.6
12 17.6 16.9 16.0 21+.6 25.3 17.2 19.7 19.8 19.6 3.5
13 17.1 15.3 15.2 23.1 21.6 16.1 19.1 19.6 18.1+ 3.0
11+ 17.5 15.1+ 11+. 8 2U.3 22.2 15.0 17.9 18.8 18.2 3.5
21 18.0 15.6 22.2 15.5 22.2 19.2 17.8 19.1 18.7 2.6
28 21.5 17.9 20.2 28.8 25.8 16.8 16.3 16.2 20.1+ 1+.7








IgG1 LEVELS OP SUSCEPTIBLE SHEEP TREATED WITH CORTICOSTEROID
BEFORE BEING INFECTED WITH ORF VIRUS - GROUP 12.
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 37 38 36 51 66 69 32 61+ Mean s.d.
0 8.1+ 3.5 10.5 11.3 6.7 15.6 17.1+ 16.6 11.25 5.0
1 10.6 1+.6 11.3 9.0 5-2 15.0 15.7 13.5 10.6 1+.2
3 10.0 1+.6 10.5 9.7 7.1+ 15.7 16.6 12.7 10.9 l+.o
5 9-5 1+.6 12.8 11.3 6.7 13.0 15.7 12.7 10.8 3.7
6 9.5 1+.6 N.D. N.D. N.D. N.D. 15.7 12.7 10.6 1+.7
7 9.5 5.1 9.7 9.7 6.7 15.7 15.7 11+.3 10.8 l+.o
8 '6.1 7.8 9.0 10.5 9.0 15.6 15.6 12.7 10.9 3.1+
9 7.3 7.3 6.7 11.3 7.1+ 15.7 15.7 13.5 10.6 3.9
10 8.9 5.1 7.5 11.3 9.0 16.6 16.6 12.7 11.0 1+.2
11 10.6 10.0 . 8.2 10.5 8.0 15.7 15.7 12.7 11.1+ 3.0
12 5.6 7.3 8.3 11.3 9.0 15.7 15.7 12.7 10.7 3.8
13 5.1 6.7 8.2 11.3 8.2 15.6 15.7 12.7 10.1+ l+.o
11+ 7.3 8.1+ 8.2 11.3 6.7 16.6 15.7 12.7 10.85 3.8
21 1+.6 7.8 8.2 12.8 12.8 16.6 15.6 13.5 11.5 1+.2
28 8.9 8.9 8.2 10.1+ 11.3 15.6 13.9 13.5 11.3 2.7








IgG2 LEVELS' OP SUSCEPTIBLE SHEEP TREATED WITH CORTICOSTEROID
BEFORE BEING INFECTED WITH ORF VIRUS - GROUP 12.
NUMBER OF SHEEP STATISTICSDays
Post-
Challenge 37 38 36 51 66 69 32 61+ Mean s.d.
0 o.b 0.9 2.5 2.0 1+.3 1+.1+ 6.5 1+.1+ 3.2 2.1
1 0.9 1.1+ 3.0 2.0 3.8 1+.1+ 6.1 1+.1+ 3.3 1.8
3 1.1+ 0.9 2.9 1.6 3.1+ 1+.1+ 5.8 1+.1+ 3.1 1.7
5 1.1+ 1.1+ 2.9 2.0 3.1+ 1+.1+ 6.1 1+.1+ 3.3 1.7
6 1.1+ 1.1+ N.D. N.D. N.D. N.D. 6.1 1+.8 3.1+ 2.1+
7 1.1+ 2.5 2.9 2.5 3.8 1+.7 6.1 1+.8 3.6 1.5
8 1.9 2.5 2.9 2.8 2.9 1+.7 N.D. N.D. 3.0 0.9
9 1.9 2.5 2.5 2.5 2.9 1+.7 6.5 5.2 3.6 1.7
10 1.1+ 2.5 2.9 2.0 2.9 1+.7 6.8 5.0 3.5 1.8
11 2.5 3.0 2.9 2.0 3.8 1+.7 6.5 1+.8 3.8 1.5
12 2.3 3.0 1.6 2.5 1+.8 5.1 6.8 5.2 3.9 1.8
13 2.5 3.0 2.0 2.5 2.5 5.1 7.1 1+.8 3.7 1.8
11+ 3.0 3.0 2.9 2.6 2.9 5.1 6.8 5.2 3.9 1.6
21 3.5 2.5 1+.8 3.1+ 6.6 5.1 6.8 1+.8 1+.7 1.5
28 3.0 3.5 7-5 3.5 1+.3 5.1 7.5 5.6 5.0 1.8









Igpl LEVELS OF SUSCEPTIBLE SHEEP TREATED WITH CORTICOSTEROID BEFORE
BEING INFECTED WITH ORF VIRUS - GROUP 12
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 37 38 36 $1 66 69 32 6U Mean s.d.
0 1.2 2.6 2.7 2.U 2.0 U.o U.7 3.6 2.9 1.1
1 l.U 1.6 2.7 1.2 2.U U.o 5.0 3.9 2.8 l.U
3 i.b 1.9 1.6 l.U 2.2 U.o 5.0 3.6 2.6 l.U
5 l.b 1.9 l.U 1.8 l.u U.2 u.7 3.9 2.6 l.U
6 1.2 1.9 N.D. N.D. N.D. N.D. 5.7 3.6 3.1 2.0
7 0.9 2.3 l.U 2.0 2.7 U.o 3.7 3.9 2.6 1.2
8 0.9 2.3 2.7 2.2 2.U 3.7 N.D. N.D. 2.U 0.9
9 1.6 2.8 2.9 2.0 2.7 U.o 3.7 U.2 3.0 0.9
10 l.U 1.9 3.2 2.0 2.7 U.2 U.O 5.1 3.1 1.3
11 l.b 2.8 2.U 1.6 2.0 3.7 U.o 5.U 2.9 l.u
12 1.5 1.9 2.7 2.0 2.8 U.2 U.2 U.U 3.0 1.2
13 l.U 1.6 2.7 2.0 2.8 U.2 U.o U.U 2.9 1.2
lb l.U 1.9 1.2 1.8 2.8 U.2 5.6 U.7 2.95 1.7
21 1.6 2.3 1.6 1.8 2.8 U.2 U.6 U.5 2.9 1.3
28 1.6 2.1 2.9 1.8 2.8 U.o U.5 5.1 3.1 1.3








ORE ANTIBODY TITHES OF SUCEPTIBLE SHEEP TREATED WITH CORTICOSTEROID









51 66 69 32 61+
STATISTICS
Mean s.d.
0 0 2 2 0 0 2 0 0 0.75 1.03
1 0 2 2 0 0 2 0 0 0.75 1.03
3 0 2 2 0 0 2 0 0 0.75 1.03
5 0 2 0 0 0 0 0 0 0.25 0.71
6 2 2 Nr.D. N.D. N.D. N.D. 0 2 1.50 l.OC
7 2 2 2 2 0 2 0 2 1.50 0.93
8 2 2 2 2 0 2 N.D. N.D. 1.67 0.82
9 2 2 2 0 2 2 2 2 1.75 0.71
10 2 2 2 2 2 2 2 2 2.0 0.00
11 2 3 3 3 0 3 3 3 2.12 0.99
12 2 3 3 3 0 2 2 2 2.12 0.99
13 2 2 2 2 0 3 2 2 1.87 O.83
11+ 2 2 2 2 0 3 2 2 1.87 0.83
21 3 2 2 3 2 3 2 2 2.37 0.52
28 3 2 2 3 3 3 2 2 2.50 0.53
35 1+ 2 2 3 3 3 2 2 2.62 0.7U
s.d. = standard deviation.





TOTAL SERUM PROTEIN CONTENTS OP PREVIOUSLY INPECTED SHEEP TREATED
WITH CORTICOSTEROID BEFORE BEING CHALLENGED 'WITH ORP VIRUS -
GROUP 13.
rNUMBER OP SHEEP STATISTICS
Post-
Challenge 836 775 777 882 936 91+3 9U5 927 Mean s.d.
0 81+ 71 77 71 83 70 70 66 71+.0 6.6
1 73 69 73 61+ 73 69 69 62 69.0 1+.2
2 76 79 69 66 73 65 70 62 70.0 5.8
1+ 80 69 65 69 70 66 63 66 68.5 5.2
6 69 61+ 69 67 61+ 61+ 68 63 66.0 2.5
8 71+ 66 61+ 69 71 66 61+ 67 67.6 3.5
9 68 67 69 71 68 67 61+ 67 67.6 2.0
10 71 N.D. N.D. 69 68 67 N.D. 61+ 67.8 2.6
11 70 69 65 67 66 73 61+ 61+ 67.2 3.2
12 71+ 70 66 70 71 70 61+ 67 69.0 3.2
13 71 N.D. 61+ 72 71 70 62 69 68.1+ 3.9
11+ 71 70 70 76 71 70 65 69 70.2 3.0
21 69 61+ 71 69 70 69 66 69 68.1+ 2.3
28 71 69 67 68 61+ 76 67 61+ 68.2 3.9










ALBUMIN LEVELS OP PREVIOUSLY INFECTED SHEEP TREATED WITH CORTICOSTEROID
BEFORE BEING CHALLENGED WITH ORF VIRUS - GROUP 13.
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 836 775 777 882 936 9U3 9U5 927 Mean s.d.
0 38.60 30.00 Ul.60 ■ i|l.00 37.20 3U.30 31.50 31+.90 36.10 i|.22
1 30.30 25.1|0 i|2.20 30.90 3k.20 32.20 29.50 30.80 33.90 U-8i|
2 37.00 37-20 38.I|0 30.90 i|0.00 28.00 39.90 33.90 35.60 ii.36
il ill.50 ill.80 35.90 33.60 29.1|0 37.90 35.30 30.30 35.70 i|.62
6 37.80 25.50 31.70 31.60 33.50 31.90 28.i|0 30.20 33.30 3.60
8 3i|.90 35.20 31.90 32.20 36.70 30.60 26.80 30.20 32.30 3.21
9 31.90 3b.90 39.30 31.10 32.60 31.60 29.30 32.30 32.90 3.03
10 37.80 N.D. N.D. 32.90 32.90 30.90 N.D. 28.30 3U.60 3.i|8
11 37.10 32.90 35.80 3U.90 29.90 36.i|0 29.30 3U.10 33.80 2.91
12 37.10 32.20 35.20 36.i|0 32.10 36.i|0 32.50 28.90 33.80 2.87
13 3k.30 N.D. 33.80 33.20 30.70 38.50 29.60 31.60 33.10 2.93
iii 35.00 29.iiO 35.00 35.10 30.00 37.80 31.20 30.20 32.96 3.13
21 36.U0 30.30 35.i|0 37.00 30.10 37.00 32.90 iii.20 35.00 3.78
28 31.1+0 3U.30 38.30 37.50 26.80 39.80 3U.90 39.90 35.UO ii.53
35 31.60 31.60 36.80 3U.10 28.00 36.80 26.10 36.60 32.70 i|. 12
s.d. = standard deviation.





ALPHA1-GLOBIJLIN LEVELS OP PREVIOUSLY INPECTED SHEEP TREATED WITH





777 882 936 91+3 91+5
STATISTICS
927 Mean s.d.
0 5.00 I+.30 1+.60 3.50 6.60 1+.90 5.60 3.30 1+.72 l.Of
1 3.60 1+.80 3.60 3.90 6.60 U.10 6.20 3.70 1+.56 1.2C
2 6.00 6.30 2.10 3.90 3.60 5.90 3.50 3.70 1+.37 1.5:
U 6.80 3.1+0 0.60 3.1+0 5.60 2.00 2.50 5.30 3-70 2.0'
6 2.70 3.80 1+.10 i+.OO 3.90 2.50 6.80 3.80 3.95 1.3<
8 3.70 1+.70 1+.50 3.bO 2.70 1+.70 7.60 6.00 1+.66 1.5!
9 l+.io l+.oo 3.1+0 3.50 3.1+0 i+.oo 5.10 5.1+0 l+.ll 0.7<
10 3.60 N.D. N.D. 3.1+0 i+.io 5.1+0 N.D. 3.20 3.91+ 0.8!
11 3.5o 3.1+0 3.20 2.70 I+.70 3.60 1+.50 3.20 1+.60 0.6!
12 3.00 5.60 i+.oo 3.50 5.00 1+.20 1+.50 1+.70 1+.31 0.8;
13 3.60 N.D. 3.80 3.60 5.00 1+.90 1+.90 1+.10 1+.27 0.61
lb 3.60 1+.90 1+.20 3.10 5.70 1+.20 5.20 i+.io 1+.37 0.8;
21 3.U0 3.90 2.80 1.1+0 7.00 2.10 1+.60 2.10 l+.l+l 1.7!
28 5.00 3.U0 3.1+0 2.00 6.14.0 1.50 1+.70 1.30 1+.1+6 1.8:
35 5.1+0 1+.60 2.90 1.30 6.50 2.60 1+.80 2.50 3.83 i.7<
s.d. = standard deviation.
N.D. = Not Done.
* = g/l.
APPENDIX TABLE 51+.
ALPHA -GLOBULIN LEVELS*" OP PREVIOUSLY INFECTED SHEEP TREATED WITH
2
CORTICOSTEROID BEFORE BEING CHALLENGED WITH ORF VIRUS - GROUP 13.
Days NUMBER OF SHEEP STATISTICS
Post-
















10.00 11.30 11.60 8.1+0
8.70 9.70 9.30 6.90
7.30 9.90 7.30 9.10
7.20 9-60 8.1+0 5.30
11.00 10.10 7.10 7.00
9.60 9.60 6.80 8.00
8.30 11.30 8.20 7.1+0
N.D. 11.00 8.00 6.70
7.80 8.10 8.60 8.00
8.60 11.20 9.30 7.00
8.30 10.80 10.70 9.10
9.80 10.70 9.10 9.10
8.30 11.70 9.60 8.20
8.10 10.20 9.60 7.60
11.00 11.1+0 9.10 7.20
9.80 8.60 10.25 1.26
11.00 8.60 9.63 1.57
9.80 8.60 8.95 1.10
8.80 9.90 9.1+0 1.53
9.30 10.10 8.99 1.70
8.90 9.1+0 9.1+3 l.ll
8.90 8.70 8.96 1.16
N.D. 9.70 8.91+ 1.65
9.30 9.00 9.5U .0.58
7.60 10.80 9.1+1 1.61
7.1+0 10.30 9.51 1.29
8.50 9.60 9.1+9 0.65
8.60 8.20 9.09 1.15
8.70 7.70 9.11 1.33









BETA-GLOBULIN LEVELS OP PREVIOUSLY INFECTED SHEEP TREATED WITH CORTI¬
COSTEROID BEFORE BEING CHALLENGED WITH ORF VIRUS - GROUP 13.
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 836 775 777 882 936 91+3 9U5 927 Mean s.a.
0 7.60 5.70 3.90 1+.90 l+.io 1+.90 6.30 2.60 5.00 1.55
1 5.80 I+.80 5.10 5.80 3.60 1+.80 6.90 U.90 5.20 0.97
2 6.80 6.30 1+.80 3.90 2.90 5.20 1+.20 1.20 5.1+1 1.81
1+ 7.20 2.70 1+.60 1+.10 1+.90 i+.OO 5.00 3.80 1+.51+ 1.30
6 5.50 11.1+0 6.20 1+.00 2.60 3.20 6.80 2.70 5.30 2.9I+
8 6.70 5.30 5.10 1+.80 3-1+0 3.30 5.10 l+.oo 1+.71 1.12
9 6.10 5.1+0 1+.80 1+.90 5-UO 1+.70 5.70 3.20 5.02 0.88
10 5.00 N.D. N.D. 5.50 l+.io 5.1+0 N.D. 3.90 1+.78 0.71+
11 1+.90 6.90 6.50 1+.00 i+.OO l+.l+o 5.10 3.1+0 1+.90 1.21+
12 6.70 7.00 6.70 8.1+0 3.60 1+.90 1+.50 l+.io 5.71+ 1.69
13 5.00 N.D. 5.10 5.00 2.90 1+.90 1+.90 3.1+0 1+.1+6 0.91
11+ 5.70 8.1+0 6.30 7.60 1+.30 5.60 1+.60 1+.10 5.83 1.55
21 5.50 1+.50 7.10 l+.io 3.50 1+.80 5.1+0 2.70 1+.70 1.35
28 7.80 6.90 i+.oo 3.1+0 1+.50 1+.50 1+.70 2.60 1+.80 1.73










GAMMAGLOBULIN LEVELS OP PREVIOUSLY INPECTED SHEEP TREATED WITH CORTI¬
COSTEROID BEFORE BEING CHALLENGED WITH ORF VIRUS - GROUP 13.
Days NUMBER OP SHEEP STATISTICS
Post-
Challenge 836 775 777 882 936 9b3 91+5 927 Mean s.d.
0 21.8 20.0 16.9 19.1 23.1 17.5 16.8 16.5 19.0 2.5
1 21.8 22.0 13.1 11+.2 18.9 20.6 15.1 13.6 n.b 3.8
2 16.6 19.0 15.8 17.1 18.9 16.9 12.6 11+. 2 16.1+ 2.2
b 16.9 12.3 17.0 17.8 18.2 17.3 11.1+ 17.1 16.0 2.6
6 15.8 114.7 15.8 17.8 n.b 19.1 16.2 16.1+ 16.7 l.b
8 18.6 13.3 12.7 18.5 18.3 20.0 15.3 17.5 16.8 2.7
9 17.7 13.U 13.1 19.8 18.3 19.5 lb. 7 17.5 16.8 2.7
10 15.7 13.0 N.D. 15.8 19.2 18.8 N.D. 18.0 16.8 2.1+
11 16.1 16.5 11.7 17.5 20.0 20.1+ 15.3 11+.2 16.5 2.9
12 17.8 ll+.O 12.0 17.5 21.1+ 17.5 lb. 7 18.8 16.7 3.0
13 18.6 15.0 12.7 18.7 20.7 12.6 11+.8 19.3 16.6 3.2
lb 17.9 17.5 1U.7 22.1 22.1 16.1 15.6 20.6 18.3 2.9
21 18. k 16.7 17.0 19. b 18.9 16.5 11+.5 19-1+ 17.6 1.7
28 18.7 1U.1+ 18.1+ 15.0 16.6 18.1 ll+.l 19.2 16.8 2.1
35 15.5 1U.5 16.9 13.3 N.D. I6.5 N.D. 19.6 16.9 2.1
s.d. = standard deviation.




IgG LEVELS OP PREVIOUSLY INPECTED SHEEP TREATED WITH CORTICOSTEROID
BEPORE BEING CHALLENGED WITH ORP VIRUS - GROUP 13.
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 836 775 777 882 936 91+3 91+5 927 Mean s.d.
0 11.7 12.3 13.8 11.6 13.0 12.0 11.8 12.1+ 12.3 0.7
1 7.6 9.6 13.6 12.7 8.1; 9.9 12.0 12.1+ 10.8 2.2
2 7.6 10.8 9.0 8.5 10.6 10.9 11.1+ 11.8 10.1 1.5
1+ 6.7 7.3 7.9 13.9 10.6 7.9 11.1+ 8.6 9.3 2.5
6 11.7 10.8 13.1 13.8 9.5 6.9 12.3 12.1 10.5 2.2-
8 12.8 10.3 10.1 7.5 8.1+ 10.9 12.0 11.9 10.5 1.8
9 13.1+ 9.6 12.2 10.5 12.7 10.2 12.1 12.1+ 11.0 1.3
10 13.9 8.5 N.D. 12.7 8.1+ 8.9 N.D. 11.2 10.6 2.1+
11 8.6 8.5 11+.6 10.5 7.3 10.3 12.1 11.8 10.5 2.1+
12 7.3 8.5 13.1 11.2 16.9 8.5 9.0 11.2 10.7. 3.1
13 13.1 9.0 12.1+ H.5 15.6 10.2 12.1+ 12.5 12.1 2.0
11+ 7.3 13.0 11+.9 11.6 11+.5 10.8 12.9 12.1 12.1 2.1+
21 11+. 7 13.1+ 12.9 11.61 13.1 13.6 12.1 11.8 12.9 1.0
28 16.3 12.9 11+.9 11.7 11+.1+ 13.6 9.0 12.1 13.1 2.2









IgG2LEVELS~OP PREVIOUSLY INEECTED SHEEP TREATED WITH CORTICOSTEROID
BEFORE BEING CHALLENGED WITH ORF VIRUS - GROUP 13
Days NUMBER OF SHEEP STATISTICS
Bost-
Challenge 836 775 777 882 936 91+3 91+5 927 Mean s.d,
0 1.1+ 3.5 5.0 6.3 1.7 2.2 3.8 1.6 3.2 1.8
1 1.1+ 2.7 5.6 7.2 1.7 2.2 1+.3 2.0 3.1+ 2.1
2 1.1+ 3.7 5.0 8.2 1.7 1.8 3.2 1.6 3.1+ 2.1+
1+ 1.1+ 3.1 5.6 7.9 2.2 2.2 1+.3 2.1+ 3.6 2.2
6 1.9 3.1 7.7 9.7 2.2 1.8 1+.3 2.1+ l+.l 3.0
8 1.9 3.5 5.6 8.7 3.3 1.5 A+.3 2.0 3.8 2.1+
9 2.3 3.1 6.3 8.7 1+.1+ 1.8 1+.8 1.6 l+.l 2.5
10 1.1+ 3.1 N.D. 8.2 3.3 1.5 N.D. 1.6 3.2 2.6
11 1.1+ 3.5 6.3 8.7 2.7 1.8 3.7 2.1+ 3.8 2.5
12 1.9 3.1+ 7.7 7.7 2.7 1.8 1+.8 2.0 . l+.o 2.5
13 1.9 3.5 6.3 9.2 2.2 2.2 5.3 2.0 l+.l 2.6
11+ 1.1+ 3.9 6.0 9.2 1.7 2.2 5.0 2.0 3.9 2.7
21 1.8 3.9 5.9 7.7 3.3 2.6 3.8 2.0 3.9 2.0
28 1.8 3.1 6.3 9.7 3.3 2.2 3.8 2.0 l+.o 2.1+








IgM LEVELS OF PREVIOUSLY INFECTED SHEEP TREATED WITH CORTICOSTEROID
BEFORE BEING CHALLENGED WITH ORF VIRUS - GROUP 13
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 836 775 777 882 936 9U3 9U5 927 Mean s.d.
0 6.5 5.9 U.3 3.2 3-9 3.1 U.2 2.1 U.2 1.5
1 5.6 U.U 3.8 3.2 3.3 3.1 3.3 2.U 3.6 1.0
2 U.2 5.9 3.0 3.2 3.9 2.7 3.3 3.8 3.6 1.1
U 1+.7 3.9 3.0 5-2 3.9 2.3 3.3 2.1 3.6 1.1
6 1+.7 5.U 3.8 U.6 2.9 2.9 U.U 2.U 3.8 1.2
8 5.6 6.5 3.U 6.7 U.9 2.7 3.8 3-5 U.3 1.5
9 6.1 5.9 U.7 2.6 3.9 2.3 3.8 2.9 U.3 1.9
10 6.0 U.7 N.D. 3.9 3.9 2.3 N.D. U.3 U.2 1.2
11 5.6 6.U 5.2 U.6 3.U 1.9 3.3 U.7 U.U l.U
12 U.2 7.0 U.2 3.9 3.9 2.7 2.5 5.2 U.2 l.U
13 1+.2 U.5 3.8 3.9 3.U 2.3 2.9 3.9 3.6 0.7
11+ U.2 U.7 3.8 U.6 2.9 2.7 3.8 3.9 3.8 0.7
21 U.2 5.U 5.6 U.6 3.U 3.5 6.7 2.7 U.5 1.3
28 3.8 3.9 3.U 5.2 3.U 3.5 5.3 3.1 3.9 0.8








ORE ANTIBODY TIIREs" OP PREVIOUSLY INPECTED SHEEP TREATED WITH
CORTICOSTEROID BEFORE BEING CHALLENGED WITH ORP VIRUS - GROUP 13
Days NUMBER OP SHEEP STATISTICS
Post-
illenge 836 775 777 882 936 9k3 9U5 927 Mean s.d.
0 2 0 0 0 0 2 2 0 0.75 1.03
1 2 0 0 0 0 2 2 0 0.75 1.03
2 2 0 0 0 0 2 2 2 1.25 1.03
1+ 2 0 0 2 0 0 2 2 1.00 1.07
6 2 0 0 2 0 2 2 3 1.37 1.19
8 2 0 0 2 0 2 2 3 1.37 1.19
9 2 0 2 2 2 2 2 3 1.87 0.83
10 2 N.D. N.D. 3 2 2 N.D. k 2.12 1.12
11 2 0 2 3 2 2 2 k 2.12 1.12
12 3 0 2 3 3 2 2 N.D. 2,1k 1.07
13 3 2 2 3 3 2 2 k 2.62 o.7U
Ik 3 2 2 3 3 2 3 3 2.62 0.52
21 3 2 2 3 3 . 3 k 3 2.87 0.61+
28 2 2 2 3 k 3 k 3 2.87 0.83








TOTAL SERUM PROTEIN CONTENTS* OP PREVIOUSLY INFECTED SHEEP CHALLENGED
WITH ORP VIRUS - GROUP 11+
Days NUMBER OP SHEEP STATISTICS
Post-
)hallenge 833 ■ 780 112 378 937 91+2 91+U 920 Mean s.d.
0 77 lb 16 63 76 61 76 61+ 71.6 5.93
1 81+ 75 80 63 71 10 73 67 72.9 6.79
2 80 71 16 61+ 76 71 76 70 73.0 U.99
b 81 71 11 69 7U 67 70 66 71.1 U.70
6 78 lb 70 66 7U 65 68 67 70.2 1+.6
8 lb lb 73 71 66 66 66 66 69.5 3.85
9 77 80 72 69 70 69 71 67 71.9 1+.1+2
10 77 N.D. N.D. 69 69 67 N.D. 61+ 69.2 1+.82
11 70 76 73 67 70 71 66 66 69.9 3.52
12 80 78 72 70 78 69 70 69 73.3 1+.62
13 73 N.D. 71 71 71 70 65 61+ 69.3 3-UO
lb 73 81 7U 70 71 73 73 69 73.0 3.66
21 71 76 71 70 67 69 69 67 70.0 2.88
28 69 lb 72 69 70 69 70 68 70.1 1.96
35 lb lb 78 67 70 66 D 63 70.3 5.31
s.d. = standard deviation.
D = Died.




ALBUMIN LEVELS* OP PREVIOUSLY INFECTED SHEEP CHALLENGED WITH ORP
VIRUS - GROUP ll|.
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 833 780 772 378 937 91+2 914+ 920 Mean s.d.
0 48.50 37.50 32.50 22.10 30.20 38.30 3U.00 31.50 34.30 7.60
1 47.00 39.70 36.70 27.10 27.80 37.80 33.50 36.30 35.70 6.44
2 40.70 32.10 36.30 21.90 37.80 38.60 33.30 37.80 34.80 5.92
4 39.00 40.00 35.50 24.70 31.90 45.70 32.80 38.80 36.00 6.34
6 36.80 38.20 30.10 27.60 31.90 29.90 25.70 30.90 31.40 4.26
8 33.40 33.10 31.30 31.10 23.00 35.90 26.60 30.30 30.59 4.08
9 34.70 37.00 31.70 24.70 29.40 36.40 26.90 37.60 32.30 4.90
10 39.30 N.D. N.D. 24.70 30.90 32.90 N.D. 38.00 33.16 5.87
11 35.70 41.2 34.20 26.90 30.10 40.00 28.60 39.50 34.50 5.52
12 36.70 35.00 33.90 23.10 31.10 35.70 35.00 37.00 33.44 4.56
13 32.80 N.D. 30.40 24.00 29.30 23.80 27.30 35.40 29.00 4.33
14 34.90 42.2 33.40 21.70 35.70 29.10 29.80 35.70 32.80 6.05
21 32.80 42.30 35.40 28.00 28.20 34.30 27.40 40.30 33.60 5.66
28 30.20 40.10 42.50 29.80 26.60 39.10 26.60 40.90 34.50 6.79
35 30.10 39.30 31.90 25.70 27.30 37.90 D. 38.10 32.90 5.55
s.d. = standard deviation.
D = Died





ALPHAS-GLOBULIN LEVELS OF PREVIOUSLY INFECTED SHEEP CHALLENGED WITH
ORF VIRUS - GROUP li+.
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 833 780 772 378 937 91+2 91+1+ 920 Mean s.d.
0 3.0 3.70 3.80 3.20 3.80 3.1+0 3.00 3.20 3.39 0.31+
1 1.70 5.20 3.20 l+.l+o 3.60 1+.20 2.90 2.00 3.1+0 1.20
2 l+.oo 3.60 3.80 1+.50 1.50 6.1+0 6.00 3.50 1+. 16 1.51+
1+ 3.20 1+.30 2.10 L+.80 1+.50 1.30 1+.90 3.30 3.55 1.32
6 3.90 l+.l+o 1+.20 3.90 3.70 5.20 3.1+0 1+.70 1+.17 0.58
8 2.20 5.90 3.60 1+.20 1+.60 1+.70 2.70 3.90 3-975 1.17
9 3.10 5.6o 2.90 3.1+0 1+.90 3.1+0 1+.20 3.1+0 3.86 0.95
10 1.50 N.D. N.D. 2.70 3.1+0 5.1+0 N.D. 3.20 3.21+ l.l+i
11 2.10 3.80 2.90 2.70 3-50 5.oo 3.30 2.60 3.2b 0.89
12 3.20 5.1+0 3.60 3.50 U-70 U-80 l.l+o 3.1+0 3.75 1.21+
13 2.20 N.D. 1+. 20 1+.90 1+.30 6.30 2.60 2.60 3.87 1.1+9
11+ 2.90 5.70 3.70 U. 90 2.90 5.80 5.io 2.10 1+.11+ 1.1+2
21 2.90 3.00 3.50 2.10 3.1+0 1+.80 1+.10 1.30 3.11+ 1.10
28 3.1+0 3.70 3.60 2.10 1+.20 2.70 1+.20 2.70 3-32 0.76










ALPHA2 - GLOBULIN LEVELS OP PREVIOUSLY INFECTED SHEEP CHALLENGED
WITH ORP VIRUS - GROUP ll+.
Days NUMBER OF SHEEP STATISTICS
Post-
Challenge 833 780 772 378 937 9b2 9J+J+ 920 Mean s.d.
0 5.1+0 10.30 9.80 12.60 12.90 8.80 9.80 10.30 9.99 2.33
1 8.1+0 9.70 10.1+0 11.30 9.30 9.80 9.50 9-1+0 9.93 0.85
2 8.80 10.70 9.80 9.00 8.30 9.30 12.90 10.50 9.91 1.1+6
1+ 8.90 8.60 8.50 10.30 11.90 6.00 9.80 8.60 9.07 1.70
6 9.1+0 9.60 8.1+0 9.20 8.90 9.80 8.10 11.1+0 9.35 1.01
8 7.1+0 11.80 8.70 9.20 10.50 8.00 8.00 10.50 9.26 1.53
9 8.50 12.90 10.10 11.00 9.10 9.60 9.20 9.1+0 9.97 1.1+0
10 7.70 N.D. N.D. 11.70 9.60 8.10 N.D. 9.00 9.22 1.57
11 7.00 9.90 6.50 8.10 9-80 7.10 8.60 8.60 8.20 1.27
12 8.80 11.70' 7.90 9.10 11.70 8.90 5.60 11.70 9.1+2 2.18
13 10.20 N.D. 9.20 8.50 9.30 10.50 7.20 9.70 9.23 1.11
11+ 7.30 11.1+0 9.60 9.10 8.60 9.50 8.70 11.70 9.^9 1.1+6
21 8.60 10.60 7.90 11.90 9.1+0 8.20 8.20 9.1+0 9.27 1.38
28 9.60 9.60 5.80 9-00 9.10 7.50 8.1+0 10.20 8.65 1.1+2
35 10.30 io.l+o 11.70 8.10 11.20 8.00 D 9.I+0 9.87 1.1+1+
s.d. = standard deviation.




BETA-GLOBULIN LEVELS* OF PREVIOUSLY INFECTED SHEEP CHALLENGED WITH
ORF VIRUS - GROUP 11+.
Days NUMBER OF SHEEP STATISTICS
Post-











3.10 7.I+0 7.60 6.30 5.30
3.1+0 5.20 6.1+0 3.20 7.90
6.80 8.60 3.80 5.20 6.80
7.20 6.1+0 3.50 1+.10 8.90
5.50 6.60 8.1+0 7.20 7.1+0
6.70 6.60 8.70 7.80 7.90
6.10 8.10 6.50 1+.10 7.00
5.00 N.D. N.D. 3.1+0 5.50
1+.90 6.10 5.80 1+.70 5.60
6.70 7.00 6.50 5.60 6.20
5.00 N.D. 5.70 5.70 5.70
5.70 5.70 5.20 5.60 1+.30
5.50 6.00 5.70 1+.90 6.00
7.80 5.90 1+.30 ^.90 6.30





























6.00 D 2.50 5.30 1.76
■*
s.d. = standard deviation.






GAMMAGLOBULIN LEVELS OF PREVIOUSLY INFECTED SHEEP CHALLENGED WITH




NUMBER OF SHEEP STATISTICS
772 378 937 9U2 9UU 920 Mean s.d,
0 20.0 11+. 7 21.9 18.9 21.2 13.1+ 21+.2 15.5 18.7 3.8
1 23.5 15.0 23.1 17.0 20.0 ll+.O 21.8 ll+. 8 18.7 3.9
2 23.9 16.1+ 22.7 23.8 21.2 12.9 18.0 11+. 7 19.2 1+.3
1+ 21+.1+ 12.1 21.3 21+.7 19.3 11.1+ 16.8 13.2 17.9 5.1+
6 21.2 11+.7 18.9 17.8 22.3 11+.3 25.6 16.1 18.9 1+.0
8 25.2 16.9 20.1+ 18.1+ 19.7 11+.6 25-3 16.1+ 19.6 3.9
9 21+. 6 16.9 20.9 25.1+ 19.6 15.1 21+.0 13.5 20.0 1+.5
10 23.9 17.0 N.D. 26.1 19.2 16.1 N.D. 11.6 19.0 5-3
11 21.7 15.3 23.3 21+. 9 21.0 15.0 21.9 12.5 19.5 1+.5
12 21+.7 18.6 20.2 28.7 21+.1 15.1 21+. 5 13.7 21.2 5.2
13 22.6 18.0 21.2 27.6 22.8 23.1 23.1+ 11+.2 21.6 l+.o
lb 22.6 16.2 22.1+ 28.7 20.0 21.8 21.8 16.5 21.3 3-9
21 21.1+ 13.6 18.1+ 23.1 20.2 12.3 22.6 11.1+ 19.9 1+.8
28 19.9 11+. 8 16.3 23.6 23.8 13.7 21.7 11.6 18.3 1+.7
35 22.1 22.3 21+.1 25.7 21.0 16.6 N.D. 1.00 20.3 5.3
s.d. = standard deviation.
N.D. = Not Done.
* = g/l.
APPENDIX TABLE 67.




Challenge 833 980 772 378
NUMBER OF SHEEP STATISTICS
937 9^2 9UU 920 Mean s.d.
0 lii.it 10.8 10.1 13.9 15.5 7.9 llt.l 9.9 12.1 2.7
1 12.8 8.5 10.it 13.1 9.5 ON•O1—1 13.9 11.1 11.3 1.9
2 16.3 7.3 11.2 10.5 10.6 6.9 9.0 12.5 10.5 3.0
h 11+.3 9.6 10.8 10.7 13.0 6.9 13.2 7.it 10.7 2.7
6 13.7 7.3 11.7 11.8 10.6 6.0 lit. 9 15.2 ll.it 3.it
8 13.1+ 10.8 12.3 12.8 11.8 7.9 13.2 lit. 8 12.1 2.1
9 lit. 9 9.6 13.5 18.8 lit. 5 6.9 15.8 13.8 13.5 3-7
10 lit. 7 6.3 N.D. 20.1 16.9 6.9 N.D. lit. 8 13.3 5.5
11 111. 7 111.7 lit. 6 lit.8 16.3 6.9 20.0 lit.8 lit. 6 3.6
12 lii.5 lii.7 13.6 llt.l 13.3 6.9 21.3 11.5 13.7 U.o
13 lil.0 lit. 2 13.8 lit. 8 lit. 8 8.5 10.8 12.5 12.9 2.2
lit lii. 7 llt.O 13.0 15.0 lit. 7 12.0 11.6 12.it 13.it 1.3
21 lit. 8 13.2 17.0 lit.9 lit.it 12.0 10.0 10.it 13.3 2.it
28 lii.5 13.0 11.6 15 lit. 8 12.0 lil.O 10.5 13.2 1.7
35 lii. 3 13.it lit. 9 15.2 13.1 13.8 D 10.5 13.3 1.7
s.d. = standard deviation.




IgG2 LEVELS OP PREVIOUSLY INFECTED SHEEP CHALLENGED WITH ORE VIRUS -
GROUP lk.
Days NUMBER OP SHEEP STATISTICS
Post-
Challenge 833 780 772 378 937 91+2 91+1+ 920 Mean s.d.
0 5.0 6.1 8.1+ 7.2 1.3 2.6 3.8 6.8 5.1 2.1+
1 3.3 5.2 6.3 7.2 0.1+ 2.2 3.3 6.3 1+.3 2.3
2 3.7 3.1 1+.3 6.3 0.8 2.2 2.8 9.3 l+.l 2.6
k 3.3 5.2 5.6 7.2 1.3 1.8 2.8 5.7 l+.l 2.1
6 h.h 5.6 6.3 11. h 1.3 1.8 3.8 8.7 5.1+ 3.1+
8 3.9 6.1 5.6 8.6 2.7 2.2 3.3 8.7 5.1 2.5
9 5.5 6.1 7.0 5.8 3.3 2.6 3.8 7.7 5.2 1.8
10 1+.1+ 5.6 N.D. 1+.6 2.7 2.2. N.D. 7.1+ 1+.5 1.9
11 3.9 6.1 8.1+ 7.7 2.7 1.8 3.8 6.3 5.1 2.1+
12 3.3 6.1 7.0 6.7 3.3 2.2 2.1+ 6.3 1+.7 2.0
13 2.8 7.9 5.6 7.7 2.7 2.2 2.1+ 8.7 5.0 2.8
11+ 2.8 11.5 5.6 8.7 3.3 2.6 3.3 9.3 5.9 3.5
21 h.h 7.9 5.6 8.2 1+.1+ 3.5 3.3 9.3 5.8 2.3
28 h.h 5.6 6.3 7.7 h.h i+.o 2.1+ 9.3 5.5 2.2
33 k.k 5.2 5.0 7.7 1+.1+ 2.6 D 9.3 5.1+ 2.1
s.d. = standard deviation.





IgM LEVELS' OP PREVIOUSLY INFECTED SHEEP CHALLENGED WITH ORE
VIRUS - GROUP 11+
Days NUMBER OP SHEEP STATISTICS
Post-
Challenge 833 780 112 378 937 91+2 91+1+ 920 Mean s.d.
0 6.0 5.6 h.l 3.2 1+.9 3.1 1+.2 3.1 1+.3 1.1
1 6.0 h.9 5.2 3.2 2.9 3.1 5.2 3.1 1+.2 1.2
2 6.0 h.h 1+.3 2.0 3.1+ 2.7 1+.2 2.1+ 3.7 1.3
1+ 5.6 h.h 5.2 3.2 3.9 2.3 3.3 3.9 l+.o 1.1
6 5.6 5.1+ 6.6 3.9 3.1+ 2.3 1+.2 3.9 h.h 1.1+
8 5.6 U.9 1+.7 3.9 h.h 2.3 1+.7 1+.8 h.h 1.0
9 6.5 3.9 5.2 3.2 h.9 2.7 1+.7 3.1 1+.3 1.3
10 6.0 1+.1+ N.D. 3.9 3.9 3.6 N.D. 3.5 1+.2 0.9
11 1+.2 5.U 5.2 3.9 2.9 3.6 h.l 3.9 1+.2 0.9
12 1+.7 1+.9 1+.3 3.9 2.9 3.6 6.1 3.9 1+.1+ 1.1
13 1+.2 5.0 5.2 3.2 2.9 3.6 3.3 3.9 3.9 0.8
11+ h.l 5.1+ 5.2 5.2 2.1+ l+.o 1+.2 3.9 h.h 1.0
21 h.l 5.1+ 5.2 2.6 2.9 3.6 5.2 3.5 1+.2 1.2
28 3.8 5.1+ 5-2 6.7 2.9 2.7 1+.7 3.9 1+.1+ 1.3
33 1+.7 h.h h.l 1+.6 2.9 l+.o D 3.9 l+.l 0.6
s.d. = standard deviation.




ORE ANTIBODY TITHES OP PREVIOUSLY INPECTED SHEEP CHALLENGED WITH
ORP VIRUS - GROUP llu
Days NUMBER OP SHEEP STATISTICS
Post-
Challenge 833 378 780 772 937 9U2 9bb 920 Mean s.d.
0 3 2 2 3 0 2 0 2 1.75 1.16
1 3 2 2 3 0 2 0 2 1.75 1.16
2 3 2 2 3 0 2 0 2 1.75 1.16
b 3 2 d. 3 2 2 2 2 2.25 0.U6
6 3 3 2 b 2 2 2 3 2.62 0.7U
8 4 3 3 b 3 2 2 3 3.0 0.76
9 b 3 3 b 3 2 3 3 3.12 0,6b
10 b 3 3 b 3 3 3 3 3.25 0.U6
11 5 3 b b b 3 3 3 3.62 0.7b
12 5 3 . b b b 3 3 3 3.62 0.7b
13 5 3 b 5 b 3 3 3 3.75 O.89
lh 5 b b 5 b 3 b It U. 12 0.6b
21 5 b b 5 b 3 b b it. 12 0.6b
28 5 b b 5 b 3 b b it. 12 0.6b
35 it 3 5 1+ 3 3 D b 3.62 0.7b
standard deviation.
Died
Not Done.
